{ "schema": "longview.chain/1", "public_key_ed25519_hex": "55140ddd4034c2765e6169600931eb1dec0641ce2109fc1e7f02abd8e054e8a7", "entry_count": 20, "entries": [ { "seq": 0, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "GENESIS", "payload_sha256": "8e69b660bf4f4f3a47cdcece82e48b9b79a03c2daa2bf5d8604bf12869b25f96", "prev_hash": "0000000000000000000000000000000000000000000000000000000000000000", "chain_hash": "224b53285d91df6b8069f21738b98e0c6af7a742587079ff47e6ad07e6df7a74", "sig": "65b5647c2dd25df2e3425ad624a012ba2d8e9956ed12960bb8da8738b229814d5f0858399bf31f0c20a42a66ec287c3b4dfb9e2012e1b69fb10f5b275f33b30d" }, { "seq": 1, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "988e294be026fc775dd467bd3d5ca0e48e415bd46d4cbb4377b8beadd30bc7d5", "prev_hash": "224b53285d91df6b8069f21738b98e0c6af7a742587079ff47e6ad07e6df7a74", "chain_hash": "ba6eab1f56e0ab69bf536e7d8c341f513dfe95c6e1b61b112f406497a7188210", "sig": "114bb6b74f431d42d540259f6bf920e8beafc7c496d6ad2b5918075d1a3d8ed9e2d0ee1f8a2801c65e6e2c098fe8eb346673296ed736037886d91135db2d310d" }, { "seq": 2, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "0288f016ece01fc310134673e9b6958b8219ee528c73f87a18d5d48a6a39b0a7", "prev_hash": "ba6eab1f56e0ab69bf536e7d8c341f513dfe95c6e1b61b112f406497a7188210", "chain_hash": "63870b1a70ec69230b75a79e2c16583d445650c3653e4a3ac917ddc5e94021b4", "sig": "5707abaaa59f7d8e02c8c1e72bbda1e741c6db04a71fe8287f2e6c71c367fd04b4602da9b71f1725be525036598c2353c1fab7e4f59a49d9a7850a2c2a833a0e" }, { "seq": 3, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "a5de8ec4451174efe5239731bb58d11fe36b4c95d767d7f7c7d84ccede27c432", "prev_hash": "63870b1a70ec69230b75a79e2c16583d445650c3653e4a3ac917ddc5e94021b4", "chain_hash": "e1931e150e112a8e9a3706b14dab0e2918ba918adceefc0e68049554ae799fa5", "sig": "a9cafe8efd9ac38b00516b73589c11aed01e156d64e8a81a77fcdcc1334f9416d627a9795461f61fc271ec79cc51a1b086e782d1948c68abc976f6d30021a50c" }, { "seq": 4, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "24640debe0f5c720ed2a74a4a76b67eaac64f9dfd84d58ba578b4d69d0c73d23", "prev_hash": "e1931e150e112a8e9a3706b14dab0e2918ba918adceefc0e68049554ae799fa5", "chain_hash": "99f5f82bd02f11df4490eb4e9c55ed1229083d4894034bc79ab3873ebd563843", "sig": "d3faa3d1bf962fba9338bc03884ffa2a96eea46217411aae34af00cbfb05bb6acfab73fe255228281150f7637d6a5f2b9fdcfbade873a48d6b669842342b6d05" }, { "seq": 5, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "38dd7bbbd0cab8395a43a34a7f5f9e7b1b6976f0b22988d58d77a71c712baf00", "prev_hash": "99f5f82bd02f11df4490eb4e9c55ed1229083d4894034bc79ab3873ebd563843", "chain_hash": "99310f72438eb08aff50d1ba9d7ddb444b90789b9e828de092ec0f9997203304", "sig": "721c82d49341ced75a4bdcae2e5a29cf4aab083dd7ffcaa65cb877f16f4893335d5a01b8d12e5e9dc15482f7945b351957bdd9fa262e8ed5b146d026d520250d" }, { "seq": 6, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "2ab746d6da92407326ac475ab2c43747ccc5bd31752d95dcb6c2e8c777dde6ee", "prev_hash": "99310f72438eb08aff50d1ba9d7ddb444b90789b9e828de092ec0f9997203304", "chain_hash": "a4d0ed245c222a6249db2dfe0ae1c1e8e72fd33665997cd46056b64137ea5f4c", "sig": "c9a7a8d5647c95ae837a73b9091c8953b8fc206946e43305b80da07587d90c163605b7bfb94d73a9736097668a64cce59cc82a078b03f06c82791475b121d301" }, { "seq": 7, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "8f34740984bce478a39ed6162cc3a1e10d62aa2dbda201ef163d089b9d162066", "prev_hash": "a4d0ed245c222a6249db2dfe0ae1c1e8e72fd33665997cd46056b64137ea5f4c", "chain_hash": "3816fdf9855819af258ec0b0d5ce74c2a0d5f8c1bb4615bf262c80fa0581097a", "sig": "a509d2a7bacbe156fb3f07be181b1eec387cd503091548abd0031eb90afcb25468672cea147ad50634571d39b9205b102c14f84de7a25697f4865c229910990a" }, { "seq": 8, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "b225c1b29dda089724f82c1b29186b32f7159dcb1a7966908711f14aa2662afa", "prev_hash": "3816fdf9855819af258ec0b0d5ce74c2a0d5f8c1bb4615bf262c80fa0581097a", "chain_hash": "61fbf4272a482df9da19a756b278c1db9ade9a1c0cc311f65cf2d7adb5503e32", "sig": "1ad4e7e31aafa0321bd8ebd51f83ac693772cd62f2f633f78014b4ca1595c47e75239df0389c107f9bb693f1a00323ebf72f377dd734fb9902bb6d35097a9704" }, { "seq": 9, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "1a63a8d0f2a82f3aa066515b75015172d2b019a83416fcc1abac2457ea4eaea5", "prev_hash": "61fbf4272a482df9da19a756b278c1db9ade9a1c0cc311f65cf2d7adb5503e32", "chain_hash": "df7655f0224f8f9b0c6819456079c19278748c8aaacd2a68289b09b0d9cfa36d", "sig": "74204fd1323312927e05a2ee7e73c3bbeb2c29611b4e3383dcfcba5d3c562b8fc1f3098bf878694d5b9f22f1274c7777476e7eecb0e70aedd411cc1956a93006" }, { "seq": 10, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "c30e1dcacf7b48483313650aa66d3c4a3cf6bff16c971e784d60895f9d30eba9", "prev_hash": "df7655f0224f8f9b0c6819456079c19278748c8aaacd2a68289b09b0d9cfa36d", "chain_hash": "4c8bd4ee27246a3bbcb74333550139e8d164cddb01297d582876a0eba35d4dac", "sig": "a019c8b0a6dd3ff17fbdb1fdf245e767e822e0301a22a41bb19f31b993d000dae426bbc6a84893fd31bee3899fc2a98ca60b0bb660680464dd4fa056e02b3809" }, { "seq": 11, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "ab559f3351d54604a333da5604727b1bde92c105e2ebd031580887739f77b5b2", "prev_hash": "4c8bd4ee27246a3bbcb74333550139e8d164cddb01297d582876a0eba35d4dac", "chain_hash": "be92024ada55ebf0a4d583588e66ee664dfa8bb4f882020221a60a61cef2b539", "sig": "394c1d2d1ca4132da5c9cd89986928cdac0e5772e74e9a1f0bab62260c454ecd978cf6d1829c2dff11600f74b8caa43bc0c0caf5e7ac55fd4abcc5625e058f0f" }, { "seq": 12, "ts_utc": "2026-07-23T21:04:24+00:00", "type": "WATCHLIST_NOTE", "payload_sha256": "0bc1235288706ad1d9ef43ad02ec40b27cb8c4449a45f4f866f140f4f0037793", "prev_hash": "be92024ada55ebf0a4d583588e66ee664dfa8bb4f882020221a60a61cef2b539", "chain_hash": "655d13b6fb96f28771c419db98d0ab84aa331e34d1c151bb8bdd6e150946fbb2", "sig": "aa379c817583808919b3744c010c079887cf643249d9a5485bdbc0a64aa586f333f5a1179a98fc81dd840aa9044922e4db663c08313c77bebbe224f8f1cf520a" }, { "seq": 13, "ts_utc": "2026-07-23T21:05:17+00:00", "type": "SNAPSHOT", "payload_sha256": "d3fdb5daf992a7176dbcbe94cb5363a7acdd0c97400d132e2db300738b93f5c3", "prev_hash": "655d13b6fb96f28771c419db98d0ab84aa331e34d1c151bb8bdd6e150946fbb2", "chain_hash": "ba666b305ab5fe2430196c8a90f7e3a95301c3434839f116608db44cceca3240", "sig": "aafab32b93d37f84ddb91f2a0c0d9a3063d76aa01a4de6fd89a304319c1ee5e34060d3ae4c09f98ded6fca4cf67d47f6b56243b5bd686e99bd41acf7a3cac902" }, { "seq": 14, "ts_utc": "2026-07-29T06:19:46+00:00", "type": "SNAPSHOT", "payload_sha256": "756723f8a842c64b21ad9c55189d028705da303fd83264eede747553ecd9116c", "prev_hash": "ba666b305ab5fe2430196c8a90f7e3a95301c3434839f116608db44cceca3240", "chain_hash": "da18df991324ed1c02371aa7f8d9edabcce9b32a756ed1f3edc8ba577bcfccb2", "sig": "0d0a91333f2ef440b3c7c8188b67b5a51317b553f60f6d5a4c15629a3302bb1e7cd3f5463366c0b8d484e9b274ad02fca3f18de8112e630ac330d88ac08b1102" }, { "seq": 15, "ts_utc": "2026-07-29T06:52:28+00:00", "type": "METHOD_CHANGE", "payload_sha256": "385f790c52c4f78072807d44698f72845c9e0ae3833476b96d92d8a7ba124dfd", "prev_hash": "da18df991324ed1c02371aa7f8d9edabcce9b32a756ed1f3edc8ba577bcfccb2", "chain_hash": "ddf3beee35640615cafe3772f0fe2641daa8386a8b764690cb184cca06ee3357", "sig": "2850f1595add2a45cc6b9bcd9fc36039aa4a930a864f0fe3dd85ae71cdc633ac3e4d53ce8ea6585a0b0753456538ede4a36fd90dda55d5e4151eba6ada2d7e03" }, { "seq": 16, "ts_utc": "2026-07-29T09:07:09+00:00", "type": "SNAPSHOT", "payload_sha256": "3e45184f8799dd05ee1345027bbf255536fb5accdf36ce42976ee7ad2bef9aef", "prev_hash": "ddf3beee35640615cafe3772f0fe2641daa8386a8b764690cb184cca06ee3357", "chain_hash": "1562f95df7e77b613d40e732ff6a07754c67a45f8c89d24c56a0ec14099b642c", "sig": "2d2e104bef5f2770eb000fcc27e8ff2c33f68b29074f7c3e1b7347d2651947b7023f014a2e1b35d50550df73481c87250c7af6bea9cea3e17dfeaf474658100e" }, { "seq": 17, "ts_utc": "2026-07-30T02:10:09+00:00", "type": "SNAPSHOT", "payload_sha256": "47901194067bbef57bf96895c1d4496d765e5045f5f5d3a8776b434adadc9cc5", "prev_hash": "1562f95df7e77b613d40e732ff6a07754c67a45f8c89d24c56a0ec14099b642c", "chain_hash": "861960aba731dec4a30e6b09dac16666c13d02ccb7fad66bd985c9e83160c780", "sig": "b2bb558803787c674cd453fbd9966347a0d64aa13737c1329b0aeffa6f7f1f1ed576af1b6126be1767e38f8ca26b5a0f2e6707b7d66f9ed5c70f540328d49004" }, { "seq": 18, "ts_utc": "2026-07-31T02:10:10+00:00", "type": "SNAPSHOT", "payload_sha256": "f9fe79d5960ecfb597fc0ac17d8c7a9732ed89b1b41e96d5d329d9817ff5e0ed", "prev_hash": "861960aba731dec4a30e6b09dac16666c13d02ccb7fad66bd985c9e83160c780", "chain_hash": "10a37d2ff10ca0ccec02e4b3f4780e972f1be2b5ba7641d726d7a74019fdc0ff", "sig": "597e967c0f90d6be2aa206795cc7691107df6aa08c49508ec3238fee0a33289876b39efbfb0dd6e5045822e0b724e79e229b3856af1fcbef966c67df9967490d" }, { "seq": 19, "ts_utc": "2026-08-02T02:24:35+00:00", "type": "SNAPSHOT", "payload_sha256": "f9a747e124919df0053c82cf7d344caddfd7dc96b4f40e4f1f71211440ba6fca", "prev_hash": "10a37d2ff10ca0ccec02e4b3f4780e972f1be2b5ba7641d726d7a74019fdc0ff", "chain_hash": "595c7d90b35034108772380153ed235ce081303788a44473c9b6b87fb8db8927", "sig": "2c9d7601a35070b3607d543fd7e79ae031d2a1df4aeda0dedaf27d5a038c0470cca058a8fc40a228dbd7860e91597dbae81cc9c94c40a7c72d54757568232d01" } ], "payloads": { "8e69b660bf4f4f3a47cdcece82e48b9b79a03c2daa2bf5d8604bf12869b25f96": { "kind": "genesis", "methodology_sha256": "1632d582f9f158dadb50f9fb8576779b14b6f40bab8851c05b5df44ecb716140", "methodology_version": 1, "public_key_ed25519_hex": "55140ddd4034c2765e6169600931eb1dec0641ce2109fc1e7f02abd8e054e8a7", "publication": "Longview", "publisher": "Canli / AlphaC", "statement": "Long-horizon research on emerging industries, published into an append-only, Ed25519-signed record. Forward-only from this event. Losers included. Forever." }, "988e294be026fc775dd467bd3d5ca0e48e415bd46d4cbb4377b8beadd30bc7d5": { "actionable_below": 128.42, "company": "Celestica Inc.", "kind": "watchlist_note", "markdown": "## Thesis\n\nCelestica is the purest large-cap manufacturing play on hyperscaler AI networking and rack integration \u2014 CCS segment revenue grew 76% y/y in Q1 2026 and management guides $19.0B for 2026 \u2014 and we expect revenue to compound roughly 16%/yr through 2031. But at $339 the stock already discounts near-flawless execution: our base case is worth roughly $160 in present value against a $339 price, so this publishes as a watchlist thesis, not a buy. The operating thesis is falsified if CCS growth stalls to zero for two consecutive quarters or a top-three hyperscaler program is lost; the valuation becomes actionable below roughly $170.\n\n## Why Now\n\nThe inflection is in the filings, and it is steep. Q1 2026 revenue was $4,047.0M, up 53% from $2,648.6M a year earlier (Q1 2026 earnings release, 8-K exhibit filed 2026-04-27, for the 10-Q period ended 2026-03-31). Inside that, the Connectivity & Cloud Solutions (CCS) segment \u2014 hyperscaler networking switches plus AI/ML compute and storage \u2014 did $3.24B, up 76% y/y, with segment margin expanding to 8.6% from 8.0%. Hardware Platform Solutions, Celestica's own-designed platforms rather than build-to-print work, reached roughly $1.7B in the quarter, up 63%, meaning Celestica-designed hardware is now about 42% of total company revenue. Management raised the 2026 outlook from $17.0B to $19.0B in revenue and from $8.75 to $10.15 in adjusted EPS in a single quarter \u2014 a $2B guide-up 90 days after the prior guide was set (Q4/FY2025 release, 2026-01-28; Q1 2026 release, 2026-04-27).\n\nThe full-year 2025 numbers show this is acceleration, not a one-quarter blip: FY2025 revenue was $12.39B, up 28% from $9.65B in 2024, with Q4 2025 alone at $3.65B, up 44% y/y (Q4/FY2025 press release, 2026-01-28; FY2025 Form 10-K filed 2026-02-27). Sequencing the quarterly growth rates \u2014 +28% for FY2025, +44% in Q4 2025, +53% in Q1 2026, with Q2 2026 guided to $4.15\u20134.45B \u2014 growth is speeding up as AI programs ramp, not decaying.\n\nThe demand side is corroborated by the customers' own filings: the big four hyperscalers (Microsoft, Amazon, Alphabet, Meta) have guided roughly $700\u2013725B of combined 2026 capex, up ~77% from about $410B in 2025, with roughly three-quarters of it AI-related. Celestica also disclosed a new design win in the Q1 release \u2014 a 1.6-terabit co-packaged-optics Ethernet switch for a hyperscaler's AI scale-out network, ramping production in 2027 \u2014 which extends program visibility into the next networking generation. On 2026-04-27 the company upsized its credit facility to approximately $2.5B explicitly to fund the working capital of this scale-up.\n\nThe reason to write this now rather than later: the stock has corrected roughly 28% from its 52-week high of $474 to $339, Q2 2026 results land within days of publication, and the honest question is whether the drawdown has created a five-year entry point. Our math below says it has not \u2014 yet.\n\n## Business Quality\n\nCelestica has spent a decade migrating from commodity electronics assembly toward an ODM model, and the mix shift is now the story. HPS \u2014 platforms Celestica designs itself, primarily networking switches and storage systems for hyperscalers \u2014 is ~42% of revenue and growing 63% y/y. That design layer is why CCS segment margin runs at 8.6% while traditional EMS competitors (Flex, Jabil, Benchmark) operate at 4\u20135% operating margins. Gross margin is still thin at 10.8% (Q1 2026: $437M gross profit on $4,047M revenue) \u2014 this is manufacturing, not software \u2014 but returns on capital are strong because the balance sheet is light: net debt of roughly $0.4B against annualized net earnings of ~$850M, and Q1 2026 GAAP net margin of 5.2%.\n\nThe moat is execution and co-design entanglement rather than pricing power. Winning an 800G or 1.6T switch program means years of joint engineering with the hyperscaler's silicon and thermal roadmap (the new CPO win involves co-packaged optics and liquid cooling); those programs do not move to a competitor mid-generation. The counterweight is brutal customer concentration: the FY2025 10-K discloses that the top ten customers were 79% of revenue and three CCS customers individually represented 32%, 14%, and 12%. These customers are far larger than Celestica, dual-source deliberately, and reset pricing at every generation transition. Celestica's margin gains to date suggest it is winning more value per box, but there is no world where it accrues pricing power over Microsoft or Meta-scale buyers.\n\nCapital allocation has been shareholder-aligned: no dividend, consistent buybacks (diluted weighted-average shares fell from 116.9M to 115.7M y/y even during a capex ramp), and debt used sparingly. Cash generation is the soft spot in hypergrowth \u2014 2026 free cash flow is guided to just $500M on $19B of revenue (2.6%), because receivables ($3.17B) and inventory absorb cash as programs ramp. That is acceptable while growth is funded at high incremental returns, but it means the equity's cash yield today is ~1.3%, and the FCF margin must roughly double post-ramp for the valuation to work on cash flow terms.\n\nCompetitively, Celestica sits in the strongest niche of the AI-hardware food chain below the chipmakers: white-box switches and integrated racks are gaining share from branded networking (Cisco, Arista lose share to ODM-direct at hyperscalers), and Celestica is the western-listed leader of that trade versus Taiwanese rivals (Accton, Quanta, Wiwynn, Foxconn). The durable risk is that value migrates again \u2014 co-packaged optics pushes more content into silicon vendors, and hyperscalers could take switch design fully in-house the way they took server design.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $13,788M, 115.7M diluted shares, net debt of $394M, and a share price of $339.10. Sources:\n\n- Q1 2026 earnings release with condensed FS (8-K exhibit, filed 2026-04-27; period ended 2026-03-31) \u2014 revenue $4,047.0M (+53% y/y); CCS segment $3.24B (+76%), segment margin 8.6%; HPS ~$1.7B (+63%); diluted weighted-avg shares 115.7M; cash $378.0M; borrowings under credit facility and finance lease obligations $772.4M ($25.9M current + $746.5M non-current); net earnings $212.3M\n- Q4/FY2025 press release (2026-01-28) and FY2025 Form 10-K (filed 2026-02-27) \u2014 FY2025 revenue $12.39B (+28% vs $9.65B in 2024); Q4 2025 revenue $3.65B (+44% y/y); top-10 customers 79% of FY2025 revenue; three CCS customers at 32%, 14%, and 12% of total revenue\n- TTM revenue construction: FY2025 $12,390M \u2212 Q1 2025 $2,648.6M + Q1 2026 $4,047.0M = $13,788.4M\n- Share price $339.10 at close 2026-07-23 (GuruFocus market data; 52-week range $153.11\u2013$474.03); implies market cap ~$39.2B, EV ~$39.6B, 2.87\u00d7 EV/TTM sales, ~33\u00d7 2026 guided adjusted EPS of $10.15\n- 2026 guidance (Q1 2026 release, 2026-04-27): revenue $19.0B, adjusted EPS $10.15, adjusted operating margin 8.1%, free cash flow $500M; credit facility upsized to ~$2.5B on 2026-04-27\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (6%): AI capex bust combined with loss or insourcing of a top-three hyperscaler program (top customer alone is 32% of revenue); CCS shrinks back toward 2024 scale and the market pays a trough EMS multiple. $100 is ~29% of the current price and ~13\u00d7 a bust-case ~$7-8 EPS.\n- **Bear** (24%): 2026 lands near guide but hyperscaler capex digests in 2027-28 (the 77% y/y capex surge proves unsustainable); revenue dips then partially recovers to ~$17.6B by year 5. Exit at 0.8\u00d7 EV/Sales \u2014 the upper end of Flex/Jabil's historical range, credited for Celestica's better margin structure. FV $118/share, PV $73.\n- **Base** (50%): AI infrastructure buildout continues but decelerates: $19B in 2026 (guided) fading to single-digit growth by 2030, reaching ~$29B in year 5. FCF margin doubles from today's 2.6% to 6% as working-capital absorption ends (in line with guided ~6.2% adjusted net margin); 17\u00d7 P/FCF exit matches mature high-quality manufacturers (Flex/Jabil trade 12-16\u00d7, premium for ODM mix). Modest continued buybacks. FV $258/share, PV $160 \u2014 below today's $339.\n- **Bull** (20%): Hyperscaler capex keeps compounding through 2030; Celestica holds share through the 1.6T/CPO generation and full-rack integration scales, reaching ~$40B revenue in year 5 with 7% FCF margin (implied exit ~1.4\u00d7 sales at 20\u00d7 FCF). FV $511/share, PV $317 \u2014 an 8.5%/yr IRR from today's price even in the bull case.\n\n## Kill Conditions\n\n1. CCS segment revenue growth is zero or negative year-over-year for two consecutive quarters (10-Q segment note; baseline +76% in Q1 2026) \u2014 the AI-driven growth engine has stalled.\n2. Any of the three CCS customers disclosed at 32%, 14%, and 12% of FY2025 revenue (FY2025 10-K) falls below the 10% disclosure threshold in a subsequent 10-K without an offsetting new 10% customer, or the company discloses transfer/insourcing of a major hyperscaler program.\n3. Combined quarterly capex of Microsoft, Amazon, Alphabet, and Meta declines year-over-year for two consecutive quarters (public earnings releases) \u2014 the theme's funding source is contracting.\n4. Management cuts the annual revenue outlook by 10% or more in any quarterly update (e.g., 2026's $19.0B guided below $17.1B).\n5. CCS segment margin prints below 7.0% for two consecutive quarters (vs 8.6% in Q1 2026) \u2014 evidence hyperscalers are clawing back the ODM margin premium.\n\n## Risk Register\n\n- Customer concentration \u2014 severe: top customer is 32% of revenue, top three are 58% (FY2025 10-K); one insourcing or dual-sourcing decision resets the model in a single quarter.\n- AI capex cyclicality \u2014 severe: big-4 hyperscaler capex is guided up ~77% y/y to ~$725B in 2026; ~80% of Celestica's revenue rides on spending growing faster than the customers' AI revenues, a gap the market is already questioning.\n- Valuation \u2014 severe: at 2.87\u00d7 EV/TTM sales and ~33\u00d7 2026 adjusted EPS for a 10.8%-gross-margin manufacturer, multiple compression alone can produce large losses even if operations execute (the stock is already 28% off its $474 high).\n- Technology value migration \u2014 moderate: co-packaged optics shifts content toward silicon/optics vendors; Celestica's 1.6T CPO win (ramping 2027) mitigates but does not eliminate the risk that the next generation carries less manufacturable value.\n- Competition \u2014 moderate: Accton, Quanta, Wiwynn, Foxconn in white-box networking and racks; hyperscalers deliberately dual-source and re-bid at each generation.\n- Cash conversion \u2014 moderate: 2026 FCF guided at $500M on $19B revenue (2.6%); receivables of $3.17B and ramp inventory absorb cash, and the thesis requires FCF margin to roughly double post-ramp.\n- Tariffs/geopolitics \u2014 moderate: management assumes customers keep absorbing tariff costs (Q1 2026 release assumptions); a change in that pass-through breaks the margin structure.\n\n## Theme Position\n\nCelestica's theme exposure is about as direct as the public markets offer outside the chipmakers. The CCS segment \u2014 hyperscaler networking switches, AI/ML compute racks, and storage \u2014 was $3.24B of $4.05B total revenue in Q1 2026, exactly 80% of the company, growing 76% y/y with Enterprise (AI/ML compute) up 101% and Communications (800G/400G switch ramps) up 69%. Within that, ~$1.7B per quarter is HPS: hardware Celestica itself designed, sold to hyperscalers building AI data centers. Strictly, some CCS revenue is legacy networking rather than AI, so \\\"~80% AI-exposed\\\" is the ceiling, not a precise floor \u2014 but management attributes essentially all segment growth to AI/data-center programs. The remaining 20% (ATS: aerospace/defense, industrial, health tech) was flat y/y and is diversification ballast.\n\nAlternatives considered. **Fabrinet (FN)** \u2014 purer optics exposure to the same buildout, but concentrated in one customer (Nvidia optical transceivers) and trades at a similar premium; it swaps Celestica's hyperscaler concentration for single-vendor concentration without a cheaper price. **Vertiv (VRT)** \u2014 power and cooling is the least substitutable layer of the AI data center, but the market figured that out first; it has re-rated harder than Celestica and fails the same valuation gates by a wider margin. **Flex (FLEX) / Jabil (JBL)** \u2014 meaningfully cheaper (~0.7-1.2\u00d7 EV/S), and Flex has a real data-center power business, but AI-exposed revenue is diluted to an estimated 20-40% of the company; they are cheaper because they are less of the thing this theme is about. Celestica was chosen as the highest-purity, highest-growth expression of the ODM-networking trade \u2014 which is precisely why its price already reflects it.\n\n## Benchmark\n\nBeating means CLS total return from publication exceeds QQQ total return over the same 5-year window. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Combined 2026 capex plans of the big-4 hyperscalers (Microsoft $190B, Amazon ~$200B, Alphabet $175-185B, Meta up to $145B) total roughly $700-725B, up ~77% from ~$410B in 2025, with ~75% AI-related (company guidance compiled by CNBC 2026-02-06 and Tom's Hardware, Feb 2026). Company-level confirmation: Celestica CCS segment revenue +76% y/y in Q1 2026 (8-K exhibit filed 2026-04-27).", "company": "Celestica Inc.", "confidence_notes": "Verification status: TTM revenue ($13,788.4M) is computed exactly from press-release figures (FY2025 $12,390M \u2212 Q1 2025 $2,648.6M + Q1 2026 $4,047.0M), all cross-checked against the SEC-filed condensed statements. Diluted shares (115.7M) is the Q1 2026 weighted average, not period-end. Net debt ($394.4M) uses the balance-sheet line 'borrowings under credit facility and finance lease obligations' ($772.4M total) minus cash ($378.0M); the condensed statements do not split finance leases from the term loan, so pure financial-debt net debt is modestly lower \u2014 immaterial at ~1% of market cap. Share price ($339.10, 2026-07-23) is from secondary market data, not an exchange feed. Timing caveat: Q2 2026 results are due within days (late July 2026) and could move every forward number here; the customer-concentration figures (32%/14%/12%) come via secondary summaries of the FY2025 10-K rather than my direct read of the filing text. THE VALUATION GATES FAIL, AND NOT NARROWLY: the base case (16% revenue CAGR to ~$29B, 6% terminal FCF margin, 17\u00d7 P/FCF) yields a 5-year IRR of approximately \u22125%/yr and a PV of ~$160 vs the $339 price; the probability-weighted PV is ~$167, or 0.49\u00d7 price \u2014 versus required gates of +15%/yr and 1.3\u00d7. Even the bull case (24% CAGR, 7% margin, 20\u00d7 FCF) returns only ~8.5%/yr from today's price. To pass the gates, the base case would need ~29% revenue CAGR for five years AND a ~2.7\u00d7 EV/Sales exit multiple \u2014 indefensible against any mature comparable (Flex, Jabil, Benchmark all exit well below 1.5\u00d7 sales). We did not torture the assumptions; the business is excellent and the price is wrong for a 5-year 15% hurdle. This publishes as a WATCHLIST note: the operating thesis is live and the kill conditions are being monitored, but the entry does not exist above roughly $170 (where base-case PV \u2248 price with a margin of safety). A ~50% drawdown \u2014 which this stock has delivered twice in its history \u2014 would make it actionable.", "financials": { "as_of": "2026-07-23", "citations": [ "Q1 2026 earnings release with condensed FS (8-K exhibit, filed 2026-04-27; period ended 2026-03-31) \u2014 revenue $4,047.0M (+53% y/y); CCS segment $3.24B (+76%), segment margin 8.6%; HPS ~$1.7B (+63%); diluted weighted-avg shares 115.7M; cash $378.0M; borrowings under credit facility and finance lease obligations $772.4M ($25.9M current + $746.5M non-current); net earnings $212.3M", "Q4/FY2025 press release (2026-01-28) and FY2025 Form 10-K (filed 2026-02-27) \u2014 FY2025 revenue $12.39B (+28% vs $9.65B in 2024); Q4 2025 revenue $3.65B (+44% y/y); top-10 customers 79% of FY2025 revenue; three CCS customers at 32%, 14%, and 12% of total revenue", "TTM revenue construction: FY2025 $12,390M \u2212 Q1 2025 $2,648.6M + Q1 2026 $4,047.0M = $13,788.4M", "Share price $339.10 at close 2026-07-23 (GuruFocus market data; 52-week range $153.11\u2013$474.03); implies market cap ~$39.2B, EV ~$39.6B, 2.87\u00d7 EV/TTM sales, ~33\u00d7 2026 guided adjusted EPS of $10.15", "2026 guidance (Q1 2026 release, 2026-04-27): revenue $19.0B, adjusted EPS $10.15, adjusted operating margin 8.1%, free cash flow $500M; credit facility upsized to ~$2.5B on 2026-04-27" ], "net_debt": 394400000, "price": 339.1, "rev_ttm": 13788400000, "shares_diluted": 115700000 }, "kill_conditions": [ "CCS segment revenue growth is zero or negative year-over-year for two consecutive quarters (10-Q segment note; baseline +76% in Q1 2026) \u2014 the AI-driven growth engine has stalled.", "Any of the three CCS customers disclosed at 32%, 14%, and 12% of FY2025 revenue (FY2025 10-K) falls below the 10% disclosure threshold in a subsequent 10-K without an offsetting new 10% customer, or the company discloses transfer/insourcing of a major hyperscaler program.", "Combined quarterly capex of Microsoft, Amazon, Alphabet, and Meta declines year-over-year for two consecutive quarters (public earnings releases) \u2014 the theme's funding source is contracting.", "Management cuts the annual revenue outlook by 10% or more in any quarterly update (e.g., 2026's $19.0B guided below $17.1B).", "CCS segment margin prints below 7.0% for two consecutive quarters (vs 8.6% in Q1 2026) \u2014 evidence hyperscalers are clawing back the ODM margin premium." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 100, "name": "loss", "p": 0.06 }, { "dilution_pa": 0, "exit_multiple": 0.8, "multiple_type": "ev_sales", "name": "bear", "p": 0.24, "rev_cagr_5y": 0.05 }, { "dilution_pa": -0.005, "exit_multiple": 17, "multiple_type": "p_fcf", "name": "base", "p": 0.5, "rev_cagr_5y": 0.16, "terminal_margin": 0.06 }, { "dilution_pa": -0.01, "exit_multiple": 20, "multiple_type": "p_fcf", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.24, "terminal_margin": 0.07 } ], "statement": "Celestica is the purest large-cap manufacturing play on hyperscaler AI networking and rack integration \u2014 CCS segment revenue grew 76% y/y in Q1 2026 and management guides $19.0B for 2026 \u2014 and we expect revenue to compound roughly 16%/yr through 2031. But at $339 the stock already discounts near-flawless execution: our base case is worth roughly $160 in present value against a $339 price, so this publishes as a watchlist thesis, not a buy. The operating thesis is falsified if CCS growth stalls to zero for two consecutive quarters or a top-three hyperscaler program is lost; the valuation becomes actionable below roughly $170.", "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "CLS", "version": 1 }, "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "CLS", "valuation": { "base_irr": -0.053, "discount_rate": 0.1, "ev_to_price": 0.493, "expected_pv": 167.24, "gates": { "base_irr_gate": { "actual": -0.053, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.493, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2167, "multiple_type": "ev_sales", "name": "loss", "p": 0.06, "price_5y": 100.0, "pv_today": 100.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.0, "exit_multiple": 0.8, "irr_5y": -0.19, "multiple_type": "ev_sales", "name": "bear", "p": 0.24, "price_5y": 118.27, "pv_today": 73.44, "rev_cagr_5y": 0.05, "terminal_margin": 0.0 }, { "dilution_pa": -0.005, "exit_multiple": 17.0, "irr_5y": -0.053, "multiple_type": "p_fcf", "name": "base", "p": 0.5, "price_5y": 258.3, "pv_today": 160.38, "rev_cagr_5y": 0.16, "terminal_margin": 0.06 }, { "dilution_pa": -0.01, "exit_multiple": 20.0, "irr_5y": 0.0854, "multiple_type": "p_fcf", "name": "bull", "p": 0.2, "price_5y": 510.74, "pv_today": 317.13, "rev_cagr_5y": 0.24, "terminal_margin": 0.07 } ], "sensitivity": { "current_price": 339.1, "growth_rows": [ 0.06, 0.11, 0.16, 0.21, 0.26 ], "multiple_cols": [ 8.5, 12.75, 17.0, 21.25, 25.5 ], "pv_grid": [ [ 49.61, 75.51, 101.4, 127.29, 153.18 ], [ 63.04, 95.64, 128.24, 160.84, 193.45 ], [ 79.11, 119.74, 160.38, 201.02, 241.66 ], [ 98.2, 148.38, 198.57, 248.75, 298.94 ], [ 120.72, 182.17, 243.61, 305.06, 366.51 ] ] } }, "version": 1 }, "0288f016ece01fc310134673e9b6958b8219ee528c73f87a18d5d48a6a39b0a7": { "actionable_below": 90.24, "company": "Credo Technology Group Holding Ltd", "kind": "watchlist_note", "markdown": "## Thesis\n\nCredo is the purest public play on active electrical cables becoming the default rack-scale interconnect for AI clusters: FY2026 (ended 2026-05-02) revenue tripled to $1,335.1M, management guided FY2027 to grow another 80%+ with a second $600M+ optical leg, and the model already prints 68% gross margins and ~50% non-GAAP net margins with $1.44B net cash. The thesis holds if revenue compounds roughly 28%/yr through FY2031 (~$4.6B) as AEC and optical-DSP attach rates rise with each 100G-to-200G-per-lane transition across at least four hyperscaler customers. At $236.50 the market already capitalizes materially more than that \u2014 this publishes as a watchlist thesis with an entry gate near $85-90, not a buy at today's price.\n\n## Why Now\n\nThe inflection is no longer a forecast; it is printed in the filings. Revenue for fiscal 2026 (ended May 2, 2026) was **$1,335.1M versus $436.8M in FY2025 \u2014 up 206%** (Q4 FY2026 press release, furnished on Form 8-K, issued 2026-06-01). The exit rate is even steeper: Q4 FY2026 revenue of **$437.0M grew 157% year over year** \u2014 the fourth quarter alone matched the entire prior fiscal year. Operating leverage arrived with it: GAAP operating margin swung from 8.5% to 33.3% year over year, GAAP net income rose from $52.2M to $472.3M, and non-GAAP net income quintupled to $661.5M \u2014 a 49.5% non-GAAP net margin (same release, GAAP-to-non-GAAP reconciliation).\n\nWhy now, mechanically: at 100G-per-lane signaling, passive copper (DAC) reach collapses below ~2 meters while pluggable optics burn roughly 5x the power and introduce link flaps that stall GPU training jobs. AECs \u2014 copper cables with retimer silicon at each end \u2014 landed in the gap, and Credo's ZeroFlap positioning turned a cable into a reliability product hyperscalers now spec by default for intra-rack and adjacent-rack connectivity. Adoption is visibly broadening, not concentrating: **four hyperscale customers each contributed 10%+ of revenue in Q4 FY2026** (top three at roughly 34%/27%/16% per Zacks' summary of the quarter), versus the FY2025 profile where a single customer (Amazon) dominated. The FY2026 Form 10-K (period ended 2026-05-02, filed June 2026) shows the top ten customers at ~90% of revenue with two customers each \u226510% for the full year.\n\nThe forward evidence is equally concrete. Q1 FY2027 guidance is **$465-475M** (+~110% YoY at the midpoint; same 8-K press release), and on the June 1, 2026 earnings call management guided **fiscal 2027 revenue growth above 80%**, with the optical portfolio \u2014 optical DSPs, silicon-photonics PICs, and ZeroFlap optical transceivers, each guided to $100M+ \u2014 contributing **more than $600M**, while non-GAAP opex grows only ~50%. The balance sheet corroborates the demand signal: inventories rose from $90.0M to $250.8M year over year (build-ahead for committed demand), and cash plus short-term investments ended at $1,443.3M with zero borrowings (press release balance sheet, 2026-05-02).\n\n## Business Quality\n\nCredo's moat is SerDes IP expressed as a system. The founders' serializer/deserializer pedigree lets Credo build retimer and DSP silicon with industry-leading power per bit, then sell it in the highest-margin form factor available: a finished cable qualified into a hyperscaler's rack design, wrapped with the PILOT diagnostics software layer. Qualification is the real switching cost \u2014 once an AEC SKU is designed into a cluster generation, ripping it out mid-buildout risks GPU utilization, which is the one metric hyperscalers will not trade for pennies on a cable. The unit economics show it: 68.2% GAAP gross margin in Q4 FY2026 \u2014 extraordinary for anything cable-shaped \u2014 and non-GAAP operating margin of 49.6%, with FY2026 non-GAAP net margin at 49.5%. The fabless model (TSMC) keeps capital intensity low: property and equipment is just $101.6M against $1.34B of revenue.\n\nCompetition is real and coming from above and below. Marvell sells AEC DSPs into competing cable vendors, Point2 Technology and Spectra7 attack the retimer socket on price, and in optical DSPs Credo is the challenger against entrenched Marvell and Broadcom. The structural risk is architectural rather than competitive: NVIDIA's rack-scale designs (NVL72-class) use an integrated copper backplane for scale-up, so Credo's AEC franchise is disproportionately levered to hyperscalers' custom-ASIC clusters (AWS Trainium, Microsoft, xAI). A world where NVIDIA's integrated racks take a larger share of installed accelerators dilutes Credo's attach rate. Concentration compounds this: ~90% of FY2026 revenue came from ten customers, and the top three were ~77% of the latest quarter. Any one of them dual-sourcing aggressively resets the growth curve.\n\nCapital allocation is conservative to a fault: $1.44B of cash and short-term investments, no debt, no buyback, one small acquisition in FY2026 ($92.8M goodwill + $29.3M intangibles, likely the OmniConnect memory line). The offset is stock-based compensation of $182.6M in FY2026 (~13.7% of revenue) \u2014 real dilution, with diluted weighted shares up ~5.8% YoY (182.1M to 192.7M in Q4). Management is founder-led (CEO Bill Brennan since 2013 alongside founding technologists), and execution over FY2025-26 \u2014 tripling revenue while expanding gross margin 320bps \u2014 has been close to flawless. The open question is not quality; it is duration of hypergrowth, and that is precisely what today's multiple assumes.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $1,335M, 192.7M diluted shares, net debt of $-1,443M, and a share price of $236.50. Sources:\n\n- Q4 & FY2026 press release (furnished on Form 8-K), fiscal year ended 2026-05-02, issued 2026-06-01 \u2014 FY2026 revenue $1,335.116M; Q4 revenue $437.003M; FY2025 revenue $436.775M; GAAP net income $472.279M; non-GAAP net income $661.543M\n- Same release, condensed balance sheet as of 2026-05-02 \u2014 cash & equivalents $1,164.952M + short-term investments $278.334M = $1,443.286M; no borrowings on the balance sheet (net debt shown as negative = net cash; excludes ~$25-30M operating lease liabilities)\n- Same release, statements of operations \u2014 Q4 FY2026 GAAP diluted weighted-average shares 192.681M (FY2026 full-year diluted 188.232M); GAAP diluted EPS $0.88 (Q4)\n- FY2026 Form 10-K, period ended 2026-05-02, filed June 2026 \u2014 top ten customers ~90% of FY2026 revenue; two customers each \u226510% of full-year revenue (per StockTitan/Zacks 10-K summaries)\n- Q4 FY2026 earnings call, 2026-06-01 (Seeking Alpha summary) \u2014 FY2027 guided to >80% revenue growth; optical portfolio guided to >$600M with three $100M+ product lines; Q1 FY2027 revenue guidance $465-475M per the 8-K press release\n- Share price $236.50, Nasdaq close 2026-07-23 (web quote aggregators; intraday range in July 2026 spanned ~$214-290, all-time high $302.52 on 2026-06-22 per Macrotrends)\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (5%): AI capex bust coincides with architectural displacement: NVIDIA-style integrated copper backplanes plus a Marvell/Point2 price war strand the AEC franchise; revenue halves and the multiple collapses onto a business worth little more than its ~$7.50/share net cash plus a shrunken royalty on connectivity silicon.\n- **Bear** (30%): FY2027 largely lands (H1 is effectively booked) but 2028-29 brings hyperscaler digestion and AEC ASP compression; revenue stalls near $2.4-2.9B (FY28-31 growth ~5%/yr) and the stock re-rates to a mature mixed-signal multiple \u2014 6x EV/S is where Marvell and Microchip have traded as single-digit growers with strong gross margins.\n- **Base** (45%): FY2027 grows ~75-80% per guidance, then decelerates (+30%/+18%/+12%/+8%) to ~$4.6B by FY2031 as AEC broadens across hyperscalers and optical becomes a real second leg but competition normalizes pricing; 32% terminal FCF margin (vs 35.4% FY2026 GAAP net margin) at 26x P/FCF \u2014 the ADI/TXN mature-analog range for a low-teens grower with fabless economics.\n- **Bull** (20%): AI cluster buildouts sustain through 2030, AECs become standard in scale-up as well as scale-out fabrics, optical DSP/transceivers scale past $1.5B, and Credo reaches ~$8B revenue at ~50% non-GAAP operating margins; 10x EV/S at exit matches where premium connectivity franchises (pre-froth Broadcom, peak-quality Marvell) have traded while still growing 15-20%.\n\n## Kill Conditions\n\n1. Two consecutive quarters of sequential revenue decline greater than 10% in the 10-Q \u2014 the digestion/displacement scenario has begun and the bear/loss branch is live.\n2. FY2027 revenue (10-K, period ending ~May 2027) comes in below $2.0B \u2014 i.e., below +50% growth versus the >+80% guided on 2026-06-01 \u2014 falsifying the demand-durability leg of the thesis.\n3. Optical portfolio revenue below $400M for FY2027 versus the >$600M guided (disclosed on earnings calls) \u2014 the second growth leg failed, leaving a single-product AEC story.\n4. Non-GAAP gross margin below 60% for two consecutive quarters (press releases; Q4 FY2026 was 68.3%) \u2014 evidence AEC pricing is commoditizing under Marvell/Point2 competition.\n5. Any single customer exceeds 45% of quarterly revenue for two consecutive quarters, or two of the current four 10%+ hyperscalers drop below 10% simultaneously (10-Q concentration disclosures) \u2014 the diversification that de-risked FY2026 is unwinding.\n\n## Risk Register\n\n- Valuation \u2014 extreme severity: ~33x EV/TTM sales and ~18x guided-FY2027 sales leaves zero room for deceleration; in our bear case the stock falls ~65% even though revenue still doubles from FY2026.\n- Customer concentration \u2014 high: top ten customers ~90% of FY2026 revenue, top three ~77% of the latest quarter; a single dual-sourcing decision resets the curve.\n- Architectural displacement \u2014 high: NVIDIA integrated copper backplanes (scale-up) and, later in the window, co-packaged optics could shrink the AEC socket; Credo's franchise is levered to custom-ASIC hyperscaler clusters.\n- Competition \u2014 medium-high: Marvell sells AEC DSPs to rival cable makers, Point2/Spectra7 attack on price, and in optical DSPs Credo challenges entrenched Marvell/Broadcom.\n- Hyperscaler capex cyclicality \u2014 medium-high: revenue is tied to cluster buildout schedules that have historically paused with little warning (2019, 2022 precedents).\n- Supply chain/geopolitics \u2014 medium: fabless at TSMC with assembly concentrated in Asia; Taiwan disruption or China export rules would hit both supply and a portion of demand.\n- Stock-based compensation \u2014 medium: $182.6M in FY2026 (~14% of revenue), driving ~3-6%/yr dilution that compounds against shareholders in every scenario.\n\n## Theme Position\n\nCredo is effectively a pure play: substantially all revenue is AI/data-center connectivity \u2014 AECs plus optical DSPs, transceivers, retimers, and line cards sold into hyperscaler AI clusters \u2014 so theme revenue exposure is realistically **95%+** (the legacy non-AI remainder is de minimis after FY2026's triple). Within the ai-infrastructure theme, it is the cleanest public expression of the specific angle: AECs became the standard intra-cluster rack interconnect, and Credo defined the category.\n\nAlternatives considered: **Marvell (MRVL)** offers AEC-DSP plus optical-DSP exposure at roughly a third of Credo's sales multiple, but the AI story is diluted by a large legacy business and lumpy custom-silicon wins \u2014 you buy the theme at maybe 40% purity. **Astera Labs (ALAB)** is the closest analog (PCIe retimers/scale-up connectivity, hyperscaler concentration) but carries the same problem as Credo \u2014 a valuation that already prices the bull case \u2014 without Credo's finished-cable systems moat. **Amphenol/TE Connectivity** win physical-layer content in every AI rack and trade at defensible multiples, but AI is a minority of revenue, so they are diversified industrials, not theme vehicles. Credo wins on purity and business quality; the entire debate is price.\n\n## Benchmark\n\nBeating means CRDO total return exceeds QQQ total return over the full window from publication (late July 2026) to late July 2031. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "AEC adoption proxy = Credo revenue and customer breadth: FY2026 revenue $1,335.1M, +206% YoY, with Q4 FY2026 at $437.0M (+157% YoY) and four hyperscale customers each \u226510% of Q4 revenue (Q4/FY2026 press release furnished on Form 8-K, 2026-06-01; concentration per FY2026 10-K and Zacks quarter summary). Forward reading: Q1 FY2027 guided $465-475M and FY2027 guided >+80% with optical >$600M (2026-06-01 earnings call) \u2014 adoption is still steepening, now on a second (optical) curve.", "company": "Credo Technology Group Holding Ltd", "confidence_notes": "Verified hard: all FY2026/Q4 P&L and balance-sheet figures are taken directly from the company's June 1, 2026 results release (read in full, including GAAP/non-GAAP reconciliations) \u2014 revenue $1,335.116M, diluted shares 192.681M (Q4 weighted avg; year-avg 188.232M), cash + short-term investments $1,443.3M, no borrowings. Net debt of -$1.443B counts short-term investments as cash and excludes ~$25-30M of operating-lease liabilities; using strict cash-only ($1.165B) changes per-share values by under $1.50. Estimates/secondary: the $236.50 price is the 2026-07-23 close per quote aggregators (the stock traded ~$214-290 during July 2026 \u2014 conclusions below are robust across that whole range); the 34%/27%/16% top-three customer split and the \"top ten = 90%\" figure come from Zacks/StockTitan summaries of the FY2026 10-K, not my own reading of the filing; FY2027 \">80% growth / optical >$600M\" guidance is from earnings-call coverage (Seeking Alpha), not a filed document. THE GATES DO NOT PASS, and I will not torture assumptions to make them: at $236.50 the base case (28%/yr revenue CAGR to ~$4.6B, 32% FCF margin, 26x P/FCF) yields a 5-year IRR of about -5%/yr, and probability-weighted PV is ~$117, roughly 0.50x price versus the 1.3x required. Even the bull case (~$8B revenue, 10x exit EV/S) returns only ~10%/yr. Passing both gates would require assuming ~50%/yr revenue growth for five years (>$10B revenue) at a 10x exit multiple as the BASE case \u2014 indefensible for a component maker with ~77% top-three customer concentration. Both gates converge on an entry price of roughly $85-90 (~62% below the July 23 close), which the stock's own 2025 drawdown history shows is not an absurd level to wait for. Publish as a WATCHLIST note: world-class business, pre-registered kill conditions, defined entry gate \u2014 not a buy at today's price.", "financials": { "as_of": "2026-07-23", "citations": [ "Q4 & FY2026 press release (furnished on Form 8-K), fiscal year ended 2026-05-02, issued 2026-06-01 \u2014 FY2026 revenue $1,335.116M; Q4 revenue $437.003M; FY2025 revenue $436.775M; GAAP net income $472.279M; non-GAAP net income $661.543M", "Same release, condensed balance sheet as of 2026-05-02 \u2014 cash & equivalents $1,164.952M + short-term investments $278.334M = $1,443.286M; no borrowings on the balance sheet (net debt shown as negative = net cash; excludes ~$25-30M operating lease liabilities)", "Same release, statements of operations \u2014 Q4 FY2026 GAAP diluted weighted-average shares 192.681M (FY2026 full-year diluted 188.232M); GAAP diluted EPS $0.88 (Q4)", "FY2026 Form 10-K, period ended 2026-05-02, filed June 2026 \u2014 top ten customers ~90% of FY2026 revenue; two customers each \u226510% of full-year revenue (per StockTitan/Zacks 10-K summaries)", "Q4 FY2026 earnings call, 2026-06-01 (Seeking Alpha summary) \u2014 FY2027 guided to >80% revenue growth; optical portfolio guided to >$600M with three $100M+ product lines; Q1 FY2027 revenue guidance $465-475M per the 8-K press release", "Share price $236.50, Nasdaq close 2026-07-23 (web quote aggregators; intraday range in July 2026 spanned ~$214-290, all-time high $302.52 on 2026-06-22 per Macrotrends)" ], "net_debt": -1443286000, "price": 236.5, "rev_ttm": 1335116000, "shares_diluted": 192681000 }, "kill_conditions": [ "Two consecutive quarters of sequential revenue decline greater than 10% in the 10-Q \u2014 the digestion/displacement scenario has begun and the bear/loss branch is live.", "FY2027 revenue (10-K, period ending ~May 2027) comes in below $2.0B \u2014 i.e., below +50% growth versus the >+80% guided on 2026-06-01 \u2014 falsifying the demand-durability leg of the thesis.", "Optical portfolio revenue below $400M for FY2027 versus the >$600M guided (disclosed on earnings calls) \u2014 the second growth leg failed, leaving a single-product AEC story.", "Non-GAAP gross margin below 60% for two consecutive quarters (press releases; Q4 FY2026 was 68.3%) \u2014 evidence AEC pricing is commoditizing under Marvell/Point2 competition.", "Any single customer exceeds 45% of quarterly revenue for two consecutive quarters, or two of the current four 10%+ hyperscalers drop below 10% simultaneously (10-Q concentration disclosures) \u2014 the diversification that de-risked FY2026 is unwinding." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 65, "name": "loss", "p": 0.05 }, { "dilution_pa": 0.03, "exit_multiple": 6, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "rev_cagr_5y": 0.17 }, { "dilution_pa": 0.025, "exit_multiple": 26, "multiple_type": "p_fcf", "name": "base", "p": 0.45, "rev_cagr_5y": 0.28, "terminal_margin": 0.32 }, { "dilution_pa": 0.02, "exit_multiple": 10, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.43 } ], "statement": "Credo is the purest public play on active electrical cables becoming the default rack-scale interconnect for AI clusters: FY2026 (ended 2026-05-02) revenue tripled to $1,335.1M, management guided FY2027 to grow another 80%+ with a second $600M+ optical leg, and the model already prints 68% gross margins and ~50% non-GAAP net margins with $1.44B net cash. The thesis holds if revenue compounds roughly 28%/yr through FY2031 (~$4.6B) as AEC and optical-DSP attach rates rise with each 100G-to-200G-per-lane transition across at least four hyperscaler customers. At $236.50 the market already capitalizes materially more than that \u2014 this publishes as a watchlist thesis with an entry gate near $85-90, not a buy at today's price.", "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "CRDO", "version": 1 }, "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "CRDO", "valuation": { "base_irr": -0.0514, "discount_rate": 0.1, "ev_to_price": 0.496, "expected_pv": 117.31, "gates": { "base_irr_gate": { "actual": -0.0514, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.496, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2276, "multiple_type": "ev_sales", "name": "loss", "p": 0.05, "price_5y": 65.0, "pv_today": 65.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.03, "exit_multiple": 6.0, "irr_5y": -0.1849, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "price_5y": 85.09, "pv_today": 52.83, "rev_cagr_5y": 0.17, "terminal_margin": 0.0 }, { "dilution_pa": 0.025, "exit_multiple": 26.0, "irr_5y": -0.0514, "multiple_type": "p_fcf", "name": "base", "p": 0.45, "price_5y": 181.7, "pv_today": 112.82, "rev_cagr_5y": 0.28, "terminal_margin": 0.32 }, { "dilution_pa": 0.02, "exit_multiple": 10.0, "irr_5y": 0.1007, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "price_5y": 382.07, "pv_today": 237.23, "rev_cagr_5y": 0.43, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 236.5, "growth_rows": [ 0.18, 0.23, 0.28, 0.33, 0.38 ], "multiple_cols": [ 13.0, 19.5, 26.0, 32.5, 39.0 ], "pv_grid": [ [ 40.3, 58.4, 76.49, 94.59, 112.68 ], [ 48.65, 70.92, 93.18, 115.45, 137.72 ], [ 58.47, 85.64, 112.82, 140.0, 167.18 ], [ 69.94, 102.86, 135.78, 168.7, 201.61 ], [ 83.29, 122.87, 162.46, 202.05, 241.63 ] ] } }, "version": 1 }, "a5de8ec4451174efe5239731bb58d11fe36b4c95d767d7f7c7d84ccede27c432": { "actionable_below": 25.85, "company": "Astera Labs, Inc.", "kind": "watchlist_note", "markdown": "## Thesis\n\nAstera Labs is the purest merchant-silicon play on inside-the-rack AI connectivity \u2014 PCIe 6 retimers today, Scorpio scale-up fabric switches ramping in 2H 2026 \u2014 and we expect revenue to roughly quadruple from ~$1.0B TTM to ~$4.2B by mid-2031. At $326.97 (~55x EV/TTM sales), that outcome is already over-discounted: our base case is worth ~$123/share today and even a bull case (~$6.6B 2031 revenue) returns under 4%/yr. This publishes as a watchlist thesis, not a buy \u2014 the business passes every quality test, the price fails both valuation gates; our pre-registered entry zone is roughly $95-100.\n\n## Why Now\n\nThe inflection is documented, not hoped for. Q1 FY2026 revenue was $308.4M, up 93% year over year and 14% sequentially, with GAAP net income of $80.3M (+152%) and a 76.3% gross margin (10-Q for the quarter ended 2026-03-31, filed 2026-05-05). That follows a fiscal 2025 in which revenue grew 115% to $852.5M and net income reached $219.1M (10-K FY2025, filed 2026-02-20). Guidance for Q2 FY2026 is $355-365M \u2014 another 15-18% sequential step \u2014 meaning the run-rate exits 2026 well above $1.4B annualized (Q1 FY2026 earnings release, 2026-05-05).\n\nThe mix shift is the real story. Astera was born as a retimer company riding Nvidia GPU-attach; it is becoming a fabric company. Scorpio fabric switches plus Taurus Ethernet cables reached 30% of revenue in Q4 FY2025, up from effectively zero at the start of that year (Q4/FY2025 earnings release, 2026-02-10), and PCIe Gen 6 products crossed one-third of revenue in Q1 FY2026 (Q1 FY2026 earnings call, 2026-05-05). The Scorpio X-Series 320-lane scale-up switch \u2014 supporting PCIe 6, UALink, and Nvidia's NVLink Fusion \u2014 enters production ramp in 2H 2026, targeting a merchant scale-up switch market the company sizes at $20B by 2030 (company announcements, May-June 2026). Scale-up fabric is the highest-value new silicon socket in AI racks as accelerator clusters move from 8-GPU nodes to 72+ GPU coherent domains.\n\nThe commercial anchor is contractual, not rhetorical: Astera's expanded agreement with Amazon (announced November 2025) ties warrants for roughly 3.3M shares to up to $6.5B of future purchases \u2014 a hyperscaler pre-committing its custom-silicon rack roadmap to Astera's fabric. The cost shows up in filings as a roughly two-point quarterly gross-margin drag as tranches vest, and Q2 FY2026 gross-margin guidance of ~73% (down from 76.4%) marks the hardware-heavy mix arriving. The why-now for the theme is genuine; as we show below, the why-now for the stock is not.\n\n## Business Quality\n\nThe unit economics are among the best in semiconductors: 76.3% GAAP gross margin, 36.2% non-GAAP operating margin, and $74.6M of quarterly operating cash flow on $308.4M of revenue (Q1 FY2026 10-Q). The balance sheet is pristine \u2014 $148.3M cash plus $1.04B marketable securities against zero debt \u2014 and the model is fabless with only 756 employees at year-end 2025 (10-K FY2025), so revenue per head exceeds $1.1M and scales without heavy capital. Growth is entirely self-funded.\n\nThe moat is real but narrower than the multiple implies. Astera's edge is co-design intimacy and speed: it shipped PCIe 6 retimers and fabric switches into production roughly a generation ahead of merchant rivals, and its COSMOS software layer (fleet-scale link diagnostics and telemetry) creates switching costs at hyperscalers who wire it into their rack-management stacks. Protocol breadth \u2014 one vendor covering PCIe, CXL, Ethernet, UALink, and NVLink Fusion \u2014 makes it the default fabric partner for every custom-ASIC program that is not Nvidia. But the competition is the most dangerous in the industry: Broadcom owns PCIe switching incumbency and is pushing scale-up Ethernet (Tomahawk Ultra), Marvell and Parade sell competing retimers, and Nvidia keeps NVLink largely captive. The step-down in guided gross margin to ~73% is the first visible print of that pressure plus hardware mix.\n\nThe structural flaw is concentration: one end customer exceeded 70% of FY2025 revenue and the top three were ~86% (10-K FY2025). The Amazon warrant deepens the dependence even as it secures it \u2014 the customer is being paid in equity to stay. Capital allocation is unproven: cash accumulates while stock-based compensation runs heavy (diluted weighted shares grew ~3.5% year over year to 181.2M), and there is no buyback offsetting it. Nothing here is disqualifying for the business; all of it matters for what you should pay.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $1,002M, 181.2M diluted shares, net debt of $-1,188M, and a share price of $326.97. Sources:\n\n- 10-Q Q1 FY2026 (period ended 2026-03-31, filed 2026-05-08... filed 2026-05-05) \u2014 revenue $308.4M, net income $80.3M, cash $148.3M + marketable securities $1.04B, no debt, diluted weighted-average shares 181.2M, 171.4M shares outstanding as of 2026-04-30\n- Q4/FY2025 earnings release, 8-K furnished 2026-02-10 \u2014 Q4 FY2025 revenue $270.6M (+92% YoY); FY2025 revenue $852.5M (+115%); Scorpio + Taurus = 30% of revenue\n- Q3 FY2025 earnings release (Nov 2025) \u2014 revenue $230.6M (+104% YoY), GAAP gross margin 76.2%\n- Q2 FY2025 revenue $191.9M \u2014 cross-checked: FY2025 $852.5M minus Q1 $159.4M, Q3 $230.6M, Q4 $270.6M; TTM = 191.9+230.6+270.6+308.4 = $1,001.5M\n- 10-K FY2025 (filed 2026-02-20) \u2014 largest end customer >70% of FY2025 revenue, top three ~86%; FY2025 net income $219.1M; 756 employees\n- Share price $326.97, Nasdaq close 2026-07-23 (stockanalysis.com); 52-week range $97.93-$499.48\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (10%): AI capex bust coincides with architectural displacement: Nvidia keeps NVLink captive, Broadcom wins the scale-up Ethernet standard, and the >70% end customer redesigns Astera out of its next rack generation \u2014 revenue halves and the multiple collapses. $70 is ~21% of today's price, well above the ~$6.60/share of net cash.\n- **Bear** (25%): AI infrastructure spending digests in 2027-28 and Broadcom/Marvell price aggression caps share: growth decelerates hard after 2026 (5y CAGR 20% still reaches ~$2.5B), margins settle at 32% FCF, and the market pays 18x FCF \u2014 the pre-AI Broadcom/Microchip range for low-growth quality semis.\n- **Base** (45%): Scorpio X ramps across three-plus hyperscaler custom-ASIC programs and PCIe 7 holds the retimer franchise: revenue ~4.2x to ~$4.2B by mid-2031 (a leading share of the merchant scale-up/connectivity TAM), 36% terminal FCF margin, and 27x FCF \u2014 where mature high-quality semis (ADI ~25-30x, NVDA-mature ~30x) trade with mid-teens growth.\n- **Bull** (20%): Scorpio becomes the de facto merchant scale-up fabric standard (UALink + NVLink Fusion both ramp) and optics attach adds a layer: ~$6.6B revenue by 2031 \u2014 roughly a third of the projected $20B scale-up switch market plus the retimer base \u2014 at 38% FCF margins and a still-compounding 32x FCF.\n\n## Kill Conditions\n\n1. Share-loss signal: two consecutive quarters of sequential revenue decline while combined data-center capex at Microsoft, Amazon, Alphabet, and Meta (from their 10-Qs) is still growing quarter over quarter \u2014 demand exists and Astera is not winning it.\n2. Fabric transition stalls: Scorpio + Taurus fall below 30% of revenue (the Q4 FY2025 disclosed level) for two consecutive quarters after the 2H 2026 Scorpio X production ramp, or the company stops disclosing the mix metric entirely.\n3. Pricing power breaks: non-GAAP gross margin prints below 70% for two consecutive quarters (vs. 76.4% in Q1 FY2026 and ~73% guided) \u2014 evidence Broadcom/Marvell competition is repricing retimers and switches faster than mix explains.\n4. Concentration unwind without replacement: disclosed largest end customer drops from >70% of revenue (FY2025 10-K) toward <40% in FY2026-27 filings while total revenue growth simultaneously falls below 25% YoY \u2014 the anchor left and nobody filled the hole.\n\n## Risk Register\n\n- Valuation \u2014 critical: ~55x EV/TTM sales means even our bull case ($6.6B revenue, 38% FCF margin by 2031) returns ~3.6%/yr; the multiple, not the business, is the dominant risk.\n- Customer concentration \u2014 critical: one end customer was >70% of FY2025 revenue (10-K); a single architecture change at that customer invalidates most of the model.\n- Nvidia vertical integration \u2014 high: NVLink stays largely captive; if hyperscaler custom-ASIC programs disappoint, the merchant scale-up TAM Astera targets shrinks structurally.\n- Broadcom/Marvell competition \u2014 high: Broadcom owns PCIe switch incumbency and pushes scale-up Ethernet (Tomahawk Ultra); guided gross margin step-down to ~73% is the first print of pricing/mix pressure.\n- AI capex cyclicality \u2014 high: 2025-26 is a historic build; a 2027-28 digestion phase hits a company priced for uninterrupted hypergrowth.\n- Amazon warrant structure \u2014 medium: ~2pts of quarterly gross-margin drag as tranches vest, and the anchor customer is partly paid in equity, deepening dependence.\n- Dilution \u2014 medium: heavy SBC with no offsetting buyback; diluted shares grew ~3.5% YoY.\n\n## Theme Position\n\nAstera Labs is effectively a 100% theme-pure holding: the 10-K describes a company \"built from the ground up for cloud and AI infrastructure,\" and substantially all revenue \u2014 Aries retimers, Taurus Ethernet cabling, Leo CXL, Scorpio fabric switches \u2014 ships into AI/cloud racks. Within ai-infrastructure it occupies the specific angle our theme research flagged: the inside-the-rack connectivity layer (PCIe 6/CXL signal integrity plus the emerging scale-up fabric socket), which grows with accelerator density per rack rather than just accelerator units.\n\nAlternatives considered. Broadcom (AVGO): the incumbent giant in switching and custom ASICs and the safer way to own the theme, but AI is a minority of revenue, the market cap is ~30x Astera's, and the thesis is fully consensus \u2014 no edge in us writing it. Marvell (MRVL): cheaper (mid-single-digit EV/sales) with real electro-optics exposure, but its custom-ASIC narrative has been losing sockets and the connectivity attach story is muddier; it is a value case, not this theme's sharpest expression. Credo (CRDO): the closest pure-play comp in AEC cables/retimers with similar hyperscaler concentration, but a narrower product ladder (no fabric-switch equivalent to Scorpio) at a similarly froth-priced multiple \u2014 inferior business at the same style of price. Astera is the best asset on the angle; the entire debate is price.\n\n## Benchmark\n\nBeating means total return above QQQ over the 5-year window from publication; our base case implies a negative absolute return from $326.97, i.e., clear expected underperformance versus QQQ at today's price. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Scale-up fabric adoption: Scorpio + Taurus = 30% of revenue in Q4 FY2025 (Q4/FY2025 earnings release, 2026-02-10), up from ~0% a year prior; PCIe Gen 6 products >1/3 of revenue in Q1 FY2026 (Q1 FY2026 earnings call, 2026-05-05); Scorpio X 320-lane scale-up switch production ramp begins 2H 2026 into a merchant scale-up switch market the company projects at $20B by 2030 (Computex announcement, June 2026).", "company": "Astera Labs, Inc.", "confidence_notes": "THE GATES FAIL, AND NOT NARROWLY \u2014 this is a watchlist note, not a buy. Base-case 5y IRR is approximately -9.5%/yr (vs. the >=15% gate) and probability-weighted PV is ~$122, about 0.37x the $326.97 price (vs. the >=1.3x gate). We could not construct a defensible base case that passes: forcing a pass requires ~60% revenue CAGR for five years (~$10.5B revenue, larger than the company's own $12-20B TAM projections support at plausible share) or a permanent 50x+ FCF exit multiple \u2014 both indefensible. The gates would pass near $95-100 (which the stock touched at its 52-week low of $97.93), so the pre-registered entry zone is $95-100 absent thesis-changing fundamentals. Number confidence: Q1 FY2026 figures (revenue $308.4M, cash+securities $1.19B, zero debt, 181.2M diluted WAS) are from the 10-Q via a secondary summary (StockTitan), not the raw EDGAR document \u2014 high confidence, minor rounding possible. Q2 FY2025 revenue ($191.9M) is derived by subtraction from FY2025 and quarterly disclosures and cross-foots exactly. The Amazon warrant terms (~3.3M shares, up to $6.5B purchases, ~2pt quarterly GM drag) come from press coverage of the November 2025 agreement and 10-K summaries; we did not verify the underlying 8-K exhibit. The $20B-by-2030 scale-up TAM is a company projection, not independent. Price is the 2026-07-23 close; the stock is extremely volatile (fell from ~$418 to ~$320 within July 2026). One modeling artifact to disclose: the bear scenario's PV (~$46) sits below the loss scenario's fixed price ($70) \u2014 an honest consequence of a ~55x EV/sales entry, where a slow-deceleration path destroys more value than an immediate markdown; we kept both rather than smoothing the ordering.", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q Q1 FY2026 (period ended 2026-03-31, filed 2026-05-08... filed 2026-05-05) \u2014 revenue $308.4M, net income $80.3M, cash $148.3M + marketable securities $1.04B, no debt, diluted weighted-average shares 181.2M, 171.4M shares outstanding as of 2026-04-30", "Q4/FY2025 earnings release, 8-K furnished 2026-02-10 \u2014 Q4 FY2025 revenue $270.6M (+92% YoY); FY2025 revenue $852.5M (+115%); Scorpio + Taurus = 30% of revenue", "Q3 FY2025 earnings release (Nov 2025) \u2014 revenue $230.6M (+104% YoY), GAAP gross margin 76.2%", "Q2 FY2025 revenue $191.9M \u2014 cross-checked: FY2025 $852.5M minus Q1 $159.4M, Q3 $230.6M, Q4 $270.6M; TTM = 191.9+230.6+270.6+308.4 = $1,001.5M", "10-K FY2025 (filed 2026-02-20) \u2014 largest end customer >70% of FY2025 revenue, top three ~86%; FY2025 net income $219.1M; 756 employees", "Share price $326.97, Nasdaq close 2026-07-23 (stockanalysis.com); 52-week range $97.93-$499.48" ], "net_debt": -1188000000, "price": 326.97, "rev_ttm": 1001500000, "shares_diluted": 181200000 }, "kill_conditions": [ "Share-loss signal: two consecutive quarters of sequential revenue decline while combined data-center capex at Microsoft, Amazon, Alphabet, and Meta (from their 10-Qs) is still growing quarter over quarter \u2014 demand exists and Astera is not winning it.", "Fabric transition stalls: Scorpio + Taurus fall below 30% of revenue (the Q4 FY2025 disclosed level) for two consecutive quarters after the 2H 2026 Scorpio X production ramp, or the company stops disclosing the mix metric entirely.", "Pricing power breaks: non-GAAP gross margin prints below 70% for two consecutive quarters (vs. 76.4% in Q1 FY2026 and ~73% guided) \u2014 evidence Broadcom/Marvell competition is repricing retimers and switches faster than mix explains.", "Concentration unwind without replacement: disclosed largest end customer drops from >70% of revenue (FY2025 10-K) toward <40% in FY2026-27 filings while total revenue growth simultaneously falls below 25% YoY \u2014 the anchor left and nobody filled the hole." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 70, "name": "loss", "p": 0.1 }, { "dilution_pa": 0.03, "exit_multiple": 18, "multiple_type": "p_fcf", "name": "bear", "p": 0.25, "terminal_margin": 0.32 }, { "dilution_pa": 0.03, "exit_multiple": 27, "multiple_type": "p_fcf", "name": "base", "p": 0.45, "terminal_margin": 0.36 }, { "dilution_pa": 0.03, "exit_multiple": 32, "multiple_type": "p_fcf", "name": "bull", "p": 0.2, "terminal_margin": 0.38 } ], "statement": "Astera Labs is the purest merchant-silicon play on inside-the-rack AI connectivity \u2014 PCIe 6 retimers today, Scorpio scale-up fabric switches ramping in 2H 2026 \u2014 and we expect revenue to roughly quadruple from ~$1.0B TTM to ~$4.2B by mid-2031. At $326.97 (~55x EV/TTM sales), that outcome is already over-discounted: our base case is worth ~$123/share today and even a bull case (~$6.6B 2031 revenue) returns under 4%/yr. This publishes as a watchlist thesis, not a buy \u2014 the business passes every quality test, the price fails both valuation gates; our pre-registered entry zone is roughly $95-100.", "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "ALAB", "version": 1 }, "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "ALAB", "valuation": { "base_irr": -0.3077, "discount_rate": 0.1, "ev_to_price": 0.106, "expected_pv": 34.57, "gates": { "base_irr_gate": { "actual": -0.3077, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.106, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2653, "multiple_type": "ev_sales", "name": "loss", "p": 0.1, "price_5y": 70.0, "pv_today": 70.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.03, "exit_multiple": 18.0, "irr_5y": -0.3674, "multiple_type": "p_fcf", "name": "bear", "p": 0.25, "price_5y": 33.12, "pv_today": 20.56, "rev_cagr_5y": 0.0, "terminal_margin": 0.32 }, { "dilution_pa": 0.03, "exit_multiple": 27.0, "irr_5y": -0.3077, "multiple_type": "p_fcf", "name": "base", "p": 0.45, "price_5y": 52.0, "pv_today": 32.29, "rev_cagr_5y": 0.0, "terminal_margin": 0.36 }, { "dilution_pa": 0.03, "exit_multiple": 32.0, "irr_5y": -0.2792, "multiple_type": "p_fcf", "name": "bull", "p": 0.2, "price_5y": 63.63, "pv_today": 39.51, "rev_cagr_5y": 0.0, "terminal_margin": 0.38 } ], "sensitivity": { "current_price": 326.97, "growth_rows": [ -0.1, -0.05, 0.0, 0.05, 0.1 ], "multiple_cols": [ 13.5, 20.25, 27.0, 33.75, 40.5 ], "pv_grid": [ [ 12.01, 16.25, 20.5, 24.75, 29.0 ], [ 14.64, 20.21, 25.78, 31.34, 36.91 ], [ 17.9, 25.09, 32.29, 39.48, 46.67 ], [ 21.87, 31.06, 40.24, 49.42, 58.6 ], [ 26.68, 38.27, 49.85, 61.44, 73.02 ] ] } }, "version": 1 }, "24640debe0f5c720ed2a74a4a76b67eaac64f9dfd84d58ba578b4d69d0c73d23": { "actionable_below": 166.19, "company": "Modine Manufacturing Company", "kind": "watchlist_note", "markdown": "## Thesis\n\nAfter the Gentherm spin-off closes (targeted Q4 CY2026), Modine becomes a majority data-center-cooling company: Data Centers revenue of $1.1B in FY26 (+73%) compounds roughly 25%/yr through FY2031, underwritten by a >$4B CY2027-29 hyperscale capacity agreement, while Climate Solutions adjusted EBITDA margin recovers above 20% as capacity-expansion costs roll off. At $249.62 the market already pays ~21x FY27 guided EBITDA for that outcome, so the defensible base case returns only ~7%/yr over five years \u2014 the business thesis is confirmed but the price fails our gates, making this a watchlist entry at or below ~$165. It is falsified by two consecutive quarters of year-over-year Data Centers revenue decline, sequential contract-liability drawdown, or Climate Solutions adjusted EBITDA margin below 16%.\n\n## Why Now\n\nThe inflection is no longer a forecast \u2014 it is printed in the filings. Modine's Q4 FY2026 earnings release (8-K Ex-99.1, fiscal year ended 2026-03-31, filed 2026-05-26) shows record quarterly net sales of $954.4M, up 47% y/y, with Climate Solutions up 87% to $665.9M and Data Centers product sales up 158% in the quarter to over $400M. For the full year, Data Centers revenue grew 73% to $1.1B \u2014 roughly 35% of the company's $3,181.1M in net sales, and about 42% of Q4's run-rate. Management guided FY2027 to net sales growth of 20-35% and adjusted EBITDA of $650-680M, growth of 38-44% over FY26's $471.0M \u2014 an acceleration, not a fade.\n\nThree forward markers in the same release make this more than a momentum print. First, the landmark agreement: Modine will guarantee capacity to supply more than $4 billion of data-center cooling products (chillers) to a major hyperscale customer during calendar years 2027-2029 \u2014 an average above $1.3B/yr from a single customer against $1.1B of total FY26 data-center revenue. Second, the cash-flow statement shows contract liabilities swinging +$159.0M in FY26 (vs -$44.5M in FY25) \u2014 customers are paying deposits ahead of shipments, hard evidence of an order book. Third, capex rose 71% to $143.3M as Modine launched what the CEO called the largest capacity expansion in company history.\n\nThe structural catalyst that resolves this thesis's pure-play caveat was announced in the 8-K of 2026-01-29: Modine will spin its Performance Technologies (vehicular) segment and merge it with Gentherm in a Reverse Morris Trust \u2014 PT valued at ~$1.0B (6.8x TTM adjusted EBITDA), with ~$210M cash to Modine and ~$790M of Gentherm stock to Modine shareholders (40% of the combined company), targeted to close in Q4 CY2026. Post-close, RemainCo is Climate Solutions ($2,062.3M FY26 sales, 18.3% adjusted EBITDA margin), of which Data Centers is already ~53% \u2014 the below-50% exposure caveat expires within two quarters on a signed transaction, not a hope.\n\nThe honest complication is the tape: the stock ran from a 52-week low of $94.55 to a high of $323.25 and sits at $249.62 (2026-07-23 close) \u2014 ~4.35x EV/FY26 sales and ~21x the midpoint of FY27 guided EBITDA. The \"why now\" for the business is emphatically confirmed by the filings; the \"why now\" for the shares is that the market got there first. Q1 FY27 results land 2026-07-29 and will be the first read on FY27 guidance and capacity-agreement ramp.\n\n## Business Quality\n\nModine is a genuine 80/20 transformation story, not a re-labeled auto supplier. Since 2021 management has rotated the portfolio from vehicular heat exchangers toward climate and thermal systems: Climate Solutions grew FY26 sales 43% to $2,062.3M (32% organic) at an 18.3% adjusted EBITDA margin, while Performance Technologies ($1,131.8M, 13.8% margin, sales down 4% organic) is being exited at 6.8x EBITDA via the Gentherm RMT. The FY26 margin picture deserves honest framing: Climate Solutions gross margin fell 350bp for the year (510bp in Q4, to 24.6%) on deliberate, management-flagged temporary costs \u2014 rapid capacity expansion, tariffs, materials. FY26 incremental Climate Solutions economics were ~12% (sales +$621.5M, adjusted EBITDA +$74.4M), well below the segment's ~21% FY25 margin. FY27 guidance implies consolidated adjusted EBITDA margin recovering to ~16.5% from 14.8%; whether expansion costs are truly temporary is the single most watchable line in the next four quarters, and one of our kill conditions.\n\nThe moat is real but conditional. Chillers, coolant distribution units, and fan walls are not monopoly IP \u2014 Vertiv, Johnson Controls, Carrier, Trane, Boyd, and Schneider's Motivair all compete. What Modine has is qualified, guaranteed capacity in a supply-constrained market (the $4B agreement contractually commits Modine's capacity to one hyperscaler through 2029), the Airedale and Scott Springfield product brands, and engineered-to-spec relationships that create switching friction on live data-center programs. Note the direction of the guarantee: Modine guarantees capacity; the disclosed terms do not establish a take-or-pay purchase minimum, so demand risk stays with Modine even as the capex commitment is real. That is a shortage-era moat \u2014 it erodes if industry supply catches up, which is exactly what our bear case prices.\n\nCapital allocation has been disciplined and the balance sheet is unstretched. FY26 net debt of $362.8M is 0.77x adjusted EBITDA; the company deployed $182.4M on three Climate Solutions acquisitions (Climate by Design International, L.B. White, AbsolutAire; $119.1M incremental sales), bought back only $7.0M of stock, and will receive ~$210M cash at RMT close. Free cash flow of $105.4M against $471M of adjusted EBITDA reflects growth working capital \u2014 receivables +$222.6M and inventory +$125.1M in FY26 \u2014 partially funded by that $159.0M of customer deposits. This is a company financing hypergrowth mostly from operations at modest leverage, which limits the wipeout tail but also shows the cash conversion of this business will not look great until the ramp normalizes.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $3,181M, 54.0M diluted shares, net debt of $363M, and a share price of $249.62. Sources:\n\n- 8-K Ex-99.1 (Q4/FY2026 earnings release), fiscal year ended 2026-03-31, filed 2026-05-26 (sec.gov/Archives/edgar/data/0000067347/000110465926066291/mod-20260526xex99d1.htm) \u2014 FY26 net sales $3,181.1M; adjusted EBITDA $471.0M; adjusted EPS $5.02; free cash flow $105.4M\n- Same 8-K, net debt reconciliation \u2014 total debt $436.3M (debt due within one year $51.4M + long-term debt $384.9M) less cash and cash equivalents $73.5M = net debt $362.8M at 2026-03-31; diluted weighted-average shares 54.0M (Q4 FY26; 53.8M full year)\n- Same 8-K \u2014 Data Centers sales +73% to $1.1B in FY26 (Q4 +158%, >$400M); Climate Solutions FY26 sales $2,062.3M, adjusted EBITDA $377.1M (18.3%); FY2027 outlook: net sales +20% to +35%, adjusted EBITDA $650-680M; >$4B CY2027-2029 hyperscale capacity agreement for chillers\n- 8-K filed 2026-01-29 (Modine/Gentherm announcement) \u2014 Performance Technologies Reverse Morris Trust: PT valued ~$1.0B (6.8x TTM adjusted EBITDA), ~$210M cash to Modine, ~$790M Gentherm stock to Modine shareholders (40% of combined company), targeted close Q4 CY2026\n- Share price $249.62 at 2026-07-23 close, market cap $13.26B, 53.11M shares outstanding, 52-week range $94.55-$323.25, next earnings 2026-07-29 \u2014 stockanalysis.com/stocks/mod/\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (5%): AI data-center capex bust in 2027-28: the hyperscale customer under-utilizes or exits the capacity agreement Modine built for (capacity is guaranteed by Modine, not purchased take-or-pay), leaving the post-spin, DC-concentrated RemainCo with stranded capacity and declining revenue. $70 is ~28% of today's price and ~8x FY26 adjusted EBITDA on the equity \u2014 a bust-and-recession clearing price below the $94.55 52-week low.\n- **Bear** (25%): Data-center demand digests after the CY27-29 agreement ramps: DC revenue plateaus near $1.3-1.5B as industry cooling supply catches up and pricing compresses, HVAC grows low-single-digit, consolidated-equivalent revenue CAGR ~4%. Exit at 1.8x EV/Sales \u2014 between mature diversified climate distributors (Watsco ~2.2-2.5x) and slower-growth industrials \u2014 for a mid-teens-margin business without a growth story.\n- **Base** (45%): Data Centers compounds ~25%/yr to ~$3.4B by FY31 (the $4B agreement delivers, plus colocation/neo-cloud customers), HVAC grows mid-single-digit plus bolt-ons; ~14% CAGR on the consolidated FY26 base approximates RemainCo plus the Gentherm stake shareholders retain. Exit 3.25x EV/Sales = ~16x EV/EBITDA at a matured ~20% EBITDA margin \u2014 mid-cycle Lennox/Trane territory, below today's froth.\n- **Bull** (25%): AI capex supercycle persists into the 2030s: the agreement is extended or replicated with second and third hyperscalers, DC revenue reaches ~$5.5B+ by FY31 with liquid-cooling content per MW rising, and post-spin Modine is a recognized top-3 data-center thermal vendor. Exit 4.0x EV/Sales (~18x EBITDA at 22% margin) \u2014 today's Trane/Lennox multiple, still below peak Vertiv.\n\n## Kill Conditions\n\n1. Data Centers product-group revenue declines year-over-year for two consecutive fiscal quarters (disclosed in each Modine earnings release/10-Q segment commentary).\n2. Contract liabilities (customer deposits, balance sheet / cash-flow statement) decline sequentially for two consecutive quarters \u2014 FY26 booked a +$159.0M inflow; a sustained reversal means the order book is eroding ahead of reported revenue.\n3. Climate Solutions adjusted EBITDA margin prints below 16.0% for two consecutive quarters (vs 18.3% in FY26 and ~21% in FY25), evidence that 'temporary' capacity-expansion costs are structural price/mix deterioration.\n4. The >$4B CY2027-2029 hyperscale capacity agreement is terminated, materially reduced, or visibly under-utilized \u2014 cumulative revenue attributed to it running below ~$1.0B/year during CY2027-2029 (vs >$1.33B/yr pro-rata) per filings/earnings calls.\n5. The Gentherm Reverse Morris Trust terminates (8-K) without an alternative Performance Technologies separation announced within two quarters, freezing data-center exposure near ~35% of consolidated revenue.\n\n## Risk Register\n\n- Valuation \u2014 HIGH: at $249.62 the stock trades at ~4.35x EV/FY26 sales and ~21x FY27 guided EBITDA (~29x FY26); years of flawless execution are pre-paid, and this alone fails our gates.\n- Single-customer concentration \u2014 HIGH: the >$4B CY27-29 agreement is with one hyperscale customer; disclosed terms are a Modine-side capacity guarantee, not a customer take-or-pay minimum, so demand risk stays with Modine while the capex is committed.\n- AI capex cyclicality \u2014 HIGH: data-center cooling demand is a derivative of hyperscaler capex; any 2027-28 digestion phase hits orders, deposits, and the multiple simultaneously (52-week range $94.55-$323.25 shows the tape knows it).\n- Margin execution \u2014 MEDIUM: Q4 FY26 gross margin fell 320bp (Climate Solutions -510bp) on expansion costs, tariffs, and materials; the thesis needs these to prove temporary, and FY27 guidance embeds that recovery.\n- Spin execution \u2014 MEDIUM: the RMT targets Q4 CY2026 close; tax-driven exchange-ratio adjustments can cut the ~$210M cash to Modine, and $30-40M of FY27 transaction costs are already guided.\n- Competitive supply response \u2014 MEDIUM/HIGH: Vertiv, Johnson Controls, Carrier, Trane, Boyd, and Schneider/Motivair are all adding chiller/CDU capacity; Modine's shortage-era pricing and share are not contractually protected beyond 2029.\n- Working-capital intensity \u2014 MEDIUM: FY26 receivables +$222.6M and inventory +$125.1M held FCF to $105.4M (22% of adjusted EBITDA); a demand air-pocket after a deposit-funded buildout would compress cash conversion further.\n- Technology shift \u2014 MEDIUM: rapid movement among direct-to-chip, rear-door, and immersion architectures could shift value toward CDU/cold-plate specialists and away from chiller-centric suppliers.\n\n## Theme Position\n\nTheme revenue exposure is roughly 35% today and rising fast: Data Centers product sales were $1.1B of $3,181.1M FY26 net sales (Q4 FY26 exceeded $400M, ~42% of that quarter's sales, +158% y/y). The pure-play caveat from our theme research is real but has a signed expiration date: the Gentherm Reverse Morris Trust (announced 2026-01-29, targeted close Q4 CY2026) removes the $1,131.8M Performance Technologies segment, leaving a RemainCo where Data Centers is already ~53% of FY26 Climate Solutions revenue \u2014 majority exposure within about two quarters, moving toward 60-70% by FY28 if the $4B CY27-29 agreement ramps as contracted. Until close, a holder owns ~35% theme exposure plus a vehicular business being exited at 6.8x EBITDA.\n\nAlternatives considered. Vertiv (VRT) is the purer expression (~75%+ data-center revenue, thermal plus power) \u2014 but purity is exactly what its multiple pays for, it carries identical hyperscaler-capex cyclicality, and it offers no analogous catalyst like a value-unlocking spin plus a disclosed $4B capacity contract. Comfort Systems (FIX) monetizes the same buildout through mechanical construction \u2014 but it is a labor/backlog business with no product IP or recurring content per megawatt, a different and lower-quality claim on the theme. Munters (Sweden-listed) has strong data-center cooling franchises but thin U.S. liquidity and a large non-DC dehumidification mix; SPX Technologies and nVent are minority-exposure hybrids; Boyd and CoolIT, arguably the best direct-to-chip assets, are private. Modine is the only listed name offering contract-backed hyperscale cooling revenue, a hard catalyst to majority purity, and a still-conservative balance sheet \u2014 the problem in July 2026 is not the asset, it is the price.\n\n## Benchmark\n\nBeating means MOD total return from publication exceeds QQQ total return over the same five-year window; at $249.62 our ~7%/yr base case likely trails QQQ, consistent with the failed gates below. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Data-center cooling revenue (Modine \"Data Centers\" product group): $1.1B in FY2026 (ended 2026-03-31), +73% y/y; Q4 FY26 exceeded $400M (+158% y/y), ~42% of quarterly net sales. Source: Q4 FY2026 earnings release, 8-K Ex-99.1 filed 2026-05-26. Corroborating forward reading: contract liabilities +$159.0M in FY26 (vs -$44.5M FY25) and >$4B CY2027-2029 hyperscale capacity agreement, same filing.", "company": "Modine Manufacturing Company", "confidence_notes": "VERDICT ON THE GATES: FAIL at today's price \u2014 publish as a watchlist note, not a buy. Base case (14% consolidated-equivalent revenue CAGR, 3.25x exit EV/Sales) yields ~$353/share in year 5, a 7.2%/yr IRR vs the 15% gate; probability-weighted PV is ~$216 vs $249.62, a 0.87x ratio vs the 1.3x gate. Passing base-IRR requires ~$176 or below and the PW gate ~$166 or below; both gates clear at or below roughly $165 (~34% down), which we register as the actionable entry zone. Forcing a pass at $249.62 would require ~22%+ five-year revenue CAGR AND a 4x+ exit multiple as the BASE case \u2014 indefensible given the spin removes ~$1.13B of revenue and mature climate comps sit at 2.5-4x sales. What is verified from primary filings: FY26 revenue $3,181.1M, net debt $362.8M (total debt $436.3M less cash $73.5M), diluted WA shares 54.0M (Q4), adjusted EBITDA $471.0M, FCF $105.4M, DC $1.1B +73%, FY27 guidance, and RMT terms \u2014 all from the 8-K of 2026-05-26 and 8-K of 2026-01-29. Estimates/caveats: (1) price $249.62 is the 2026-07-23 close per stockanalysis.com, not an exchange feed; (2) our theme note said ~38% DC exposure \u2014 the filed math is ~35% ($1.1B/$3.18B), Q4 run-rate ~42%; we use the filed figure; (3) exact DC revenue is disclosed narratively (\"$1.1 billion\", \">$400 million\" in Q4), not as an audited segment line; (4) the $4B agreement's customer-side commitment structure (take-or-pay vs forecast) is not disclosed \u2014 we flag it as a risk rather than assume protection; (5) the valuation formula cannot represent the RMT mechanics: shareholders receive ~$790M of Gentherm stock (~$15/MOD share) plus Modine gets ~$210M cash, which we approximated by modeling consolidated-equivalent CAGR on the FY26 base \u2014 this slightly flatters revenue CAGR but is the least-distorting mapping available; (6) TTM = FY2026 because Q1 FY27 reports 2026-07-29, days after this analysis \u2014 a strong beat-and-raise could move the entry zone up, but not by the ~34% needed to clear the gates.", "financials": { "as_of": "2026-07-23", "citations": [ "8-K Ex-99.1 (Q4/FY2026 earnings release), fiscal year ended 2026-03-31, filed 2026-05-26 (sec.gov/Archives/edgar/data/0000067347/000110465926066291/mod-20260526xex99d1.htm) \u2014 FY26 net sales $3,181.1M; adjusted EBITDA $471.0M; adjusted EPS $5.02; free cash flow $105.4M", "Same 8-K, net debt reconciliation \u2014 total debt $436.3M (debt due within one year $51.4M + long-term debt $384.9M) less cash and cash equivalents $73.5M = net debt $362.8M at 2026-03-31; diluted weighted-average shares 54.0M (Q4 FY26; 53.8M full year)", "Same 8-K \u2014 Data Centers sales +73% to $1.1B in FY26 (Q4 +158%, >$400M); Climate Solutions FY26 sales $2,062.3M, adjusted EBITDA $377.1M (18.3%); FY2027 outlook: net sales +20% to +35%, adjusted EBITDA $650-680M; >$4B CY2027-2029 hyperscale capacity agreement for chillers", "8-K filed 2026-01-29 (Modine/Gentherm announcement) \u2014 Performance Technologies Reverse Morris Trust: PT valued ~$1.0B (6.8x TTM adjusted EBITDA), ~$210M cash to Modine, ~$790M Gentherm stock to Modine shareholders (40% of combined company), targeted close Q4 CY2026", "Share price $249.62 at 2026-07-23 close, market cap $13.26B, 53.11M shares outstanding, 52-week range $94.55-$323.25, next earnings 2026-07-29 \u2014 stockanalysis.com/stocks/mod/" ], "net_debt": 362800000, "price": 249.62, "rev_ttm": 3181100000, "shares_diluted": 54000000 }, "kill_conditions": [ "Data Centers product-group revenue declines year-over-year for two consecutive fiscal quarters (disclosed in each Modine earnings release/10-Q segment commentary).", "Contract liabilities (customer deposits, balance sheet / cash-flow statement) decline sequentially for two consecutive quarters \u2014 FY26 booked a +$159.0M inflow; a sustained reversal means the order book is eroding ahead of reported revenue.", "Climate Solutions adjusted EBITDA margin prints below 16.0% for two consecutive quarters (vs 18.3% in FY26 and ~21% in FY25), evidence that 'temporary' capacity-expansion costs are structural price/mix deterioration.", "The >$4B CY2027-2029 hyperscale capacity agreement is terminated, materially reduced, or visibly under-utilized \u2014 cumulative revenue attributed to it running below ~$1.0B/year during CY2027-2029 (vs >$1.33B/yr pro-rata) per filings/earnings calls.", "The Gentherm Reverse Morris Trust terminates (8-K) without an alternative Performance Technologies separation announced within two quarters, freezing data-center exposure near ~35% of consolidated revenue." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 70, "name": "loss", "p": 0.05 }, { "dilution_pa": 0.005, "exit_multiple": 1.8, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "rev_cagr_5y": 0.04 }, { "dilution_pa": 0.005, "exit_multiple": 3.25, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "rev_cagr_5y": 0.14 }, { "dilution_pa": 0.005, "exit_multiple": 4, "multiple_type": "ev_sales", "name": "bull", "p": 0.25, "rev_cagr_5y": 0.22 } ], "statement": "After the Gentherm spin-off closes (targeted Q4 CY2026), Modine becomes a majority data-center-cooling company: Data Centers revenue of $1.1B in FY26 (+73%) compounds roughly 25%/yr through FY2031, underwritten by a >$4B CY2027-29 hyperscale capacity agreement, while Climate Solutions adjusted EBITDA margin recovers above 20% as capacity-expansion costs roll off. At $249.62 the market already pays ~21x FY27 guided EBITDA for that outcome, so the defensible base case returns only ~7%/yr over five years \u2014 the business thesis is confirmed but the price fails our gates, making this a watchlist entry at or below ~$165. It is falsified by two consecutive quarters of year-over-year Data Centers revenue decline, sequential contract-liability drawdown, or Climate Solutions adjusted EBITDA margin below 16%.", "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "MOD", "version": 1 }, "theme": "AI Physical Infrastructure", "theme_slug": "ai-infrastructure", "ticker": "MOD", "valuation": { "base_irr": 0.0718, "discount_rate": 0.1, "ev_to_price": 0.866, "expected_pv": 216.05, "gates": { "base_irr_gate": { "actual": 0.0718, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.866, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2245, "multiple_type": "ev_sales", "name": "loss", "p": 0.05, "price_5y": 70.0, "pv_today": 70.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 1.8, "irr_5y": -0.1373, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "price_5y": 119.28, "pv_today": 74.06, "rev_cagr_5y": 0.04, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 3.25, "irr_5y": 0.0718, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "price_5y": 353.0, "pv_today": 219.18, "rev_cagr_5y": 0.14, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 4.0, "irr_5y": 0.1975, "multiple_type": "ev_sales", "name": "bull", "p": 0.25, "price_5y": 614.62, "pv_today": 381.63, "rev_cagr_5y": 0.22, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 249.62, "growth_rows": [ 0.04, 0.09, 0.14, 0.19, 0.24 ], "multiple_cols": [ 1.62, 2.44, 3.25, 4.06, 4.88 ], "pv_grid": [ [ 66.25, 101.84, 137.0, 172.16, 207.76 ], [ 84.86, 129.87, 174.34, 218.8, 263.81 ], [ 107.21, 163.54, 219.18, 274.83, 331.15 ], [ 133.86, 203.67, 272.63, 341.59, 411.41 ], [ 165.37, 251.14, 335.85, 420.57, 506.34 ] ] } }, "version": 1 }, "38dd7bbbd0cab8395a43a34a7f5f9e7b1b6976f0b22988d58d77a71c712baf00": { "actionable_below": 101.65, "company": "Centrus Energy Corp", "kind": "watchlist_note", "markdown": "## Thesis\n\nCentrus is the only U.S.-owned uranium enricher and the only NRC-licensed HALEU producer, with a $3.9B backlog extending to 2040 and a signed $900M DOE task order that converts its Piketon cascade from demonstration to commercial operation \u2014 over five years its revenue should roughly triple as HALEU production and expanded LEU capacity come online. At $170.78 (~6x TTM sales), however, the market already pays for most of that build-out: our defensible base case yields only ~6%/yr and a probability-weighted PV of ~0.77x price, so this publishes as a watchlist thesis with an entry zone near $100-110, not a buy at today's price. The operating thesis is falsified if backlog drops below $3.5B for two consecutive quarters, cumulative DOE obligations under the $900M task order stall below $300M by the FY2027 10-K, or TENEX deliveries halt without offsetting domestic volume.\n\n## Why Now\n\nThe inflection is contractual, not narrative, and it is dated to the last eight months of filings. The FY2025 10-K (filed 2026-02-11) reported revenue of $448.7M (LEU segment $346.2M, Technical Solutions $102.5M) and net income of $77.8M ($3.90 diluted), and disclosed DOE's selection of Centrus for a $900.0M HALEU production award. The Q1 2026 10-Q (period ended 2026-03-31, filed 2026-05-06) then showed the order book that award anchors: total backlog of $3.9B extending to 2040 \u2014 $3.1B in the LEU segment (including $2.4B of contingent sales contracts, all under definitive agreements, tied to construction of new LEU capacity at Piketon) and $0.8B in Technical Solutions. Q1 revenue was $76.7M versus $73.1M a year earlier (Q1 2025 10-Q, filed 2025-05-08), and management raised 2026 revenue guidance to $450-500M from $425-475M while guiding $350-500M of capital deployment \u2014 the clearest signal yet that the expansion is moving from optionality to construction.\n\nThe decisive event came after quarter-end: on June 30, 2026, Centrus's subsidiary American Centrifuge Operating signed the $900M DOE task order (competitively awarded in January 2026 as part of DOE's ~$2.7B enrichment awards), which both funds HALEU expansion and clears the Piketon cascade to transition from government-funded demonstration to commercial operation. Centrus completed the final 900 kg deliverable under the demonstration contract in mid-June 2026, bringing cumulative HALEU output above 1,900 kg \u2014 it remains the only entity that has actually produced HALEU at scale on U.S. soil with U.S. technology. In parallel, the company announced a $560M centrifuge-manufacturing expansion at Oak Ridge with Fluor and Palantir.\n\nThe balance sheet was pre-funded into 2025's nuclear-equity froth: cash and equivalents of $1,868.2M against $1,176.1M of long-term debt at March 31, 2026 (Q1 2026 10-Q) \u2014 roughly $690M of net cash \u2014 after convertible raises took long-term debt from $390M (June 2025) to $1,173.5M (Q3 2025 10-Q, filed 2025-11-06) and diluted weighted-average shares from 16.4M (FY2024 10-K) to 22.4M (Q1 2026 10-Q). That financing is why the expansion is credible; it is also why the stock is no longer cheap on a per-share basis. Finally, the regulatory clock is the forcing function: the Prohibiting Russian Uranium Imports Act bans Russian LEU through 2040, and Centrus's DOE waiver covers only committed deliveries through 2027 \u2014 every year that passes converts Centrus's Russian-supplied legacy book into a build-or-die case for the domestic capacity its $2.4B contingent backlog is contracted against.\n\n## Business Quality\n\nThe moat is licensure and incumbency in a market where entry takes a decade. Centrus is the only U.S.-owned, U.S.-technology enricher (Urenco USA and Orano's planned plant are European-owned, which matters for defense-adjacent and HALEU-for-government work), and it holds the only NRC license for HALEU production \u2014 with more than 1,900 kg actually produced, versus zero for every would-be competitor. The $3.9B backlog to 2040 embeds long-dated utility relationships, and the $2.4B contingent tranche is under definitive agreements \u2014 customers have already signed for output from capacity that doesn't exist yet, which is as strong a demand signal as this industry produces. Enrichment at scale is a superb business: Urenco, the mature comp, runs ~50% EBITDA margins on take-or-pay contracts.\n\nToday's unit economics are more modest than the endgame. FY2025 gross margin was ~26% ($117.5M on $448.7M), because the LEU segment largely resells Russian (TENEX) and other purchased SWU rather than self-produced material, and Technical Solutions is substantially cost-reimbursable government work. The bridge from 26%-gross-margin reseller to Urenco-like producer economics runs straight through a multi-billion-dollar, multi-year centrifuge build \u2014 nuclear construction, with all the schedule risk that implies. Q1 2026 already shows the shape of the transition: net income fell to $10.0M from $27.2M on higher advanced-technology spend even as revenue grew.\n\nCapital allocation has been opportunistic and, so far, shrewd: management sold equity and convertibles aggressively into the 2025 run-up (the stock touched $464 in late 2025), banking $1.87B of cash before the froth unwound \u2014 dilution of ~37% in diluted share count over five quarters was real, but it pre-funded the first expansion phases and the $900M task order shifts a large slice of HALEU capex onto the government. Competition is arriving \u2014 DOE deliberately split ~$2.7B across multiple awardees, Urenco is expanding Eunice, and Orano has announced a U.S. plant \u2014 but the constraint on all of them is the same licensing-and-construction decade Centrus has already spent. The realistic risk is not displacement; it is that Centrus builds slower and more expensively than the contracts assume, while the resale book that funds the interim shrinks under the Russian import ban.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $452M, 22.4M diluted shares, net debt of $-689M, and a share price of $170.78. Sources:\n\n- 10-Q Q1 FY2026 (period 2026-03-31), filed 2026-05-06 \u2014 Q1 revenue $76.7M; cash & equivalents $1,868.2M; long-term debt $1,176.1M; diluted weighted-average shares 22,446,000; backlog $3.9B to 2040 ($3.1B LEU incl. $2.4B contingent, $0.8B Technical Solutions)\n- 10-K FY2025, filed 2026-02-11 \u2014 FY2025 revenue $448.7M (LEU $346.2M, Technical Solutions $102.5M); net income $77.8M; diluted EPS $3.90; DOE selection for $900M HALEU award\n- 10-Q Q1 FY2025, filed 2025-05-08 \u2014 Q1 2025 revenue $73.1M (TTM bridge: $448.7M \u2212 $73.1M + $76.7M = $452.3M)\n- 10-Q Q3 FY2025, filed 2025-11-06 \u2014 long-term debt $1,173.5M at 2025-09-30 (post-convertible raise), cash $1,631.8M\n- Company press release 2026-06-30 (8-K) \u2014 $900M DOE task order signed by American Centrifuge Operating; cumulative HALEU production >1,900 kg; Piketon cascade transitioning to commercial operation\n- Share price $170.78 at 2026-07-23 close per stockanalysis.com (market cap $3.36B on 19.67M shares outstanding); net debt = $1,179.0M total debt \u2212 $1,868.2M cash = \u2212$689.2M\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (10%): DOE appropriations for the task order are curtailed and the Piketon LEU expansion never reaches FID, while TENEX supply is severed (Russian export-license denial or waiver lapse post-2027) before domestic capacity replaces it; the $2.4B contingent backlog lapses and the company burns build capital against a shrinking resale book, reverting toward net cash plus a legacy contracting business.\n- **Bear** (25%): Advanced-reactor (SMR) deployment slips years, HALEU demand beyond the government program fails to materialize, and the LEU capacity expansion is shelved; revenue compounds only ~8%/yr on Technical Solutions and the existing book, and the market re-rates Centrus to a no-growth government contractor at ~3x EV/sales (low end of BWXT's historical 3-5x range).\n- **Base** (45%): The $900M task order executes on schedule, the Oak Ridge manufacturing expansion delivers centrifuges, and the first Piketon LEU expansion phase reaches FID by 2027 and first revenue ~2030, lifting revenue to ~$1.2B by mid-2031 (22%/yr); exit at 4.5x EV/sales, mid-range of mature government-nuclear comps (BWXT historical 3-5x, Cameco pre-froth 4-6x), justified by Urenco-like margin potential not yet proven.\n- **Bull** (20%): Full national-champion outcome: the $2.4B contingent backlog converts to firm as multiple Piketon phases are funded (further DOE awards plus allied-government offtake), HALEU commercial demand arrives with the first operating SMRs, and revenue reaches ~$1.8B by 2031 (32%/yr); exit at 6x EV/sales, a strategic-asset premium defensible only if Urenco-like ~50% EBITDA margins are demonstrated.\n\n## Kill Conditions\n\n1. Total backlog falls below $3.5B for two consecutive quarterly 10-Qs (from $3.9B at Q1 2026) \u2014 contingent contracts lapsing rather than converting to firm.\n2. Cumulative DOE obligations/funding disclosed under the $900M HALEU task order fail to reach $300M by the FY2027 10-K, or the task order is descoped or terminated.\n3. TENEX deliveries halt (Russian export-license denial or U.S. waiver lapse for 2027+) AND LEU segment revenue declines >25% year-over-year for two consecutive quarters without offsetting domestic production revenue.\n4. No final investment decision announced on the Piketon LEU capacity expansion by the FY2027 10-K (Feb 2028) while the $2.4B contingent LEU backlog shrinks sequentially for two quarters.\n5. Cash and equivalents fall below $750M in any 10-Q before first revenue from expanded LEU capacity, without a matching increase in property, plant & equipment (burn not converting into productive assets).\n\n## Risk Register\n\n- Russian supply dependence \u2014 HIGH: TENEX remains Centrus's largest LEU supplier under the 2011 contract; the DOE waiver covers only committed deliveries through 2027, Russia has already imposed shipment-by-shipment export licensing, and the LEU segment was $346.2M (77%) of FY2025 revenue.\n- Nuclear construction execution \u2014 HIGH: the base case requires a first-of-a-kind-scale centrifuge plant to reach revenue by ~2030; the industry's base rate for on-time, on-budget nuclear construction is poor.\n- Valuation / multiple compression \u2014 HIGH: at $170.78 the stock trades ~60x TTM earnings and ~6x TTM sales, already 63% off its October 2025 high of $464; the 2025 nuclear froth unwind is incomplete.\n- Government dependence \u2014 MEDIUM-HIGH: the $900M task order and much of Technical Solutions are subject to annual appropriations and DOE program continuity.\n- HALEU demand timing \u2014 MEDIUM-HIGH: no advanced reactor that burns HALEU is yet in commercial operation; if TerraPower/X-energy/Oklo timelines slip, commercial HALEU demand slips with them.\n- Dilution \u2014 MEDIUM: diluted weighted-average shares grew ~37% in five quarters (16.4M FY2024 to 22.4M Q1 2026); a multi-phase build likely requires more equity than our 4%/yr base assumption.\n- Emerging competition \u2014 MEDIUM: DOE split ~$2.7B across multiple enrichment awardees; Urenco USA is expanding Eunice and Orano has announced a U.S. plant, capping long-run pricing.\n- Legacy liabilities \u2014 LOW-MEDIUM: pension and decommissioning-era obligations from the USEC inheritance remain on the balance sheet.\n\n## Theme Position\n\nRevenue exposure to the nuclear-fuel-cycle theme is effectively **100%**: the LEU segment ($346.2M, 77% of FY2025 revenue) sells enriched uranium and SWU to utilities, and Technical Solutions ($102.5M, 23%) is fuel-cycle engineering and the HALEU demonstration/production work itself. No other listed company offers pure-play exposure to U.S. enrichment \u2014 the single most supply-constrained link in the Western fuel cycle.\n\nAlternatives considered: **Cameco (CCJ)** \u2014 the highest-quality diversified play (mining + Westinghouse), but it is a ~$25B+ company whose enrichment exposure is nil and whose theme upside is spread across links that are not supply-constrained; it dilutes the specific angle. **BWXT** \u2014 mature, superbly run government nuclear franchise, but it makes reactor components and naval fuel, not commercial enrichment; it is the comp for our exit multiple, not the vehicle for the thesis. **Oklo / ASP Isotopes / General Matter / Silex-GLE** \u2014 the HALEU-adjacent field is either pre-revenue, private, or carrying unproven technology risk (laser enrichment); none has an NRC production license or a kilogram of output. Urenco and Orano, the incumbent enrichers, are unlisted. Centrus is the only investable security whose equity value is a direct function of whether America rebuilds domestic enrichment \u2014 which is precisely the theme.\n\n## Benchmark\n\nBeating means LEU total return exceeds QQQ total return over the full 5-year window from publication date (2026-07-24). Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Contracted backlog $3.9B as of 2026-03-31, extending to 2040 \u2014 $3.1B LEU segment (of which $2.4B contingent on new Piketon capacity, all under definitive agreements) plus $0.8B Technical Solutions (Q1 2026 10-Q, filed 2026-05-06). Secondary reading: cumulative U.S. HALEU production surpassed 1,900 kg by mid-June 2026, and the $900M DOE task order was signed 2026-06-30 (company 8-K/press release).", "company": "Centrus Energy Corp", "confidence_notes": "THE GATES FAIL AT TODAY'S PRICE \u2014 this is a watchlist note, not a buy. Base case (22% revenue CAGR to ~$1.2B, 4.5x EV/sales exit, 4%/yr dilution) produces a year-5 price of ~$227: a 5.8%/yr IRR versus the 15% gate. Probability-weighted PV is ~$132 versus $170.78 \u2014 0.77x versus the 1.3x gate. We did not torture assumptions to close the gap because it cannot be closed defensibly: passing the IRR gate at today's price requires ~31%/yr revenue CAGR at 5x sales (i.e., our bull case as the base case). Both gates pass at an entry price of roughly $100-110 ($112.70 for the IRR gate, $101.66 for the PV gate) \u2014 a level the stock traded near within the past twelve months (52-week low $142 is above it, but the stock is 63% off its $464 high and remains volatile). VERIFIED NUMBERS: TTM revenue $452.3M (bridged from FY2025 10-K + Q1 10-Qs, cross-checked against stockanalysis.com), cash $1,868.2M, LT debt $1,176.1M, and diluted WA shares 22,446,000 all confirmed via SEC XBRL company-facts data from the Q1 2026 10-Q (filed 2026-05-06). ESTIMATES/CAVEATS: (1) Price $170.78 is the 2026-07-23 close per stockanalysis.com; intramonth quotes ranged $149-174, so gate arithmetic moves \u00b110% with the tape \u2014 at no plausible July price do the gates pass. (2) Net debt \u2212$689.2M uses total debt $1,179M (incl. ~$3M current portion, from an aggregator; the XBRL-verified LT figure is $1,176.1M \u2014 immaterial difference). (3) Using 22.45M diluted shares AND full convertible debt double-counts the converts conservatively; the generous if-converted treatment lifts base IRR only to 9.6% \u2014 the gate failure is robust. (4) The formula credits today's $689M net cash to year-5 equity, but 2026 capital-deployment guidance alone is $350-500M; realistic year-5 net debt makes every scenario worse, reinforcing the verdict. (5) The $3.9B headline backlog includes $2.4B contingent on capacity that requires FID \u2014 firm backlog is ~$1.5B. (6) The >1,900 kg HALEU figure and $900M task-order signing are from the 2026-06-30 press release/8-K, not yet in a 10-Q. (7) 2025 composition of the ~$785M Q3 2025 debt raise (convertible terms) was not individually verified; the $1,176.1M total is XBRL-confirmed. ACTION: publish as watchlist with alert at $110; re-run gates on any pullback or on evidence (Piketon FID, contingent-to-firm conversion) that defensibly lifts the base CAGR above ~25%.", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q Q1 FY2026 (period 2026-03-31), filed 2026-05-06 \u2014 Q1 revenue $76.7M; cash & equivalents $1,868.2M; long-term debt $1,176.1M; diluted weighted-average shares 22,446,000; backlog $3.9B to 2040 ($3.1B LEU incl. $2.4B contingent, $0.8B Technical Solutions)", "10-K FY2025, filed 2026-02-11 \u2014 FY2025 revenue $448.7M (LEU $346.2M, Technical Solutions $102.5M); net income $77.8M; diluted EPS $3.90; DOE selection for $900M HALEU award", "10-Q Q1 FY2025, filed 2025-05-08 \u2014 Q1 2025 revenue $73.1M (TTM bridge: $448.7M \u2212 $73.1M + $76.7M = $452.3M)", "10-Q Q3 FY2025, filed 2025-11-06 \u2014 long-term debt $1,173.5M at 2025-09-30 (post-convertible raise), cash $1,631.8M", "Company press release 2026-06-30 (8-K) \u2014 $900M DOE task order signed by American Centrifuge Operating; cumulative HALEU production >1,900 kg; Piketon cascade transitioning to commercial operation", "Share price $170.78 at 2026-07-23 close per stockanalysis.com (market cap $3.36B on 19.67M shares outstanding); net debt = $1,179.0M total debt \u2212 $1,868.2M cash = \u2212$689.2M" ], "net_debt": -689200000, "price": 170.78, "rev_ttm": 452300000, "shares_diluted": 22446000 }, "kill_conditions": [ "Total backlog falls below $3.5B for two consecutive quarterly 10-Qs (from $3.9B at Q1 2026) \u2014 contingent contracts lapsing rather than converting to firm.", "Cumulative DOE obligations/funding disclosed under the $900M HALEU task order fail to reach $300M by the FY2027 10-K, or the task order is descoped or terminated.", "TENEX deliveries halt (Russian export-license denial or U.S. waiver lapse for 2027+) AND LEU segment revenue declines >25% year-over-year for two consecutive quarters without offsetting domestic production revenue.", "No final investment decision announced on the Piketon LEU capacity expansion by the FY2027 10-K (Feb 2028) while the $2.4B contingent LEU backlog shrinks sequentially for two quarters.", "Cash and equivalents fall below $750M in any 10-Q before first revenue from expanded LEU capacity, without a matching increase in property, plant & equipment (burn not converting into productive assets)." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 50, "name": "loss", "p": 0.1 }, { "dilution_pa": 0.03, "exit_multiple": 3, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "rev_cagr_5y": 0.08 }, { "dilution_pa": 0.04, "exit_multiple": 4.5, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "rev_cagr_5y": 0.22 }, { "dilution_pa": 0.06, "exit_multiple": 6, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.32 } ], "statement": "Centrus is the only U.S.-owned uranium enricher and the only NRC-licensed HALEU producer, with a $3.9B backlog extending to 2040 and a signed $900M DOE task order that converts its Piketon cascade from demonstration to commercial operation \u2014 over five years its revenue should roughly triple as HALEU production and expanded LEU capacity come online. At $170.78 (~6x TTM sales), however, the market already pays for most of that build-out: our defensible base case yields only ~6%/yr and a probability-weighted PV of ~0.77x price, so this publishes as a watchlist thesis with an entry zone near $100-110, not a buy at today's price. The operating thesis is falsified if backlog drops below $3.5B for two consecutive quarters, cumulative DOE obligations under the $900M task order stall below $300M by the FY2027 10-K, or TENEX deliveries halt without offsetting domestic volume.", "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "LEU", "version": 1 }, "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "LEU", "valuation": { "base_irr": 0.0583, "discount_rate": 0.1, "ev_to_price": 0.774, "expected_pv": 132.15, "gates": { "base_irr_gate": { "actual": 0.0583, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.774, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2178, "multiple_type": "ev_sales", "name": "loss", "p": 0.1, "price_5y": 50.0, "pv_today": 50.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.03, "exit_multiple": 3.0, "irr_5y": -0.096, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "price_5y": 103.11, "pv_today": 64.02, "rev_cagr_5y": 0.08, "terminal_margin": 0.0 }, { "dilution_pa": 0.04, "exit_multiple": 4.5, "irr_5y": 0.0583, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "price_5y": 226.67, "pv_today": 140.74, "rev_cagr_5y": 0.22, "terminal_margin": 0.0 }, { "dilution_pa": 0.06, "exit_multiple": 6.0, "irr_5y": 0.1765, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "price_5y": 385.0, "pv_today": 239.06, "rev_cagr_5y": 0.32, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 170.78, "growth_rows": [ 0.12, 0.17, 0.22, 0.27, 0.32 ], "multiple_cols": [ 2.25, 3.38, 4.5, 5.62, 6.75 ], "pv_grid": [ [ 56.45, 76.93, 97.23, 117.53, 138.01 ], [ 66.4, 91.88, 117.13, 142.38, 167.86 ], [ 78.21, 109.62, 140.74, 171.87, 203.28 ], [ 92.12, 130.51, 168.56, 206.62, 245.01 ], [ 108.4, 154.97, 201.13, 247.28, 293.85 ] ] } }, "version": 1 }, "2ab746d6da92407326ac475ab2c43747ccc5bd31752d95dcb6c2e8c777dde6ee": { "actionable_below": 93.44, "company": "BWX Technologies, Inc.", "kind": "watchlist_note", "markdown": "## Thesis\n\nBWXT is the sole manufacturer of nuclear reactors and fuel for the U.S. Navy and the most complete investable expression of the nuclear-fuel-cycle build-out, with backlog up 77% year-over-year to $8.65B and 2026 revenue guided above $3.75B. The falsifiable claim: backlog and Government Operations revenue keep growing through 2031 as Columbia/Virginia-class production, HALEU/TRISO special materials, and SMR component orders convert \u2014 falsified if backlog drops below $7.0B for two consecutive quarters or Government segment revenue declines year-over-year for two straight quarters. However, at $176.67 (47x trailing EPS, ~5.2x EV/TTM sales) a defensible base case returns roughly 2%/yr over five years, so this publishes as a watchlist thesis with a buy trigger near $95, not an actionable buy.\n\n## Why Now\n\nThe inflection is visible in three consecutive filings. Backlog went from $4.9B at Q1 2025 to $7.3B at year-end 2025 (up 50% year-over-year, per the Q4/FY2025 earnings release furnished on Form 8-K, 2026-02-23) to $8.65B at Q1 2026 \u2014 up 77% year-over-year and 19% sequentially (Q1 2026 earnings release/10-Q, filed 2026-05-04). Management says roughly 60% of that backlog converts to revenue by end of 2027, with a further $2.37B of unfunded government backlog sitting outside the reported figure. This is not booked hope: Q1 2026 revenue grew 26% to $860.2M (11% organic), and the company raised full-year 2026 guidance across the board \u2014 revenue above $3.75B, adjusted EBITDA $650\u2013665M, non-GAAP EPS $4.60\u20134.75, free cash flow $315\u2013330M \u2014 one quarter into the year.\n\nThe 2025 base it builds on was itself a record. FY2025 revenue was $3,198.4M, up 18.3% (10-K filed 2026-02-23), split between Government Operations at $2.35B (+8%, driven by naval nuclear components and special materials processing) and Commercial Operations at $853.1M (+63%, driven by field services, nuclear fuel and components, medical, and the $525M Kinectrics acquisition that closed May 20, 2025). Free cash flow was $295.3M on operating cash flow of $479.8M.\n\nThe bookings pipeline extended after the quarter closed: on May 7, 2026 BWXT announced more than $1.4B in Naval Nuclear Propulsion Program contracts, including a $1.285B long-lead materials award that is the first of five annual task orders running through 2030 \u2014 effectively pre-funding the Columbia-class and Virginia-class reactor cadence into the next decade. On the fuel-cycle frontier, BWXT's TRISO fuel enabled the first new U.S. reactor criticality under the DOE's advanced reactor program (announced June 4, 2026), evidence that its special materials franchise is converting from R&D spend into production programs. The why-now, bluntly: the order book has roughly doubled in five quarters and the market has noticed \u2014 which is precisely the problem for the entry price.\n\n## Business Quality\n\nBWXT is one of the few genuine monopolies in American industry. It is the sole designer and manufacturer of nuclear reactors, reactor components, and fuel for every U.S. Navy submarine and aircraft carrier, and operates the only private facilities licensed by the NRC to handle highly enriched uranium at Category 1 levels. The switching cost is not a moat metaphor \u2014 there is no second source, qualification would take a decade-plus and billions of dollars, and the May 2026 award structure (five annual task orders through 2030) shows the Navy planning around BWXT's capacity, not shopping against it. Roughly 70% of revenue comes from the U.S. government under long-cycle contracts with substantial cost-recovery features, which caps margin upside but also truncates downside.\n\nThe economics are good but not software-like: FY2025 adjusted EBITDA of $574.3M on $3,198.4M of revenue is an ~18% margin, and free cash flow of $295.3M is a ~9% FCF margin, held down by elevated growth capex in special materials and the Cambridge (Ontario) manufacturing expansion. Q1 2026 adjusted EBITDA of $148.0M grew 14% \u2014 slower than the 26% revenue growth, because acquired Kinectrics revenue and special materials volume carry lower initial margins. The bet embedded in any bull case is that margins recover toward historical levels as first-of-a-kind programs mature.\n\nCompetitively, the naval franchise has no rival; commercial nuclear components face Curtiss-Wright, Framatome, and Doosan, but BWXT's CANDU refurbishment position (deepened by Kinectrics) and its selection for SMR reactor pressure vessels give it the strongest North American seat. Capital allocation is disciplined and dull in the right way: a small growing dividend, bolt-on M&A (Kinectrics at $525M, closed May 2025), and modest buybacks. Net debt of ~$1.51B against ~$590M of TTM adjusted EBITDA is ~2.5x \u2014 reasonable for the contract durability, though higher than its history after the acquisition spree.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $3,376M, 91.9M diluted shares, net debt of $1,506M, and a share price of $176.67. Sources:\n\n- 10-Q Q1 FY2026 (period ended 2026-03-31, filed 2026-05-04) \u2014 Q1 revenue $860.217M; cash & equivalents $512.357M; long-term debt $2,017.946M; weighted-average diluted shares 91,908,600 (all via SEC XBRL company facts)\n- 10-K FY2025 (filed 2026-02-23) \u2014 FY2025 revenue $3,198.425M; Q4 2025 revenue $885.842M; current maturities of long-term debt $0 at 2025-12-31; FY diluted shares 91,856,013\n- 10-Q Q2 FY2025 (period ended 2025-06-30, filed 2025-08-04) \u2014 Q2 2025 revenue $764.039M\n- 10-Q Q3 FY2025 (period ended 2025-09-30, filed 2025-11-03) \u2014 Q3 2025 revenue $866.286M; TTM = 764.039 + 866.286 + 885.842 + 860.217 = $3,376.384M\n- Q1 2026 earnings release (8-K furnished 2026-05-04) \u2014 backlog $8.65B (+77% YoY), 2026 guidance raised: revenue >$3.75B, adj. EBITDA $650\u2013665M, non-GAAP EPS $4.60\u20134.75, FCF $315\u2013330M\n- Share price $176.67 at 2026-07-23 close (stockanalysis.com); market cap ~$16.2B; trailing P/E ~47x\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (5%): A severe nuclear-safety incident at a BWXT facility, loss or forced second-sourcing of the sole-source naval position, or a major fixed-price program blowup impairs the franchise; $55 (~31% of price) reflects residual value of irreplaceable licensed infrastructure even in a wipeout of the growth narrative.\n- **Bear** (25%): Naval budgets flatten, Columbia-class cadence stretches, SMR component orders slip past 2031, and medical stays subscale; growth reverts to the segment's pre-2024 high-single-digit rate and the multiple compresses to 3.0x EV/sales \u2014 still a premium to mature defense primes (GD ~1.9x, HII ~1.6x) for the monopoly position.\n- **Base** (50%): Backlog converts on schedule: 2026 guidance (+11%) extends as naval task orders, special materials, Kinectrics-boosted commercial, and medical compound at ~12%/yr; FCF margin expands from ~9% to 12% as growth capex normalizes; 28x terminal FCF is a quality premium over mature defense primes (15\u201320x) justified by sole-source durability, but below today's ~55x.\n- **Bull** (20%): AUKUS adds a submarine production tranche, BWRX-300 fleet orders scale SMR components, HALEU/TRISO becomes a production business, and medical isotopes hit; 16%/yr growth with 13% FCF margins earns a persistent scarcity multiple of 32x.\n\n## Kill Conditions\n\n1. Total backlog declines for two consecutive quarters and finishes below $7.0B (vs $8.65B at Q1 2026) \u2014 checkable in every quarterly earnings release/10-Q.\n2. Government Operations segment revenue posts negative year-over-year growth for two consecutive quarters (segment note in each 10-Q) \u2014 would indicate the naval/special-materials engine is stalling despite backlog.\n3. Full-year free cash flow comes in below $250M against 2026 guidance of $315\u2013330M, or annual FCF conversion falls below 40% of adjusted EBITDA \u2014 signals backlog is converting into working capital and capex, not cash.\n4. Net debt exceeds 3.5x TTM adjusted EBITDA for two consecutive quarters without a newly closed acquisition explaining the step-up (~2.5x at Q1 2026).\n5. The Navy or DOE awards any reactor-plant component or naval fuel scope BWXT currently sole-sources to a second supplier (visible in DoD contract announcements or a changed competition disclosure in the 10-K).\n\n## Risk Register\n\n- Valuation \u2014 HIGH: at 47x trailing EPS, ~5.2x EV/TTM sales, and ~55x TTM FCF, the price already embeds most of the base case; multiple compression alone can produce years of dead money even if the business executes.\n- Customer concentration \u2014 HIGH: ~70% of revenue is U.S. government; continuing resolutions, shutdowns, or a shipbuilding-budget rephasing directly hit revenue timing.\n- First-of-a-kind execution \u2014 MEDIUM: microreactors (Pele), HALEU/enrichment scale-up, and TRISO production carry cost-overrun risk on partially fixed-price structures; Q1 2026 already showed lower microreactor volumes.\n- Margin mix \u2014 MEDIUM: EBITDA growing slower than revenue (14% vs 26% in Q1 2026) as lower-margin acquired and special-materials revenue scales; the base case requires this to reverse.\n- Integration and leverage \u2014 MEDIUM: $525M Kinectrics deal nearly doubled Commercial Operations headcount; net leverage ~2.5x is manageable but above history.\n- Nuclear-sentiment reversal \u2014 MEDIUM: the whole fuel-cycle complex (CCJ, LEU, SMR names) trades on policy enthusiasm; a sentiment break compresses BWXT's multiple regardless of backlog.\n- Operational/nuclear incident \u2014 LOW probability, HIGH severity: Category 1 HEU handling concentrates catastrophic tail risk in a small number of licensed facilities.\n\n## Theme Position\n\nEffectively **100% of BWXT's revenue is nuclear**, and most of it touches the fuel cycle directly: naval nuclear fuel and downblending of highly enriched uranium, HALEU and TRISO fuel fabrication for DOE advanced-reactor programs (Government Operations, $2.35B in FY2025), and CANDU fuel, components, refurbishment services, and medical isotopes in Commercial Operations ($853.1M in FY2025, +63% with Kinectrics). No other listed company spans defense and civilian fuel-cycle demand with sole-source economics on the defense side.\n\nAlternatives considered: **Cameco (CCJ)** \u2014 the default fuel-cycle name, but it is uranium-price beta with commodity-cycle risk and already the consensus holding; it lacks BWXT's contracted-monopoly downside protection. **Centrus (LEU)** \u2014 the purest HALEU enrichment play with more upside torque, but concentrated in a single facility, dependent on DOE appropriations for its economics, and carrying Russian-LEU supply entanglement; it is a call option, not a compounder. **Curtiss-Wright (CW)** \u2014 quality operator with SMR content, but nuclear is a minority of revenue, so it dilutes the theme. BWXT was chosen as the highest-quality expression of the theme; the honest finding of this note is that quality is not mispriced \u2014 it is over-priced.\n\n## Benchmark\n\nBeating means BWXT total return exceeds QQQ total return over the five-year window from publication; at today's entry multiple our base case implies it does not. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Total backlog $8.65B at Q1 2026, up 77% year-over-year and 19% sequentially, with ~60% expected to convert by end of 2027 (Q1 2026 earnings release furnished on Form 8-K and 10-Q, both 2026-05-04).", "company": "BWX Technologies, Inc.", "confidence_notes": "Hard numbers are strong: TTM revenue ($3,376.4M), diluted shares (91,908,600), cash ($512.4M), and long-term debt ($2,017.9M) were all pulled directly from SEC XBRL company facts for the cited 10-Qs/10-K \u2014 not from aggregators. Net debt ($1,505.6M) uses long-term debt minus cash & equivalents; current maturities were $0 at 2025-12-31 per the 10-K, but finance leases and any Q1 current maturities could shift this by low tens of millions. TTM adjusted EBITDA (~$590M) and Q1 2025 adjusted EBITDA (~$130M, back-computed from the disclosed +14% growth to $148.0M) are estimates. The $55 loss-scenario price, exit multiples, and the ~2.5x net-leverage figure are judgment calls, flagged as such. THE VALUATION GATES FAIL, AND NOT NARROWLY: the base case (12% revenue CAGR, 12% terminal FCF margin, 28x exit \u2014 each defensible individually and arguably generous together) yields a 5-year IRR of ~2.1%/yr, far below the 15% gate, and the probability-weighted PV is ~$121 vs the $176.67 price \u2014 0.69x against the 1.3x gate. Even the bull case only reaches ~11%/yr. To pass, we would need ~20%/yr revenue growth for five years or an exit multiple above today's already-rich level; neither is defensible for a business whose largest segment grew 8% in 2025. This therefore publishes as a WATCHLIST note, not a buy: world-class monopoly, wrong price. Both gates would clear near $93\u201395 per share (-47%); a less demanding half-position threshold (base IRR ~10%) arrives near $130.", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q Q1 FY2026 (period ended 2026-03-31, filed 2026-05-04) \u2014 Q1 revenue $860.217M; cash & equivalents $512.357M; long-term debt $2,017.946M; weighted-average diluted shares 91,908,600 (all via SEC XBRL company facts)", "10-K FY2025 (filed 2026-02-23) \u2014 FY2025 revenue $3,198.425M; Q4 2025 revenue $885.842M; current maturities of long-term debt $0 at 2025-12-31; FY diluted shares 91,856,013", "10-Q Q2 FY2025 (period ended 2025-06-30, filed 2025-08-04) \u2014 Q2 2025 revenue $764.039M", "10-Q Q3 FY2025 (period ended 2025-09-30, filed 2025-11-03) \u2014 Q3 2025 revenue $866.286M; TTM = 764.039 + 866.286 + 885.842 + 860.217 = $3,376.384M", "Q1 2026 earnings release (8-K furnished 2026-05-04) \u2014 backlog $8.65B (+77% YoY), 2026 guidance raised: revenue >$3.75B, adj. EBITDA $650\u2013665M, non-GAAP EPS $4.60\u20134.75, FCF $315\u2013330M", "Share price $176.67 at 2026-07-23 close (stockanalysis.com); market cap ~$16.2B; trailing P/E ~47x" ], "net_debt": 1505589000, "price": 176.67, "rev_ttm": 3376384000, "shares_diluted": 91908600 }, "kill_conditions": [ "Total backlog declines for two consecutive quarters and finishes below $7.0B (vs $8.65B at Q1 2026) \u2014 checkable in every quarterly earnings release/10-Q.", "Government Operations segment revenue posts negative year-over-year growth for two consecutive quarters (segment note in each 10-Q) \u2014 would indicate the naval/special-materials engine is stalling despite backlog.", "Full-year free cash flow comes in below $250M against 2026 guidance of $315\u2013330M, or annual FCF conversion falls below 40% of adjusted EBITDA \u2014 signals backlog is converting into working capital and capex, not cash.", "Net debt exceeds 3.5x TTM adjusted EBITDA for two consecutive quarters without a newly closed acquisition explaining the step-up (~2.5x at Q1 2026).", "The Navy or DOE awards any reactor-plant component or naval fuel scope BWXT currently sole-sources to a second supplier (visible in DoD contract announcements or a changed competition disclosure in the 10-K)." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 55, "name": "loss", "p": 0.05 }, { "dilution_pa": 0.005, "exit_multiple": 3, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "rev_cagr_5y": 0.07 }, { "dilution_pa": 0.005, "exit_multiple": 28, "multiple_type": "p_fcf", "name": "base", "p": 0.5, "rev_cagr_5y": 0.12, "terminal_margin": 0.12 }, { "dilution_pa": 0.005, "exit_multiple": 32, "multiple_type": "p_fcf", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.16, "terminal_margin": 0.13 } ], "statement": "BWXT is the sole manufacturer of nuclear reactors and fuel for the U.S. Navy and the most complete investable expression of the nuclear-fuel-cycle build-out, with backlog up 77% year-over-year to $8.65B and 2026 revenue guided above $3.75B. The falsifiable claim: backlog and Government Operations revenue keep growing through 2031 as Columbia/Virginia-class production, HALEU/TRISO special materials, and SMR component orders convert \u2014 falsified if backlog drops below $7.0B for two consecutive quarters or Government segment revenue declines year-over-year for two straight quarters. However, at $176.67 (47x trailing EPS, ~5.2x EV/TTM sales) a defensible base case returns roughly 2%/yr over five years, so this publishes as a watchlist thesis with a buy trigger near $95, not an actionable buy.", "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "BWXT", "version": 1 }, "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "BWXT", "valuation": { "base_irr": 0.0212, "discount_rate": 0.1, "ev_to_price": 0.688, "expected_pv": 121.48, "gates": { "base_irr_gate": { "actual": 0.0212, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.688, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2082, "multiple_type": "ev_sales", "name": "loss", "p": 0.05, "price_5y": 55.0, "pv_today": 55.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 3.0, "irr_5y": -0.0527, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "price_5y": 134.79, "pv_today": 83.69, "rev_cagr_5y": 0.07, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 28.0, "irr_5y": 0.0212, "multiple_type": "p_fcf", "name": "base", "p": 0.5, "price_5y": 196.2, "pv_today": 121.82, "rev_cagr_5y": 0.12, "terminal_margin": 0.12 }, { "dilution_pa": 0.005, "exit_multiple": 32.0, "irr_5y": 0.1096, "multiple_type": "p_fcf", "name": "bull", "p": 0.2, "price_5y": 297.1, "pv_today": 184.47, "rev_cagr_5y": 0.16, "terminal_margin": 0.13 } ], "sensitivity": { "current_price": 176.67, "growth_rows": [ 0.02, 0.07, 0.12, 0.17, 0.22 ], "multiple_cols": [ 14.0, 21.0, 28.0, 35.0, 42.0 ], "pv_grid": [ [ 31.35, 51.98, 72.61, 93.25, 113.88 ], [ 42.5, 68.71, 94.93, 121.14, 147.35 ], [ 55.95, 88.89, 121.82, 154.76, 187.7 ], [ 72.03, 113.0, 153.98, 194.95, 235.92 ], [ 91.1, 141.61, 192.12, 242.63, 293.14 ] ] } }, "version": 1 }, "8f34740984bce478a39ed6162cc3a1e10d62aa2dbda201ef163d089b9d162066": { "actionable_below": 32.21, "company": "Cameco Corporation", "kind": "watchlist_note", "markdown": "## Thesis\n\nCameco is the only Western vertically integrated nuclear-fuel-cycle major \u2014 tier-one uranium mining, conversion, and 49% of Westinghouse \u2014 and we expect consolidated revenue to compound roughly 8%/yr through 2031 as legacy contracts reprice toward the US$90/lb long-term price and the US government's $80B AP1000 program converts into Westinghouse backlog. But at ~$90/share the market already pays ~15.6x consolidated TTM sales and ~73x TTM adjusted earnings for that future; our probability-weighted value is ~$42/share, roughly 0.46x the current price. The thesis is falsified operationally if the contract book, the long-term uranium price, or the Westinghouse government agreements break (see kill conditions) \u2014 and it fails our valuation gates today, so this publishes as a watchlist note, not a buy.\n\n## Why Now\n\nThe operating inflection is real and it is in the filings. Q1 2026 (6-K furnished 2026-05-05, quarter ended 2026-03-31): revenue C$845M, up 7% from C$789M; adjusted net earnings C$203M versus C$70M a year earlier (more than doubled); adjusted EBITDA C$509M, up 44%; uranium segment earnings before taxes C$358M versus C$227M, on 7.8M lb delivered (+13%) at a rising average realized price. That followed FY2025 (6-K furnished 2026-02-12): revenue C$3.48B versus C$3.14B in 2024, adjusted net earnings C$627M versus C$292M, adjusted EBITDA ~C$1.9B. The balance sheet is net cash \u2014 C$1.11B in cash and short-term investments against C$1.0B of debt at March 31, 2026, per the Q1 interim statements \u2014 with a US$49M Westinghouse distribution received in Q1 and a US$124M JV Inkai dividend received just after quarter-end.\n\nThe pricing regime shifted underneath these numbers. Cameco's Q1 2026 MD&A anchors its outlook on a UxC spot price of US$84.00/lb and a long-term indicator of US$90.00/lb as of March 31, 2026 \u2014 the long-term price's highest level since 2008 \u2014 and spot sat near US$85.7/lb in mid-July 2026. Cameco's 2026 guided average realized price of C$85.00\u201389.00/lb (roughly US$64\u201367/lb at their 1.33 USDCAD assumption) still lags the market badly because legacy contracts cap upside; as those roll off, realized price grinds up mechanically. The MD&A discloses commitments averaging over 28M lb/yr of deliveries for the next five years, front-loaded in 2026\u20132028, with 2026 sales guidance of 29\u201332M lb and revenue guidance of C$3,130\u20133,370M.\n\nThe Westinghouse leg changed category in the past nine months. On October 27, 2025, the US government announced an $80B strategic partnership with Westinghouse and its owners Brookfield (51%) and Cameco (49%) to deploy a fleet of AP1000 reactors, executed as a binding term sheet with the Department of Commerce; on June 23, 2026, the DOE announced a conditional US$17.5B loan commitment to finance long-lead components for up to 10 AP1000s. Cameco's Q1 2026 MD&A guides its 49% share of Westinghouse 2026 adjusted EBITDA to US$370\u2013430M (Q1 share: C$122M versus C$92M, +33% YoY) \u2014 but states plainly that this outlook assumes definitive agreements with the US government are signed and work advances on at least one project this year. That conditionality is the honest hinge of the story.\n\nWhy write it up now rather than at the October 2025 announcement: the stock round-tripped from ~$69 to a $135.24 high and back to $90.37 (July 22, 2026 close), so the question of what the fundamentals actually support \u2014 versus what the announcement rally priced \u2014 is now answerable with two post-announcement quarters of filings. Our answer, below, is that the operating inflection is genuine but the price still capitalizes most of the bull case.\n\n## Business Quality\n\nThe moat is geology plus bifurcation. McArthur River/Key Lake and Cigar Lake are the two highest-grade uranium operations on earth (ore grades roughly 100x world average), producing 6.2M lb (Cameco's share) in Q1 2026 against 2026 guidance of 19.5\u201321.5M lb, with Key Lake licensed to 25M lb/yr \u2014 expansion headroom that requires no new permits. The fuel services segment (Port Hope conversion, guided 13\u201314M kgU in 2026, revenue C$590\u2013630M) is one of only a handful of Western conversion assets in a market actively bifurcating away from Russian supply, which is why conversion prices have held near record levels. The 49% Westinghouse stake adds the installed-base annuity \u2014 fuel and outage services for the roughly half of the world's reactor fleet built on Westinghouse technology, with historic core margins of 16\u201319% per Cameco's MD&A \u2014 plus the AP1000 new-build option that the US government has now underwritten politically. Add 40% of JV Inkai (low-cost Kazakh ISR pounds, 10.4M lb 2026 target at 100%) and 49% of Global Laser Enrichment, and one ticker touches every stage of the Western fuel cycle.\n\nUnit economics at current guidance: 2026 uranium realized price C$85\u201389/lb against unit cost of sales (including D&A) of C$61.50\u201365.00/lb \u2014 a ~30% per-pound gross margin that widens mechanically as sub-market legacy contracts expire. FY2025 adjusted EBITDA of ~C$1.9B on C$3.48B of consolidated revenue (55%, flattered by equity-accounted pickups) shows what the model produces at US$80+ uranium. The caveat: Westinghouse still loses money at the net line (Q1 2026 share of net loss C$46M) because of acquisition purchase accounting, ~US$120\u2013135M of finance costs (Cameco share), and restructuring \u2014 the EBITDA is real but so is the capital structure underneath it.\n\nCapital allocation is the strongest qualitative argument for management. Cameco held supply discipline through the decade-long bear market, keeping tier-two assets on care and maintenance (C$62\u201367M/yr of ongoing cost) rather than flooding the market, and bought 49% of Westinghouse counter-cyclically in 2022 at a US$7.9B enterprise value \u2014 a stake the market now implicitly values at several times that. Share count is essentially flat (435.3M to 435.6M diluted YoY), the balance sheet is net cash with a US$1.0B undrawn revolver, and there is no history of dilutive empire-building. Competition is thin: Kazatomprom produces cheaper pounds at greater volume but carries Kazakh custody, transit, and governance risk and offers no reactor-technology exposure; no Western peer integrates mining, conversion, and reactor services at any comparable scale. The structural weaknesses are commodity price-taking on the mining side, the long-running CRA transfer-pricing dispute (reassessments for 2003\u20132006 still being contested despite Cameco's 2021 Supreme Court win), and Inkai's operational fragility (the January 2025 production suspension).\n\n## Financial Base\n\nReference figures as of 2026-07-22: trailing-twelve-month revenue of $2,513M, 435.6M diluted shares, net debt of $-80M, and a share price of $90.37. Sources:\n\n- 6-K furnished to SEC 2026-05-05 (Q1 2026 news release, MD&A and interim financial statements for quarter ended 2026-03-31) \u2014 revenue C$845.4M (vs C$789.4M prior year); cash and equivalents C$1,075.1M + short-term investments C$34.6M = C$1,109.7M; long-term debt C$996.5M (net cash ~C$113M); weighted average diluted shares 435,632,000\n- Q1 2026 MD&A quarterly trend table (same 6-K) \u2014 Q2 2025 C$877M + Q3 2025 C$615M + Q4 2025 C$1,201M + Q1 2026 C$845M = TTM revenue C$3,538M, converted at 1.408 USDCAD (2026-07-23) = ~US$2.51B\n- 6-K furnished to SEC 2026-02-12 (Q4/FY2025 results news release) \u2014 FY2025 revenue C$3.48B (2024: C$3.14B); adjusted net earnings C$627M; adjusted EBITDA ~C$1.9B\n- 40-F for fiscal year ended 2025-12-31, filed with SEC March 2026 (officer certifications dated 2026-03-19, accession 0001193125-26-116229) \u2014 audited annual financial statements and AIF\n- Share price US$90.37 = NYSE close 2026-07-22 (stockanalysis.com / market data); 52-week range $68.96\u2013$135.24; USDCAD 1.408 on 2026-07-23 (tradingeconomics)\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (5%): A major nuclear safety event, an AI-datacenter capex bust that guts new-reactor demand, or outright collapse of the US government partnership sends spot uranium back below US$50/lb and vaporizes the Westinghouse premium; CCJ retraces to pre-2024 levels (~33% of today's price).\n- **Bear** (25%): Realized prices stall near current contract levels, definitive AP1000 agreements slip indefinitely, and Westinghouse stays a services annuity; exit at 5.5x consolidated sales \u2014 a Kazatomprom-like mature-miner multiple (~4-5x) plus modest credit for the equity-accounted stakes.\n- **Base** (50%): Contract-book repricing toward the US$90/lb long-term price plus sales volumes growing toward ~35M lb lifts consolidated revenue ~8%/yr; Westinghouse compounds 6-10%/yr with one or two AP1000 projects underway. Exit 8x consolidated sales = ~5x for the mining/fuel business (top of mature-miner range, justified by 55% look-through EBITDA margins) plus ~3 turns representing the equity-accounted 49% Westinghouse and 40% Inkai stakes whose revenue is absent from the denominator; this already equates to ~14-15x look-through EV/EBITDA, a full multiple for a mature resource company.\n- **Bull** (20%): Definitive US government agreements signed, multiple AP1000s under construction, Western supply squeeze pushes realized prices above US$100/lb, McArthur/Key Lake expands toward the licensed 25M lb/yr; a Westinghouse IPO or marker crystallizes ~US$35-40B of value (Cameco share ~$18B). 11x consolidated sales (~20x look-through EV/EBITDA) is priced-for-perfection territory even for this outcome.\n\n## Kill Conditions\n\n1. Contract book erosion: the five-year average annual committed uranium delivery volume disclosed in Cameco's quarterly MD&A falls below 25M lb/yr for two consecutive quarters (Q1 2026 reading: over 28M lb/yr).\n2. Price regime break: the UxC long-term uranium price indicator prints below US$70/lb at two consecutive quarter-ends (March 31, 2026 reading: US$90/lb, per Cameco's Q1 2026 MD&A).\n3. Westinghouse conditionality fails: no definitive agreements between Westinghouse and the US government executed by June 30, 2027, or Cameco's annual outlook for its share of Westinghouse adjusted EBITDA is set below the US$370M 2026 floor in any subsequent annual guidance.\n4. Tier-one operational failure: full-year uranium production (Cameco's share) misses the low end of annual guidance by more than 10% in any year (for 2026: actual below ~17.5M lb vs 19.5-21.5M lb guided).\n5. Balance-sheet regime change: net debt exceeds 2x TTM adjusted EBITDA in any quarterly report (currently net cash) \u2014 the signature of a leveraging acquisition that changes the risk profile.\n\n## Risk Register\n\n- Valuation \u2014 SEVERE: at $90.37 CCJ trades at ~15.6x EV/consolidated TTM sales and ~73x TTM adjusted net earnings; the $80B program is substantially priced in before definitive agreements exist.\n- AP1000 execution \u2014 HIGH: the last US AP1000 build (Vogtle 3&4) ran ~$35B and seven years late; Westinghouse's new-build economics under the government framework are unproven, and Cameco's own outlook is explicitly conditional on agreements not yet signed.\n- Westinghouse net losses and leverage \u2014 MEDIUM: Cameco's share of Westinghouse net loss was C$46M in Q1 2026 (finance costs US$120-135M/yr Cameco share); EBITDA-to-cash conversion depends on distributions (US$49M received in Q1).\n- Government partnership terms \u2014 MEDIUM: the US government participates in Westinghouse value creation above agreed thresholds, capping Cameco's share of upside in exactly the scenarios that justify today's multiple.\n- Kazakhstan/Inkai \u2014 MEDIUM: the January 2025 production suspension showed fragility; sulfuric acid supply, transport routing, and Kazakh fiscal changes threaten the 4.2M lb purchase allocation and dividends (US$124M received April 2026).\n- CRA transfer-pricing dispute \u2014 LOW/MEDIUM: reassessments for 2003-2006 continue despite Cameco's Supreme Court win; a tail risk of cash tax and penalties.\n- Commodity reversal \u2014 MEDIUM: per Cameco's own sensitivity, a US$5/lb drop in spot cuts revenue ~C$36M; a return to the US$60s would stall the realized-price escalator that drives the base case.\n- Currency \u2014 LOW: CAD-reported financials against mostly USD-denominated sales; USDCAD moved from the 1.33 outlook assumption to 1.41 spot, distorting USD comparisons.\n\n## Theme Position\n\nEffectively 100% of Cameco's revenue is nuclear-fuel-cycle: 2026 guidance splits consolidated revenue of C$3,130\u20133,370M into uranium (C$2,540\u20132,730M, ~79%) and fuel services/conversion (C$590\u2013630M, ~19%), and every equity-accounted asset \u2014 49% of Westinghouse (reactor services and AP1000 new-build), 40% of JV Inkai (ISR uranium), 49% of Global Laser Enrichment \u2014 sits inside the theme too. No other SEC-filing ticker (40-F/6-K) spans mining, conversion, fuel fabrication, reactor services, and reactor technology in one instrument.\n\nAlternatives considered. Kazatomprom (KAP LI): the world's largest, lowest-cost producer at roughly half Cameco's sales multiple \u2014 but London GDRs of a Kazakh SOE with material custody/transit exposure through Russian-adjacent routes, no reactor-technology leg, and governance we cannot underwrite for a 5-year hold. BWX Technologies (BWXT): high-quality naval-reactor and SMR services with real backlog \u2014 but no uranium price torque, and it has re-rated as hard as anything in the theme. Sprott Physical Uranium Trust (U.UN): the clean way to own the commodity thesis without paying 15x sales for an operator \u2014 the honest answer for pure spot exposure, but it carries no operating leverage, no contract book, and no Westinghouse, which is the specific integrated angle this thesis exists to examine. Pre-revenue reactor developers (Oklo, NuScale) fail our framework outright: no revenue to underwrite. Cameco is the right vehicle for the theme; the problem in July 2026 is strictly the price.\n\n## Benchmark\n\nBeating means CCJ total return from publication ($90.37, 2026-07-22) exceeds QQQ total return over the same 5-year window; at our probability-weighted PV of ~$42 we expect it will not from this price, which is why this is a watchlist note with a low-$30s framework entry rather than a buy. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "UxC long-term uranium price: US$90.00/lb at March 31, 2026 \u2014 highest since 2008 (source: Cameco Q1 2026 MD&A, 6-K furnished 2026-05-05); uranium spot US$85.74/lb as of July 19, 2026 (carboncredits.com uranium tracker). Corroborating fuel-cycle demand reading: Cameco's committed deliveries average >28M lb/yr over the next five years (same MD&A).", "company": "Cameco Corporation", "confidence_notes": "VERDICT ON THE GATES: they fail, decisively, and this must publish as a watchlist note, not a buy. At $90.37 our base case (8% revenue CAGR, 8x exit EV/consolidated sales \u2248 14-15x look-through EV/EBITDA \u2014 already generous versus mature miners at 5-8x EV/EBITDA and Kazatomprom at ~4-5x sales) yields a year-5 price of ~$66 and a 5-year IRR of approximately MINUS 6%/yr \u2014 nowhere near the +15% gate. Probability-weighted PV \u2248 $42 \u2248 0.46x the current price versus the 1.3x gate. Even the bull case (13% CAGR, 11x exit sales) only reaches ~$114 in year 5, a ~5% IRR. Under this framework the gates would pass only near the low-$30s \u2014 below the 52-week low \u2014 so no defensible assumption set rescues the thesis at today's price; to pass at $90 you would need a ~20x exit multiple on consolidated sales in 2031, which no mature comparable supports. One structural caveat cuts in Cameco's favor: EV/consolidated-sales mechanically penalizes CCJ because the 49% Westinghouse and 40% Inkai stakes are equity-accounted, so their revenue (Cameco's share of Westinghouse revenue alone was C$868M in Q1 2026, roughly equal to consolidated revenue) never enters the denominator. We compensated by inflating exit multiples ~3 turns above pure-miner comps; a full SOTP that marks Westinghouse at the $30-60B figures circulating post-announcement could defend today's price, but that is marking to the announcement, not to signed agreements or delivered reactors \u2014 Cameco's own MD&A flags that its Westinghouse outlook assumes definitive agreements that do not yet exist. NUMBER QUALITY: TTM revenue is exact in CAD (C$3,538M summed from the MD&A quarterly trend table: 845+1,201+615+877); the USD conversion uses the 1.408 spot rate of 2026-07-23 rather than period-average rates, so US$2.51B is approximate within ~\u00b14%. Net debt (\u2212US$80M, i.e., net cash) uses the interim statements' long-term debt of C$996.5M against C$1,109.7M cash+STI and excludes small lease obligations (MD&A rounds total debt to C$1.0B). Diluted shares (435.63M) are Q1 2026 weighted-average, not period-end. Price is the 2026-07-22 NYSE close from market-data aggregators, not verified against an exchange feed. Q2 2026 results are due within days of this analysis (late July 2026) and could move every figure here; the 40-F filed date is inferred from certification dates (2026-03-19) in the SEC document. Uranium spot for July 2026 comes from a secondary tracker (carboncredits.com), not UxC directly.", "financials": { "as_of": "2026-07-22", "citations": [ "6-K furnished to SEC 2026-05-05 (Q1 2026 news release, MD&A and interim financial statements for quarter ended 2026-03-31) \u2014 revenue C$845.4M (vs C$789.4M prior year); cash and equivalents C$1,075.1M + short-term investments C$34.6M = C$1,109.7M; long-term debt C$996.5M (net cash ~C$113M); weighted average diluted shares 435,632,000", "Q1 2026 MD&A quarterly trend table (same 6-K) \u2014 Q2 2025 C$877M + Q3 2025 C$615M + Q4 2025 C$1,201M + Q1 2026 C$845M = TTM revenue C$3,538M, converted at 1.408 USDCAD (2026-07-23) = ~US$2.51B", "6-K furnished to SEC 2026-02-12 (Q4/FY2025 results news release) \u2014 FY2025 revenue C$3.48B (2024: C$3.14B); adjusted net earnings C$627M; adjusted EBITDA ~C$1.9B", "40-F for fiscal year ended 2025-12-31, filed with SEC March 2026 (officer certifications dated 2026-03-19, accession 0001193125-26-116229) \u2014 audited annual financial statements and AIF", "Share price US$90.37 = NYSE close 2026-07-22 (stockanalysis.com / market data); 52-week range $68.96\u2013$135.24; USDCAD 1.408 on 2026-07-23 (tradingeconomics)" ], "net_debt": -80000000, "price": 90.37, "rev_ttm": 2513000000, "shares_diluted": 435632000 }, "kill_conditions": [ "Contract book erosion: the five-year average annual committed uranium delivery volume disclosed in Cameco's quarterly MD&A falls below 25M lb/yr for two consecutive quarters (Q1 2026 reading: over 28M lb/yr).", "Price regime break: the UxC long-term uranium price indicator prints below US$70/lb at two consecutive quarter-ends (March 31, 2026 reading: US$90/lb, per Cameco's Q1 2026 MD&A).", "Westinghouse conditionality fails: no definitive agreements between Westinghouse and the US government executed by June 30, 2027, or Cameco's annual outlook for its share of Westinghouse adjusted EBITDA is set below the US$370M 2026 floor in any subsequent annual guidance.", "Tier-one operational failure: full-year uranium production (Cameco's share) misses the low end of annual guidance by more than 10% in any year (for 2026: actual below ~17.5M lb vs 19.5-21.5M lb guided).", "Balance-sheet regime change: net debt exceeds 2x TTM adjusted EBITDA in any quarterly report (currently net cash) \u2014 the signature of a leveraging acquisition that changes the risk profile." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 30, "name": "loss", "p": 0.05 }, { "dilution_pa": 0.005, "exit_multiple": 5.5, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "rev_cagr_5y": 0.03 }, { "dilution_pa": 0.005, "exit_multiple": 8, "multiple_type": "ev_sales", "name": "base", "p": 0.5, "rev_cagr_5y": 0.08 }, { "dilution_pa": 0.005, "exit_multiple": 11, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.13 } ], "statement": "Cameco is the only Western vertically integrated nuclear-fuel-cycle major \u2014 tier-one uranium mining, conversion, and 49% of Westinghouse \u2014 and we expect consolidated revenue to compound roughly 8%/yr through 2031 as legacy contracts reprice toward the US$90/lb long-term price and the US government's $80B AP1000 program converts into Westinghouse backlog. But at ~$90/share the market already pays ~15.6x consolidated TTM sales and ~73x TTM adjusted earnings for that future; our probability-weighted value is ~$42/share, roughly 0.46x the current price. The thesis is falsified operationally if the contract book, the long-term uranium price, or the Westinghouse government agreements break (see kill conditions) \u2014 and it fails our valuation gates today, so this publishes as a watchlist note, not a buy.", "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "CCJ", "version": 1 }, "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "CCJ", "valuation": { "base_irr": -0.06, "discount_rate": 0.1, "ev_to_price": 0.463, "expected_pv": 41.87, "gates": { "base_irr_gate": { "actual": -0.06, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.463, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.1979, "multiple_type": "ev_sales", "name": "loss", "p": 0.05, "price_5y": 30.0, "pv_today": 30.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 5.5, "irr_5y": -0.1679, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "price_5y": 36.05, "pv_today": 22.39, "rev_cagr_5y": 0.03, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 8.0, "irr_5y": -0.06, "multiple_type": "ev_sales", "name": "base", "p": 0.5, "price_5y": 66.32, "pv_today": 41.18, "rev_cagr_5y": 0.08, "terminal_margin": 0.0 }, { "dilution_pa": 0.005, "exit_multiple": 11.0, "irr_5y": 0.0479, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "price_5y": 114.21, "pv_today": 70.92, "rev_cagr_5y": 0.13, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 90.37, "growth_rows": [ -0.02, 0.03, 0.08, 0.13, 0.18 ], "multiple_cols": [ 4.0, 6.0, 8.0, 10.0, 12.0 ], "pv_grid": [ [ 12.74, 19.06, 25.38, 31.69, 38.01 ], [ 16.31, 24.41, 32.51, 40.61, 48.71 ], [ 20.64, 30.91, 41.18, 51.44, 61.71 ], [ 25.86, 38.73, 51.61, 64.48, 77.35 ], [ 32.08, 48.07, 64.05, 80.04, 96.02 ] ] } }, "version": 1 }, "b225c1b29dda089724f82c1b29186b32f7159dcb1a7966908711f14aa2662afa": { "actionable_below": 1.9, "company": "Uranium Energy Corp", "kind": "watchlist_note", "markdown": "## Thesis\n\nUEC owns the largest licensed uranium production platform in the US (~12M lbs/yr) and just achieved a genuine operational inflection \u2014 first production at Burke Hollow in April 2026, the first new US ISR mine in over a decade \u2014 but at $9.73 the market pays ~$4.8B for $20.2M of TTM revenue and a ~130k lbs/yr annualized production run-rate. Our base case (4M lbs/yr by FY2031 at $80/lb realized, a 6x mature EV/Sales exit) supports only ~$3.83/share in year 5, a \u221217%/yr IRR from today's price. The stock only works from here if UEC utilizes nearly all of its licensed capacity within 5 years AND the market sustains today's scarcity premium \u2014 a joint bet we cannot underwrite; this publishes as a watchlist note, not a buy.\n\n## Why Now\n\nThe operational inflection is real and filing-verifiable. On April 8, 2026, UEC commenced production at Burke Hollow in South Texas (8-K filed 2026-04-08) \u2014 the first new US in-situ recovery uranium mine in more than a decade, with a 2,500 gallon-per-minute satellite ion-exchange plant commissioned and Phase 1A wellfield development underway. At Christensen Ranch in Wyoming, three new header houses in Wellfield 11 entered production late in fiscal Q3 2026, with five more under construction (Q3 FY2026 results, released with the 10-Q filed 2026-06-09). Cumulative production since the August 2024 restart reached 276,516 lbs of U3O8 at a cumulative total cost of $39.30/lb, and the company holds 1.456M lbs of strategic inventory valued at ~$127M at market.\n\nThe balance sheet is the strongest in UEC's history: $488.1M in cash, zero debt, and ~$794M of total liquid assets (10-Q for the quarter ended 2026-04-30, filed 2026-06-09), after an opportunistic ~$300M equity raise in October 2025 (424B5s filed 2025-10-03/06) executed near the stock's highs \u2014 cash jumped from $148.9M at 7/31/25 to $454.7M at 10/31/25 (10-Q filed 2025-12-10). The macro backdrop supports the theme: spot U3O8 sits near $86/lb and the TradeTech long-term price hit $93/lb on March 31, 2026, its highest level in over 18 years, while US policy continues to favor domestic supply following the Russian uranium import ban.\n\nHere is the honest problem: the revenue line does not yet reflect any of this, and the price already reflects all of it. TTM revenue (May 2025\u2013April 2026) is $20.2M \u2014 a single Q2 FY2026 inventory sale (10-Q filed 2026-03-10); the other three quarters were zero, and fiscal Q3 2026 production was just 32,195 lbs at a total cost of $54.61/lb. UEC's entire FY2025 revenue of $66.8M (10-K filed 2025-09-24) also came from inventory sales, not sustained production. The inflection is a reason to start the clock on the ramp \u2014 not, at ~238x TTM sales, a reason to own the stock today.\n\n## Business Quality\n\nUEC's moat is regulatory and locational, not operational. It controls roughly 12M lbs/yr of licensed production capacity across two hub-and-spoke ISR platforms (Hobson in South Texas, Irigaray in Wyoming) plus the Sweetwater plant acquired from Rio Tinto \u2014 the largest licensed uranium capacity in the United States, in the only western jurisdiction with an explicit policy tailwind (the Russian import ban and US fuel-cycle re-shoring). Licenses of this kind take a decade-plus to replicate, and Burke Hollow's April 2026 startup proves the company can permit and commission new capacity. The Roughrider project in Saskatchewan (pre-feasibility drilling 80% complete as of Q3 FY2026) adds a high-grade conventional option beyond the 5-year window.\n\nUnit economics are unproven at scale, and this is the crux. Cumulative production since the 2024 restart is 276,516 lbs \u2014 about 2% of licensed capacity per year \u2014 and the most recent quarter's total cost of $54.61/lb ($46.69 cash) ran well above the cumulative $39.30/lb, moving the wrong way during ramp-up. US ISR restarts have a long industry history of underdelivering nameplate; UEC itself produced from these Texas assets in 2011\u20132015 at rates far below licenses. Until the company demonstrates ~1M+ lbs/yr at sub-$40 cash costs, \"12M lbs licensed\" is an option, not an earnings stream. The deliberately 100% unhedged, no-term-contract strategy maximizes torque to uranium prices in both directions and means there is no contracted backlog to underwrite.\n\nCapital allocation is a mixed record executed with genuine discipline on the debt side: zero debt ever, and equity raised opportunistically at high prices (the October 2025 raise added ~$306M for ~29M shares, ~$10.50/share net). But the share count compounds relentlessly \u2014 454.0M at 7/31/25 to 494.9M by 6/8/26, roughly 9% dilution in under a year \u2014 and the strategy is serially acquisitive (UEX, Rio Tinto's Sweetwater complex, Roughrider). Shareholders are funding a land-and-license aggregation; whether it converts to per-share value depends entirely on the ramp and the uranium price.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $20M, 494.9M diluted shares, net debt of $-488M, and a share price of $9.73. Sources:\n\n- 10-Q for fiscal Q3 2026 (period ended 2026-04-30), filed 2026-06-09, acc. 0001437749-26-019889 \u2014 Q3 revenue $0; FY2026 YTD revenue $20.2M; cash & equivalents $488.053M; no debt (total liabilities $116.6M are chiefly deferred tax and asset-retirement obligations); 493,317,899 shares outstanding at 4/30/26 and 494,872,366 at the 6/8/26 cover date\n- 10-Q for fiscal Q2 2026 (period ended 2026-01-31), filed 2026-03-10 \u2014 Q2 revenue $20.2M, the only non-zero revenue quarter in the TTM window (an inventory sale)\n- 10-Q for fiscal Q1 2026 (period ended 2025-10-31), filed 2025-12-10 \u2014 Q1 revenue $0; cash $454.7M after the October 2025 equity offering (424B5 prospectus supplements filed 2025-10-03 and 2025-10-06)\n- 10-K for FY2025 (period ended 2025-07-31), filed 2025-09-24 \u2014 FY2025 revenue $66.837M, all recognized by fiscal Q2 (Q4 FY2025 revenue $0), sourced from inventory sales; establishes Q4-FY25 contribution of $0 to the TTM sum\n- 8-K filed 2026-04-08 \u2014 commencement of production at Burke Hollow, first new US ISR uranium mine in over a decade\n- Q3 FY2026 results release, 2026-06-09 (with 8-K acc. 0001437749-26-020021) \u2014 32,195 lbs produced in Q3 at $54.61/lb total cost; 276,516 lbs cumulative since the FY2025 restart at $39.30/lb; 1.456M lbs inventory (~$127M at market); ~$794M liquid assets; ~12M lbs/yr licensed capacity\n- Share price $9.73 at 2026-07-23 close (Robinhood/TradingView quote pages; intraday range $9.41\u2013$9.83; 52-week range $7.80\u2013$20.34; market cap ~$4.95B)\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (10%): Uranium falls below $60/lb for an extended period (SMR-demand disappointment plus Kazakh/restart supply), the ISR ramp stalls technically as US restarts have repeatedly done, and the unhedged, no-backlog model forces years of ATM dilution near the lows; ~$2.00 approximates today's liquid-asset backing (~$794M \u2248 $1.60/share) with modest residual option value.\n- **Bear** (30%): Chronic ramp disappointment \u2014 the pattern of every US ISR restart cycle: ~2M lbs/yr by FY2031 at ~$70/lb realized (~$148M revenue) with continued ATM funding; 5x EV/Sales matches a sub-scale, high-cost single-commodity producer (below Kazatomprom's ~5x with far better economics). Note the 49% CAGR is an artifact of the near-zero $20.2M base, not a growth claim.\n- **Base** (45%): The ramp broadly works: ~4M lbs/yr by FY2031 (Christensen Ranch ~2M + Burke Hollow/Texas ~1.5M + early Sweetwater) at ~$80/lb realized \u2248 $322M revenue; 6x EV/Sales sits between Kazatomprom (~5x) and Cameco's historical mid-cycle (6\u20138x) for a mid-cost producer with remaining growth optionality. Yields ~$3.83/share in year 5 \u2014 a \u221217%/yr IRR from $9.73.\n- **Bull** (15%): Everything goes right: ~7.5M lbs/yr by FY2031 at ~$95/lb realized (term price holds near the March 2026 $93/lb 18-year high, plus a US-origin premium) \u2248 $700M revenue; 8x EV/Sales reflects a premier western producer with Roughrider still ahead \u2014 Cameco-like status without froth. Even so, year-5 value is ~$10.56/share, only ~2%/yr above today's price.\n\n## Kill Conditions\n\n1. Ramp failure: trailing-12-month drummed U3O8 production below 750,000 lbs in the FY2027 10-K (fiscal year ending 2027-07-31), or any two consecutive quarters after January 2027 with production below 100,000 lbs \u2014 versus the multi-million-lb/yr trajectory the valuation requires (checkable in each 10-Q/10-K operational summary).\n2. Cost structure: cash cost per pound above $50 for two consecutive quarters once quarterly production exceeds 250,000 lbs \u2014 meaning scale is not delivering the sub-$40 economics the base case assumes (reported in quarterly results releases).\n3. Dilution treadmill: shares outstanding (10-Q/10-K cover page) grow more than 8% over any trailing 12 months without an accompanying acquisition of producing assets \u2014 indicating operations are not self-funding and the ATM is financing standstill.\n4. Price thesis breaks: U3O8 spot below $60/lb for two consecutive quarters (TradeTech/UxC monthly indicators) \u2014 below the incentive price for new western supply and roughly UEC's demonstrated all-in cost plus capital burden, which guts the unhedged model.\n\n## Risk Register\n\n- Valuation premium \u2014 severe: ~238x TTM revenue and ~$4.8B market cap versus a ~$322M base-case FY2031 revenue; the market has pre-paid for near-full execution plus a permanent scarcity multiple.\n- Ramp execution \u2014 high: 276,516 lbs cumulative in ~7 quarters (~2%/yr of licensed capacity); Q3 FY2026 production of 32,195 lbs annualizes to ~130k lbs; US ISR restarts have chronically missed nameplate for two decades.\n- Uranium price exposure \u2014 high: deliberately 100% unhedged with no term contracts or backlog; revenue timing is opportunistic (three of the last four quarters were $0), so both earnings and sentiment swing with spot.\n- Dilution \u2014 high: 454.0M to 494.9M shares in ~10 months (~9%); the FY2025 pace was higher still; growth capex for Burke Hollow, Sweetwater, and Roughrider will keep the ATM active.\n- Cost inflation \u2014 medium: Q3 FY2026 total cost of $54.61/lb rose above the $39.30/lb cumulative figure during ramp-up; margins at $80/lb are thinner than the story implies if this persists.\n- Flow/momentum volatility \u2014 medium: 52-week range of $7.80\u2013$20.34 with no fundamental change of that magnitude; the stock trades as a thematic vehicle, so drawdowns can be violent and disconnected from operations.\n\n## Theme Position\n\nRevenue exposure to the nuclear-fuel-cycle theme is 100%: every dollar of UEC revenue is U3O8 concentrate sales into the front end of the fuel cycle, and the asset base (ISR platforms, Sweetwater, Roughrider, physical inventory) is pure uranium.\n\nAlternatives considered. **Cameco (CCJ)** is the mature way to own the theme \u2014 ~$3B revenue, a real contract book, and the Westinghouse stake \u2014 but it is the consensus holding and also trades at a demanding multiple; it would score better on quality but was outside this note's US-production-capacity angle. **Centrus Energy (LEU)** has what UEC lacks \u2014 genuine revenue, a contracted backlog, and the only US HALEU line \u2014 but it is an enrichment (not mining) story with single-facility concentration and Russian LEU supply entanglement; it deserves its own thesis rather than serving as a substitute here. **Sprott Physical Uranium Trust (U.UN)** arguably dominates UEC for expressing a uranium-price bull view: at roughly NAV you get the commodity with zero execution risk and zero dilution, whereas UEC at ~$4.8B embeds both commodity beta and a large prepaid execution bet. **Kazatomprom** offers the world's cheapest pounds at ~5x sales but carries Kazakh custody and routing risk that directly contradicts the western-security-of-supply premise of this theme. The honest conclusion: UEC is the purest listed claim on future US uranium production capacity, and that is exactly what its price already pays for.\n\n## Benchmark\n\nBeating means total return above QQQ's total return over the full 5-year window from publication; our base case of \u221217%/yr implies UEC loses to QQQ decisively unless the market permanently sustains today's ~15x+ forward-scarcity multiple. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "U3O8 spot \u2248 $85.7/lb (July 19, 2026; uranium price trackers incl. uraniumtracker.com / metalcharts.org) and the TradeTech long-term price indicator hit $93/lb on March 31, 2026 \u2014 its highest in over 18 years (uranium.info) \u2014 confirming the incentive-price regime the theme requires; the company-specific adoption metric, UEC's own production, reads 276,516 lbs cumulative since the FY2025 restart with 32,195 lbs in fiscal Q3 2026 (Q3 FY2026 results, June 9, 2026).", "company": "Uranium Energy Corp", "confidence_notes": "The verdict first: the publication gates FAIL by a wide margin and no defensible assumption set changes that \u2014 base-case 5-year IRR is approximately \u221217%/yr (vs the \u226515% gate) and probability-weighted PV is ~$2.58/share, ~0.27x the $9.73 price (vs the \u22651.3x gate). For the base case to clear 15%/yr at a mature 6x EV/Sales, FY2031 revenue would need to be ~$1.98B \u2014 roughly 25M lbs at $80/lb, DOUBLE UEC's entire ~12M lb licensed capacity and ~150x the current production run-rate. Even granting a froth-preserving 15x exit multiple, base would need ~10M lbs/yr by FY2031 \u2014 near-perfect utilization of every license on a platform currently annualizing ~130k lbs. We did not torture the assumptions; this publishes as a watchlist note. What changes the verdict: a price in the low-$4s or below at unchanged fundamentals, or filing-verified evidence of a step-change ramp (>1.5M lbs produced in FY2027 at sub-$40 cash cost). Data confidence: revenue, cash, shares, and the zero-debt position are verified directly from SEC EDGAR XBRL and the filings cited (high confidence); the $9.73 price is the July 23, 2026 close from public quote pages (high). As the theme research warned, TTM revenue ($20.2M, one inventory-sale quarter and three zeros) is far too small and erratic to anchor a revenue-multiple model \u2014 the scenario CAGRs (49\u2013103%) are back-solved from a pounds-times-price production model and should be read as ramp assumptions, not growth-rate claims. Production figures (32,195 lbs, 276,516 lbs cumulative, cost per pound, $127M inventory value, ~12M lbs licensed capacity) come from the company's furnished results release and are unaudited (medium-high). Estimates: FY2031 volumes and realized prices in all scenarios are our modeling, not guidance \u2014 UEC gave no FY2027+ production guidance; the 494.9M share count is the 10-Q cover figure, and full dilution including options/RSUs likely runs ~505\u2013515M (unverified), which would make the math modestly worse; scenario dilution rates of 3\u20137%/yr are conservative versus the ~9\u201316%/yr realized in FY2025\u201326. Net debt of \u2212$488.1M excludes ~$117M of non-debt liabilities (deferred tax, asset-retirement obligations).", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q for fiscal Q3 2026 (period ended 2026-04-30), filed 2026-06-09, acc. 0001437749-26-019889 \u2014 Q3 revenue $0; FY2026 YTD revenue $20.2M; cash & equivalents $488.053M; no debt (total liabilities $116.6M are chiefly deferred tax and asset-retirement obligations); 493,317,899 shares outstanding at 4/30/26 and 494,872,366 at the 6/8/26 cover date", "10-Q for fiscal Q2 2026 (period ended 2026-01-31), filed 2026-03-10 \u2014 Q2 revenue $20.2M, the only non-zero revenue quarter in the TTM window (an inventory sale)", "10-Q for fiscal Q1 2026 (period ended 2025-10-31), filed 2025-12-10 \u2014 Q1 revenue $0; cash $454.7M after the October 2025 equity offering (424B5 prospectus supplements filed 2025-10-03 and 2025-10-06)", "10-K for FY2025 (period ended 2025-07-31), filed 2025-09-24 \u2014 FY2025 revenue $66.837M, all recognized by fiscal Q2 (Q4 FY2025 revenue $0), sourced from inventory sales; establishes Q4-FY25 contribution of $0 to the TTM sum", "8-K filed 2026-04-08 \u2014 commencement of production at Burke Hollow, first new US ISR uranium mine in over a decade", "Q3 FY2026 results release, 2026-06-09 (with 8-K acc. 0001437749-26-020021) \u2014 32,195 lbs produced in Q3 at $54.61/lb total cost; 276,516 lbs cumulative since the FY2025 restart at $39.30/lb; 1.456M lbs inventory (~$127M at market); ~$794M liquid assets; ~12M lbs/yr licensed capacity", "Share price $9.73 at 2026-07-23 close (Robinhood/TradingView quote pages; intraday range $9.41\u2013$9.83; 52-week range $7.80\u2013$20.34; market cap ~$4.95B)" ], "net_debt": -488053000, "price": 9.73, "rev_ttm": 20200000, "shares_diluted": 494872366 }, "kill_conditions": [ "Ramp failure: trailing-12-month drummed U3O8 production below 750,000 lbs in the FY2027 10-K (fiscal year ending 2027-07-31), or any two consecutive quarters after January 2027 with production below 100,000 lbs \u2014 versus the multi-million-lb/yr trajectory the valuation requires (checkable in each 10-Q/10-K operational summary).", "Cost structure: cash cost per pound above $50 for two consecutive quarters once quarterly production exceeds 250,000 lbs \u2014 meaning scale is not delivering the sub-$40 economics the base case assumes (reported in quarterly results releases).", "Dilution treadmill: shares outstanding (10-Q/10-K cover page) grow more than 8% over any trailing 12 months without an accompanying acquisition of producing assets \u2014 indicating operations are not self-funding and the ATM is financing standstill.", "Price thesis breaks: U3O8 spot below $60/lb for two consecutive quarters (TradeTech/UxC monthly indicators) \u2014 below the incentive price for new western supply and roughly UEC's demonstrated all-in cost plus capital burden, which guts the unhedged model." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 2, "name": "loss", "p": 0.1 }, { "dilution_pa": 0.07, "exit_multiple": 5, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "rev_cagr_5y": 0.49 }, { "dilution_pa": 0.05, "exit_multiple": 6, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "rev_cagr_5y": 0.74 }, { "dilution_pa": 0.03, "exit_multiple": 8, "multiple_type": "ev_sales", "name": "bull", "p": 0.15, "rev_cagr_5y": 1.03 } ], "statement": "UEC owns the largest licensed uranium production platform in the US (~12M lbs/yr) and just achieved a genuine operational inflection \u2014 first production at Burke Hollow in April 2026, the first new US ISR mine in over a decade \u2014 but at $9.73 the market pays ~$4.8B for $20.2M of TTM revenue and a ~130k lbs/yr annualized production run-rate. Our base case (4M lbs/yr by FY2031 at $80/lb realized, a 6x mature EV/Sales exit) supports only ~$3.83/share in year 5, a \u221217%/yr IRR from today's price. The stock only works from here if UEC utilizes nearly all of its licensed capacity within 5 years AND the market sustains today's scarcity premium \u2014 a joint bet we cannot underwrite; this publishes as a watchlist note, not a buy.", "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "UEC", "version": 1 }, "theme": "Nuclear Fuel Cycle", "theme_slug": "nuclear-fuel-cycle", "ticker": "UEC", "valuation": { "base_irr": -0.17, "discount_rate": 0.1, "ev_to_price": 0.266, "expected_pv": 2.58, "gates": { "base_irr_gate": { "actual": -0.17, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.266, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2712, "multiple_type": "ev_sales", "name": "loss", "p": 0.1, "price_5y": 2.0, "pv_today": 2.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.07, "exit_multiple": 5.0, "irr_5y": -0.2887, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "price_5y": 1.77, "pv_today": 1.1, "rev_cagr_5y": 0.49, "terminal_margin": 0.0 }, { "dilution_pa": 0.05, "exit_multiple": 6.0, "irr_5y": -0.17, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "price_5y": 3.83, "pv_today": 2.38, "rev_cagr_5y": 0.74, "terminal_margin": 0.0 }, { "dilution_pa": 0.03, "exit_multiple": 8.0, "irr_5y": 0.0165, "multiple_type": "ev_sales", "name": "bull", "p": 0.15, "price_5y": 10.56, "pv_today": 6.56, "rev_cagr_5y": 1.03, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 9.73, "growth_rows": [ 0.64, 0.69, 0.74, 0.79, 0.84 ], "multiple_cols": [ 3.0, 4.5, 6.0, 7.5, 9.0 ], "pv_grid": [ [ 1.19, 1.54, 1.89, 2.25, 2.6 ], [ 1.3, 1.71, 2.12, 2.53, 2.94 ], [ 1.43, 1.91, 2.38, 2.86, 3.33 ], [ 1.57, 2.12, 2.67, 3.22, 3.76 ], [ 1.74, 2.36, 2.99, 3.62, 4.25 ] ] } }, "version": 1 }, "1a63a8d0f2a82f3aa066515b75015172d2b019a83416fcc1abac2457ea4eaea5": { "actionable_below": 13.01, "company": "Rocket Lab Corporation", "kind": "watchlist_note", "markdown": "## Thesis\n\nRocket Lab is the only proven non-SpaceX end-to-end space company and its operating inflection is real \u2014 Q1 2026 revenue grew 63.5% to $200.3M with a record $2.2B backlog \u2014 but at ~$67 (~$42B market cap, ~60x TTM sales) the price already assumes near-flawless Neutron execution plus a seamless $8B debt-funded Iridium integration. Our probability-weighted value is roughly $17/share and even our bull case returns approximately zero from today's price, so this publishes as a pre-registered watchlist thesis, not a buy: we would own it in the mid-teens to low-$20s. The operating thesis is falsified if Neutron has not flown successfully by mid-2027, backlog prints below $1.8B for two straight quarters, or pre-Neutron revenue growth decays below 20% YoY.\n\n## Why Now\n\nThe operating inflection the theme research flagged is confirmed in the filings. Q1 2026 revenue was $200.3M, up 63.5% YoY and above the top of the company's own $185\u2013200M guide (10-Q for the quarter ended 2026-03-31, filed ~2026-05-08), against FY2025 revenue of $601.8M, itself up ~38% from $436M in 2024 (10-K FY2025). GAAP gross margin reached 38.2% in Q1 2026 \u2014 versus the mid-20s as recently as 2024 \u2014 and adjusted EBITDA narrowed to \u2212$11.8M on a $800M annualized run-rate. Guidance for Q2 2026 of $225\u2013240M implies 56\u201366% YoY growth (Q1 2026 earnings release, 2026-05-07). This is not a story stock waiting for revenue; the revenue is arriving.\n\nDemand evidence is the strongest part. Backlog hit a record $2.2B at Q1 2026, up 20.2% QoQ and roughly double a year earlier, and the company signed 36 new launch contracts in the quarter \u2014 31 Electron/HASTE plus five dedicated Neutron missions sold before the vehicle has flown \u2014 more launches sold in one quarter than in all of 2025 (Q1 2026 release and earnings call). Customers are pre-committing to Neutron through 2029, which is about as close as this industry gets to third-party validation of a rocket still on the test stand.\n\nWhat makes this a decision point rather than a victory lap is the tape. The stock peaked at $150.23 on 2026-05-27 and has since fallen ~55% to $67.28 (2026-07-23 close) on three real developments: Neutron slipped a second time in ~14 months to a Q4 2026 debut after a Stage 1 propellant-tank test failure traced to a defective third-party composite hand-layup process; SpaceX's June 12, 2026 Nasdaq IPO destroyed Rocket Lab's scarcity value as the only investable pure-play; and management announced an ~$8B cash-and-stock acquisition of Iridium ($54/share, $3.6B bridge facility, stock collar floored at $67.50) that converts a $1.3B net-cash growth story into a levered integration story. The question this thesis answers is whether a 55% drawdown makes the best operator in the theme buyable. Our answer, with the math shown below, is: not yet.\n\n## Business Quality\n\nThe moat is execution scarcity. Orbital launch is a business where nearly every entrant fails, and Rocket Lab is the only company outside SpaceX with a proven high-cadence orbital vehicle (50+ successful Electron missions, record annual cadence in 2025) plus a full merchant space-systems stack: satellite buses (Photon/Flatellite), solar cells (SolAero), separation systems (PSC), flight software (ASI), optical terminals (Mynaric) and EO/IR payloads (Geost). Space systems is now the majority of revenue, meaning the company already makes money selling the picks and shovels of the constellation build-out rather than depending on launch alone. That vertical integration is exactly what customers like the Space Development Agency and Golden Dome-era defense programs are paying for \u2014 witness the $515M SDA prime contract and the pace of 2025\u201326 defense awards feeding the $2.2B backlog.\n\nUnit economics are improving but not yet proven at the company level. GAAP gross margin of 38.2% in Q1 2026 (43.0% non-GAAP) is up sharply from ~27% in 2024, driven by space-systems mix and Electron pricing (~$8.5M ASP). But the company remains EBITDA-negative (\u2212$11.8M adjusted in Q1 2026, guided to \u2212$20M to \u2212$26M in Q2 as Neutron spend peaks), and the profitability case rests on Neutron: a ~$50\u201355M-per-flight medium-lift vehicle whose reusability economics are entirely unproven and which has now slipped twice. Competition is asymmetric \u2014 SpaceX's Transporter rideshare caps small-launch pricing from above, Starship threatens medium-lift pricing later, and Stoke/Firefly/Relativity are funded challengers for the same NSSL Lane 1 dollars \u2014 but none of the challengers has Rocket Lab's flight heritage or backlog.\n\nCapital allocation has been aggressive and, until now, shrewd: management sold stock heavily into strength (weighted diluted shares went from ~506M in Q1 2025 to a guided 629M for Q2 2026, ~24% in five quarters) and used the currency for capability acquisitions while banking $1.48B of cash and securities against only $139M of debt. The Iridium takeover is a different order of bet: ~$8B in cash and stock with a $3.6B bridge \u2014 2.4x the company's entire March-quarter liquidity \u2014 to buy ~$800M+ of slow-growing but ~60%-EBITDA-margin recurring satcom revenue. Strategically it completes the launch-to-services stack Peter Beck has pitched for years; financially it trades the pristine balance sheet for integration and refinancing risk at exactly the moment Neutron needs maximum margin for error. We score the business A-quality operations attached to a newly B-/C-quality balance-sheet trajectory.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $680M, 629.0M diluted shares, net debt of $-1,338M, and a share price of $67.28. Sources:\n\n- 10-Q Q1 FY2026 (quarter ended 2026-03-31), filed ~2026-05-08 \u2014 revenue $200.348M (+63.5% YoY), cash & equivalents $1,205.5M, marketable securities $271.3M (current $177.9M + non-current $93.5M), total debt ~$138.7M, 575.768M common shares outstanding, net loss $45.0M\n- Q1 2026 earnings release (2026-05-07) \u2014 backlog $2.2B (+20.2% QoQ, ~2x YoY); Q2 2026 guidance: revenue $225\u2013240M, GAAP GM 33\u201335%, adj. EBITDA \u2212$20M to \u2212$26M, weighted average shares 629M; GAAP gross margin 38.2%; adjusted EBITDA \u2212$11.75M\n- 10-K FY2025 (year ended 2025-12-31, filed ~2026-02) \u2014 FY2025 revenue $601.8M (Q2'25 $144.5M, Q3'25 $155.1M, Q4'25 $179.7M per quarterly filings); TTM = 144.5+155.1+179.7+200.3 = $679.6M\n- Share price $67.28 close 2026-07-23 (stockanalysis.com / Yahoo Finance); all-time high $150.23 on 2026-05-27 (Macrotrends) \u2014 a ~55% drawdown\n- Iridium acquisition: ~$8B cash-and-stock at $54/IRDM share, $3.6B bridge facility, RKLB stock collar floored at $67.50 \u2014 July 2026 deal press coverage; terms NOT independently verified against the merger agreement/8-K\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (10%): Neutron suffers repeated failures or a program-level defect (the composite-tank flaw already caused one slip) while the Iridium bridge closes; a levered, EBITDA-negative company in a post-SpaceX-IPO market loses access to cheap equity and the stock reprices toward asset value.\n- **Bear** (30%): Neutron slips into 2028 and flies rarely; SpaceX rideshare and Starship compress launch pricing; space systems keeps growing but decelerates to high-teens; Iridium integration consumes management attention. Exit at 5x EV/Sales \u2014 Iridium's own mature-satcom multiple, generous for a still sub-scale margin profile.\n- **Base** (45%): Neutron debuts Q4 2026\u2013H1 2027 and reaches ~8\u201312 flights/yr by 2031; space systems compounds ~25%/yr on the $2.2B backlog and defense demand; standalone revenue reaches ~$2.3B (Iridium treated as roughly NPV-neutral \u2014 its revenue offset by its debt and stock consideration). Exit at 8x EV/Sales, a deliberate premium to every mature comp (L3Harris ~2.6x, Iridium ~5x) justified only by 20%+ terminal growth; equivalent to ~65x FCF at a 12% margin.\n- **Bull** (15%): Everything works: Neutron becomes the #2 Western launcher at 20+ flights/yr, Golden Dome/NSSL Lane 1 awards land at multi-billion scale, Flatellite constellation revenue arrives, Iridium integrates accretively; revenue reaches ~$3.7B standalone-equivalent. Exit at 12x EV/Sales \u2014 a scarcity multiple equal to ~60x FCF at a 20% margin, at the outer edge of defensible against mature comparables.\n\n## Kill Conditions\n\n1. Neutron has not achieved a successful orbital flight by 2027-06-30 \u2014 i.e., more than two additional quarters of slip beyond the current Q4 2026 target (checkable from launch record / 10-Q program disclosure).\n2. Total backlog prints below $1.8B for two consecutive quarters (vs $2.2B at Q1 2026) \u2014 burn without replacement, checkable each earnings release.\n3. Quarterly revenue YoY growth falls below 20% for two consecutive quarters before first Neutron revenue recognition (vs +63.5% in Q1 2026), checkable from 10-Qs.\n4. GAAP gross margin falls below 25% for two consecutive quarters (vs 38.2% in Q1 2026), indicating the mix-driven margin story has reversed.\n5. The Iridium deal closes and pro-forma total debt exceeds $4.5B without the $3.6B bridge being termed out within 12 months while consolidated adjusted EBITDA remains negative \u2014 checkable from the first post-close 10-Q/8-K.\n\n## Risk Register\n\n- Valuation \u2014 severe: ~60x EV/TTM sales after a 55% drawdown; our bull case (40% revenue CAGR, 12x exit) still returns roughly 0%/yr from $67, meaning the price embeds outcomes beyond our bull.\n- Neutron execution \u2014 high: second delay in ~14 months, root-caused to a third-party composite hand-layup defect; reusability economics unproven; each slip defers the NSSL Lane 1 / constellation-launch revenue the multiple depends on.\n- Iridium acquisition \u2014 high: $3.6B bridge equals 2.4x March-quarter liquidity; buying ~flat-growth satcom dilutes the growth algorithm; collar at $67.50 pins the stock and the market now trades RKLB partly as merger arb.\n- SpaceX \u2014 high: the June 2026 IPO removed RKLB's public-market scarcity premium and gives the dominant competitor a public currency; Transporter/Starship cap launch pricing from above.\n- Dilution \u2014 medium: weighted diluted shares grew ~24% in five quarters (506M to guided 629M); the Iridium stock consideration adds more.\n- Cash burn \u2014 medium: adjusted EBITDA still negative (\u2212$11.8M Q1'26, guided \u2212$20M to \u2212$26M Q2) with peak Neutron capex; mitigated today by $1.48B cash+securities, but that cushion is earmarked for the deal.\n\n## Theme Position\n\nRevenue exposure to the space economy is effectively **100%** \u2014 launch services (Electron, HASTE, Neutron) plus space systems (satellite buses, components, payloads), with the pending Iridium deal adding space-based communications services. Within the theme, Rocket Lab is the purest investable expression of the \"end-to-end space infrastructure\" sub-thesis: it is the only company besides SpaceX that has actually flown its way into that claim.\n\nAlternatives considered. **SpaceX** (public since 2026-06-12): the category king and the reason RKLB's scarcity premium collapsed, but it lists at mega-cap scale with Starlink dominating the mix \u2014 the superior business, likely the more efficiently priced stock, and it deserves its own thesis rather than a footnote here. **Iridium**: now a merger-arb position on RKLB's own deal (~$54/share cash-and-stock), not a five-year theme holding. **Planet Labs / AST SpaceMobile / Firefly**: narrower single-bet exposures (EO data, direct-to-device, unproven launch respectively) with binary risk profiles we can't underwrite at better odds than Neutron. **Defense primes (L3Harris, Northrop)**: real space revenue at sane multiples, but space is a minority of revenue \u2014 theme dilution defeats the purpose. Rocket Lab remains the right *company* for this theme; at $67 it is not yet the right *stock*, which is exactly the distinction Longview exists to make.\n\n## Benchmark\n\nBeating means RKLB total return from publication exceeds QQQ total return over the same 5-year window; our base case implies roughly \u221217%/yr from $67.28, so we expect RKLB to LOSE to QQQ from today's price and publish this as a watchlist note with a ~$13\u201320 entry zone where outperformance becomes the defensible expectation. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Backlog $2.2B as of Q1 2026 (earnings release 2026-05-07), up 20.2% QoQ and roughly double YoY; 36 new launch contracts signed in Q1 2026 alone (31 Electron/HASTE + 5 Neutron) \u2014 more launches sold in one quarter than in all of 2025. Corroborating theme-level signal: five dedicated Neutron missions purchased through 2029 before first flight.", "company": "Rocket Lab Corporation", "confidence_notes": "THE GATES FAIL, AND WE SAY SO PLAINLY. At $67.28 the base case (28% revenue CAGR for five years, 8x EV/Sales exit \u2014 already a large premium to every mature comparable) produces a 5-year IRR of approximately \u221217%/yr, and the probability-weighted PV is ~$17/share, or 0.25x the current price, versus the required 1.3x. Even the bull case (40% CAGR, 12x exit) returns roughly \u22122%/yr. Both gates converge on an entry price near $13; granting bull-case assumptions as the base still only justifies ~$31. No defensible assumption set clears the gates at today's price, so this publishes as a watchlist thesis with pre-registered kill conditions and an entry zone (mid-teens to low-$20s for margin of safety; the low-$30s only if Neutron flies successfully and the Iridium bridge is termed out on reasonable terms). What is verified vs estimated: quarterly revenues, Q1 2026 balance-sheet items, backlog, guidance and share counts are sourced from press-release/10-Q data via reputable aggregators (StockTitan, stockanalysis.com); I could not pull the raw EDGAR documents directly, so filed dates are approximate (~2026-05-08 for the Q1 10-Q, ~Feb 2026 for the 10-K). Share count carries genuine uncertainty: 575.8M shares outstanding at 3/31/26 vs company-guided 629M weighted average for Q2 2026 (the gap implies heavy post-quarter issuance and/or convert dilution); I conservatively used 629M. Net debt of \u2212$1.34B is the pre-deal 3/31/26 position; if the Iridium deal closes as reported (~$8B, $3.6B bridge), pro-forma net debt swings by roughly +$5B and shares rise further \u2014 my scenarios treat the deal as roughly NPV-neutral (revenue gained offset by debt and stock paid), which is the main modeling simplification. Iridium deal terms ($54/share, $67.50 collar, $3.6B bridge) come from press coverage, not the merger agreement, and are flagged accordingly. The \u221255% drawdown from the May peak is verified (Macrotrends/stockanalysis). Benchmark risk: with QQQ compounding ~10-13%/yr historically, a thesis that can't clear a 15% base IRR should not be published as a buy \u2014 it isn't.", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q Q1 FY2026 (quarter ended 2026-03-31), filed ~2026-05-08 \u2014 revenue $200.348M (+63.5% YoY), cash & equivalents $1,205.5M, marketable securities $271.3M (current $177.9M + non-current $93.5M), total debt ~$138.7M, 575.768M common shares outstanding, net loss $45.0M", "Q1 2026 earnings release (2026-05-07) \u2014 backlog $2.2B (+20.2% QoQ, ~2x YoY); Q2 2026 guidance: revenue $225\u2013240M, GAAP GM 33\u201335%, adj. EBITDA \u2212$20M to \u2212$26M, weighted average shares 629M; GAAP gross margin 38.2%; adjusted EBITDA \u2212$11.75M", "10-K FY2025 (year ended 2025-12-31, filed ~2026-02) \u2014 FY2025 revenue $601.8M (Q2'25 $144.5M, Q3'25 $155.1M, Q4'25 $179.7M per quarterly filings); TTM = 144.5+155.1+179.7+200.3 = $679.6M", "Share price $67.28 close 2026-07-23 (stockanalysis.com / Yahoo Finance); all-time high $150.23 on 2026-05-27 (Macrotrends) \u2014 a ~55% drawdown", "Iridium acquisition: ~$8B cash-and-stock at $54/IRDM share, $3.6B bridge facility, RKLB stock collar floored at $67.50 \u2014 July 2026 deal press coverage; terms NOT independently verified against the merger agreement/8-K" ], "net_debt": -1338100000, "price": 67.28, "rev_ttm": 679580000, "shares_diluted": 629000000 }, "kill_conditions": [ "Neutron has not achieved a successful orbital flight by 2027-06-30 \u2014 i.e., more than two additional quarters of slip beyond the current Q4 2026 target (checkable from launch record / 10-Q program disclosure).", "Total backlog prints below $1.8B for two consecutive quarters (vs $2.2B at Q1 2026) \u2014 burn without replacement, checkable each earnings release.", "Quarterly revenue YoY growth falls below 20% for two consecutive quarters before first Neutron revenue recognition (vs +63.5% in Q1 2026), checkable from 10-Qs.", "GAAP gross margin falls below 25% for two consecutive quarters (vs 38.2% in Q1 2026), indicating the mix-driven margin story has reversed.", "The Iridium deal closes and pro-forma total debt exceeds $4.5B without the $3.6B bridge being termed out within 12 months while consolidated adjusted EBITDA remains negative \u2014 checkable from the first post-close 10-Q/8-K." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 20, "name": "loss", "p": 0.1 }, { "dilution_pa": 0.05, "exit_multiple": 5, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "rev_cagr_5y": 0.16 }, { "dilution_pa": 0.04, "exit_multiple": 8, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "rev_cagr_5y": 0.28 }, { "dilution_pa": 0.03, "exit_multiple": 12, "multiple_type": "ev_sales", "name": "bull", "p": 0.15, "rev_cagr_5y": 0.4 } ], "statement": "Rocket Lab is the only proven non-SpaceX end-to-end space company and its operating inflection is real \u2014 Q1 2026 revenue grew 63.5% to $200.3M with a record $2.2B backlog \u2014 but at ~$67 (~$42B market cap, ~60x TTM sales) the price already assumes near-flawless Neutron execution plus a seamless $8B debt-funded Iridium integration. Our probability-weighted value is roughly $17/share and even our bull case returns approximately zero from today's price, so this publishes as a pre-registered watchlist thesis, not a buy: we would own it in the mid-teens to low-$20s. The operating thesis is falsified if Neutron has not flown successfully by mid-2027, backlog prints below $1.8B for two straight quarters, or pre-Neutron revenue growth decays below 20% YoY.", "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "RKLB", "version": 1 }, "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "RKLB", "valuation": { "base_irr": -0.1722, "discount_rate": 0.1, "ev_to_price": 0.253, "expected_pv": 17.05, "gates": { "base_irr_gate": { "actual": -0.1722, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.253, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2154, "multiple_type": "ev_sales", "name": "loss", "p": 0.1, "price_5y": 20.0, "pv_today": 20.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.05, "exit_multiple": 5.0, "irr_5y": -0.3096, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "price_5y": 10.56, "pv_today": 6.55, "rev_cagr_5y": 0.16, "terminal_margin": 0.0 }, { "dilution_pa": 0.04, "exit_multiple": 8.0, "irr_5y": -0.1722, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "price_5y": 26.16, "pv_today": 16.24, "rev_cagr_5y": 0.28, "terminal_margin": 0.0 }, { "dilution_pa": 0.03, "exit_multiple": 12.0, "irr_5y": -0.0163, "multiple_type": "ev_sales", "name": "bull", "p": 0.15, "price_5y": 61.98, "pv_today": 38.49, "rev_cagr_5y": 0.4, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 67.28, "growth_rows": [ 0.18, 0.23, 0.28, 0.33, 0.38 ], "multiple_cols": [ 4.0, 6.0, 8.0, 10.0, 12.0 ], "pv_grid": [ [ 6.13, 8.65, 11.18, 13.7, 16.22 ], [ 7.3, 10.4, 13.5, 16.61, 19.71 ], [ 8.66, 12.45, 16.24, 20.03, 23.82 ], [ 10.26, 14.85, 19.44, 24.03, 28.62 ], [ 12.12, 17.64, 23.16, 28.68, 34.2 ] ] } }, "version": 1 }, "c30e1dcacf7b48483313650aa66d3c4a3cf6bff16c971e784d60895f9d30eba9": { "actionable_below": 7.82, "company": "Planet Labs PBC", "kind": "watchlist_note", "markdown": "## Thesis\n\nSovereign daily-Earth-imaging subscriptions are inflecting Planet into a durable, FCF-positive data business: FY2026 delivered the first profitable year ($52.9M FCF, backlog +79%), and we expect backlog above $1.2B and revenue above $500M by FY2029 with FCF remaining positive. But at $22.36 \u2014 roughly 24x TTM EV/Sales even after halving from the May 2026 peak \u2014 that success is already more than fully priced: our probability-weighted value is about $10 per share. This publishes as a pre-registered watchlist thesis with an entry gate near $8, not a buy.\n\n## Why Now\n\nThe inflection is real and it is in the filings, not the press releases. Fiscal 2026 (ended January 31, 2026; 10-K filed March 23, 2026) was Planet's first profitable year on the measures that matter for a subscription data business: revenue of $307.7M (+26%), first full-year adjusted EBITDA profit of $15.5M, and \u2014 the number this thesis hangs on \u2014 first positive annual free cash flow of $52.9M ($134.4M operating cash flow less capex), against a GAAP net loss of $246.9M that is dominated by a $161.4M non-cash warrant fair-value charge as the stock re-rated.\n\nGrowth is accelerating, not decelerating. Quarterly revenue ran $66.3M \u2192 $73.4M \u2192 $81.3M \u2192 $86.8M \u2192 $94.2M across the last five quarters (10-Qs filed June 2025 through June 5, 2026; Q4 derived from the 10-K), taking year-over-year growth from 26% for FY2026 to 42% in Q1 FY2027 (quarter ended April 30, 2026). Management guided FY2027 to $425\u2013441M, roughly 41% growth at the midpoint (Q1 FY2027 release, 8-K, June 4, 2026).\n\nThe driver is a structural shift in who buys daily imaging: governments now sign multi-year sovereign subscriptions rather than tasking orders. The \u20ac240M ($282M) multi-year German government agreement for dedicated Pelican capacity (announced July 1, 2025), a NATO contract, and Sweden's first sovereign reconnaissance satellite (a dedicated Pelican launched in Q1 FY2027) pushed backlog from roughly $500M a year ago to over $906M (+72% YoY) and RPOs to $816M (+81% YoY) at April 30, 2026. Backlog ended FY2026 up 79% year-over-year \u2014 the single best forward indicator that daily imaging is being adopted as recurring infrastructure, with roughly 97% of annual contract value recurring (Q3 FY2026 release).\n\nThe balance sheet was rebuilt to fund the Pelican/Tanager build-out on cheap terms: a $460M 0.50% convertible due 2030 (priced September 9, 2025, conversion ~$11.95) plus warrant exercises left $730.8M of cash and short-term investments at April 30, 2026 ($368.1M cash + $362.7M short-term investments, Q1 FY2027 10-Q). The one blemish: non-GAAP gross margin slipped to 56% in Q1 FY2027 from 59% a year earlier, and Q1 adjusted EBITDA was a $1M loss, as the capex-heavier high-resolution fleet ramps.\n\n## Business Quality\n\nPlanet's moat is an asset no competitor can backfill: the only complete, daily image of Earth's landmass, accumulated continuously since 2017. Each day of operation deepens an archive rivals cannot recreate at any price, and the one-to-many data model means a marginal subscriber costs approximately nothing to serve \u2014 the same PlanetScope pixels are sold to Germany, an agriculture platform, and a carbon-monitoring NGO simultaneously. Agile aerospace (mass-produced ~$1M-class SuperDoves iterated like consumer hardware, now being extended with ~30cm-class Pelicans built in San Francisco and a new Berlin facility) keeps the capital cost per delivered pixel far below the bespoke-satellite model of legacy primes. Switching costs compound through the archive: a defense or insurance customer that builds change-detection workflows on seven years of daily history cannot move to a rival that lacks the history.\n\nUnit economics are those of a data business wearing a hardware burden. Non-GAAP gross margin runs in the mid-to-high 50s (60% in Q3 FY2026, 56% in Q1 FY2027), roughly 97% of ACV is recurring, and FY2026 proved the model can self-fund: $52.9M FCF on $307.7M revenue even while building two new constellations. The Pelican transition is the swing factor \u2014 dedicated sovereign capacity deals (Germany, Sweden) carry satellite build-and-operate economics that are more capital-intensive and lower-margin near-term than pure data resale, which is exactly what the current gross-margin compression shows. If the fleet transition lands, incremental subscriptions on the deployed fleet should carry very high contribution margins; if sovereign deals keep requiring dedicated hardware, Planet drifts toward defense-contractor economics and deserves a defense-contractor multiple.\n\nCompetition is real but mostly adjacent rather than head-on: Maxar (private, high-res tasking), BlackSky (high-revisit tasking, sub-scale), ICEYE (SAR), Airbus, and heavily subsidized Chinese constellations. Nobody else operates a daily whole-Earth scan, but high-resolution tasking \u2014 where Pelican is taking Planet \u2014 is a crowded field, and a SpaceX entry into commercial imaging remains the unpriced tail risk. Capital allocation has been opportunistic and shareholder-tolerable so far: the $460M convert was raised at a 0.50% coupon into strength, the balance sheet holds $730.8M against it, and management is spending into a demand wave with a stated FCF discipline. Stock-based compensation and warrant settlements remain heavy \u2014 weighted-average shares rose from 307.8M (FY2026) to 345.5M in Q1 FY2027 \u2014 so per-share value creation lags headline growth.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $336M, 394.9M diluted shares, net debt of $-731M, and a share price of $22.36. Sources:\n\n- 10-Q Q1 FY2027 (period ended 2026-04-30), filed 2026-06-05 \u2014 quarterly revenue $94.150M; cash & equivalents $368.090M + short-term investments $362.745M = $730.835M; convertible notes carrying value $447.569M; weighted-average diluted shares 345,524,328 (SEC XBRL company facts, CIK 1836833)\n- 10-K FY2026 (period ended 2026-01-31), filed 2026-03-23 \u2014 FY2026 revenue $307.727M; nine-month FY2026 revenue $220.905M (implying Q4 revenue $86.822M); GAAP net loss $246.860M incl. $161.4M non-cash warrant fair-value charge\n- 10-Q Q3 FY2026 (period ended 2025-10-31), filed 2025-12-10 \u2014 Q3 revenue $81.254M; 10-Q Q2 FY2026 (period ended 2025-07-31), filed 2025-09-08 \u2014 Q2 revenue $73.386M; TTM = 73.386+81.254+86.822+94.150 = $335.612M\n- Q4/FY2026 earnings release (8-K, 2026-03-19) \u2014 first full-year adjusted EBITDA profit $15.5M; FY2026 free cash flow $52.9M ($134.4M operating cash flow); backlog >$900M, +79% YoY\n- Q1 FY2027 earnings release (8-K, 2026-06-04) \u2014 backlog $906M (+72% YoY); RPO $816M (+81% YoY); FY2027 revenue guidance $425\u2013441M (~41% growth at midpoint); non-GAAP gross margin 56%\n- Convertible notes pricing release, 2025-09-09 \u2014 $400M (upsized) 0.50% convertible senior notes due Oct 2030, conversion rate 83.6715 sh/$1,000 (~$11.95/sh), plus $60M option; $460M total per company counsel announcement, consistent with $447.6M carrying value\n- Share price $22.36, close 2026-07-23, and shares outstanding 356.40M \u2014 stockanalysis.com; shares_diluted 394.9M = 356.4M outstanding + 38.5M if-converted note shares; net_debt stated on the matching if-converted basis (notes as equity, $730.8M cash+STI, zero debt)\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (5%): Pelican transition fails (launch losses or performance shortfalls), the sovereign-contract wave stalls with a German-scale cancellation, and imagery commoditizes under SAR/Chinese/SpaceX supply; the company burns its cash pile chasing hardware deals and trades back toward cash value plus a shrunken data business (~29% of today's price).\n- **Bear** (30%): The defense wave proves lumpy and largely one-time: backlog is delivered but renewals reprice down, commercial stays niche, and Pelican economics look like a defense contractor's; ~$675M year-5 revenue at 4x EV/S, in line with mature defense-tech/data comps growing single digits.\n- **Base** (45%): The $906M backlog converts and sovereign daily-imaging subscriptions become standard NATO/allied infrastructure: growth decays from 41% (FY2027 guide) toward ~20%, reaching ~$1.1B revenue with ~15% FCF margins; 6x EV/S = ~40x year-5 FCF, consistent with mature recurring-data comps and a premium to defense primes at 2-3x.\n- **Bull** (20%): A space-defense supercycle: multiple Germany-scale ($200M+) sovereign programs across NATO and Indo-Pacific, Pelican takes tasking share from Maxar/Airbus, and AI analytics upsell doubles ACV per customer; ~$1.8B revenue still growing 25%+ at year 5, 8x EV/S = ~40x FCF at 20% margins.\n\n## Kill Conditions\n\n1. Backlog falls below $800M in two consecutive quarterly earnings releases, or backlog growth is negative year-over-year for two straight quarters (vs $906M, +72% YoY, at 4/30/2026) \u2014 the sovereign-subscription wave is over, not compounding.\n2. FY2027 revenue prints below $400M (guidance $425\u2013441M) or FY2027 free cash flow is negative \u2014 the 'first profitable year' ($52.9M FY2026 FCF) reverses and the inflection was a one-off.\n3. Non-GAAP gross margin below 50% for two consecutive quarters (60% in Q3 FY2026 \u2192 56% in Q1 FY2027) \u2014 the Pelican dedicated-capacity model is converting a data business into a hardware contractor.\n4. Percent recurring ACV disclosed below 90% (vs ~97% at Q3 FY2026) \u2014 the subscription character of revenue, the core of the thesis, is eroding.\n\n## Risk Register\n\n- Valuation \u2014 severe: ~24x TTM EV/Sales (~19x forward) after a re-rate from low single digits in 2024; the stock already halved from its $51.40 May 2026 high and could halve again while the business performs.\n- Customer concentration \u2014 high: backlog growth is dominated by a handful of sovereign deals (\u20ac240M Germany, NATO, Sweden); one cancellation or non-renewal removes a double-digit percentage of backlog in a single quarter.\n- Pelican transition execution \u2014 high: dedicated-capacity deals raise capex and already compressed non-GAAP gross margin 59%\u219256% YoY; Q1 FY2027 adjusted EBITDA slipped back to a $1M loss.\n- Competition/commoditization \u2014 medium: BlackSky, ICEYE, Airbus, subsidized Chinese constellations in high-revisit imaging, and a potential SpaceX commercial-imaging entry as the fat-tail threat to pricing.\n- Dilution \u2014 medium: weighted-average shares rose 307.8M (FY2026) to 345.5M (Q1 FY2027) via warrants and SBC; the $460M convert adds ~38.5M more shares at $11.95; assume 3-4%/yr ongoing.\n- GAAP optics \u2014 low/medium: net losses of $246.9M (FY2026) and $138.9M (Q1 FY2027) are mostly non-cash warrant fair-value charges, but they cap index/quality-fund ownership and can amplify drawdowns.\n\n## Theme Position\n\nPlanet is effectively a 100%-pure play on the space economy's data layer: essentially all revenue is Earth-observation data subscriptions and services (~97% of ACV recurring), sold to defense/intelligence, civil government, and agriculture/mapping customers. Within the theme it occupies the specific angle our research flagged \u2014 daily imaging sold as subscription infrastructure \u2014 and FY2026 was the year the model proved out (first $52.9M FCF year, backlog +79%).\n\nAlternatives considered. **Rocket Lab (RKLB)**: the strongest space franchise of the cycle, but launch and space-systems hardware carries structurally lower margins than data subscriptions, and it re-rated even harder in the 2025\u201326 space rally \u2014 same gate problem, worse business model fit to the 'subscriptions' angle. **Iridium (IRDM)**: genuinely cheap recurring space revenue, but ex-growth legacy comms \u2014 it fails the theme's inflection requirement entirely. **BlackSky (BKSY)**: closer comparable at a fraction of the price, but sub-scale (~$100M revenue), tasking-led rather than archive-led, and lacks Planet's daily whole-Earth moat; higher wipeout probability. **AST SpaceMobile (ASTS)**: pre-commercial and binary \u2014 unsuitable for a pre-registered 5-year scenario framework. Planet is the right vehicle for this angle; the price is the only thing wrong with it.\n\n## Benchmark\n\nBeating means total return above QQQ's total return over the full window from publication to the 5-year mark. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Backlog $906M (+72% YoY) and RPOs $816M (+81% YoY) as of April 30, 2026 \u2014 Q1 FY2027 earnings release (8-K, June 4, 2026); FY2026 ended with backlog >$900M, +79% YoY (Q4 FY2026 release, March 19, 2026); ~97% of ACV recurring (Q3 FY2026 release, December 10, 2025).", "company": "Planet Labs PBC", "confidence_notes": "THE GATES DO NOT PASS, and no defensible assumption set makes them pass \u2014 this is a watchlist note, not a buy. At $22.36, even our generous base case (27% CAGR for five years \u2014 above the 41% FY2027 guide decaying to ~20% \u2014 and a 6x exit EV/S, i.e. ~40x year-5 FCF) yields a future value of $15.74/share: a NEGATIVE 6.8%/yr base IRR. Probability-weighted PV is ~$10.17, or 0.45x price vs the 1.3x gate. Even the bull case PV ($20.58) sits below today's price. Both gates independently converge on an entry price of ~$7.80 (base-IRR gate $7.83; PW-PV gate $7.82) \u2014 we pre-register ~$8 as the level at which this thesis becomes actionable, and note the stock traded there as recently as mid-2025. Torturing the inputs to pass (e.g. 43%+ sustained 5-year CAGR to ~$2B revenue, or 12x+ mature exit multiples) would betray the exercise: the whole commercial EO market is forecast in the mid-single-digit billions by 2031. Verification status: TTM revenue ($335.61M), quarterly revenue, cash+STI ($730.8M), convert carrying value ($447.6M), and weighted-average shares (345.5M) are all from SEC XBRL company facts (10-K filed 2026-03-23; 10-Q filed 2026-06-05) \u2014 high confidence. Q4 FY2026 revenue ($86.8M) is derived (FY total minus nine-month), not separately reported. ESTIMATES/FLAGS: (1) shares outstanding 356.40M is from stockanalysis.com, not read directly off the 10-Q cover page; shares_diluted 394.9M adds 38.5M if-converted note shares (83.6715/$1,000 on $460M principal \u2014 principal inferred from the upsized $400M offering plus $60M option per company counsel's announcement, consistent with the $447.6M carrying value); (2) net_debt (\u2212$730.8M) is stated on the matching if-converted basis (notes treated as equity since the ~$11.95 conversion price is deep in the money at $22.36) \u2014 on a GAAP basis net debt is \u2212$283.3M ($447.6M debt less $730.8M cash+STI), and using that pairing instead changes base PV by well under 5% and flips no conclusion; (3) price $22.36 is the 2026-07-23 close per stockanalysis.com, cross-checked at $22.39 intraday elsewhere; (4) FY2026 FCF $52.9M and adjusted EBITDA $15.5M are from the earnings release (8-K), not recomputed from the cash-flow statement; (5) scenario probabilities and the 40% bull CAGR are judgment, not data. The business-inflection half of the thesis is strongly evidenced; the valuation half is the reason it cannot be published as a buy today.", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q Q1 FY2027 (period ended 2026-04-30), filed 2026-06-05 \u2014 quarterly revenue $94.150M; cash & equivalents $368.090M + short-term investments $362.745M = $730.835M; convertible notes carrying value $447.569M; weighted-average diluted shares 345,524,328 (SEC XBRL company facts, CIK 1836833)", "10-K FY2026 (period ended 2026-01-31), filed 2026-03-23 \u2014 FY2026 revenue $307.727M; nine-month FY2026 revenue $220.905M (implying Q4 revenue $86.822M); GAAP net loss $246.860M incl. $161.4M non-cash warrant fair-value charge", "10-Q Q3 FY2026 (period ended 2025-10-31), filed 2025-12-10 \u2014 Q3 revenue $81.254M; 10-Q Q2 FY2026 (period ended 2025-07-31), filed 2025-09-08 \u2014 Q2 revenue $73.386M; TTM = 73.386+81.254+86.822+94.150 = $335.612M", "Q4/FY2026 earnings release (8-K, 2026-03-19) \u2014 first full-year adjusted EBITDA profit $15.5M; FY2026 free cash flow $52.9M ($134.4M operating cash flow); backlog >$900M, +79% YoY", "Q1 FY2027 earnings release (8-K, 2026-06-04) \u2014 backlog $906M (+72% YoY); RPO $816M (+81% YoY); FY2027 revenue guidance $425\u2013441M (~41% growth at midpoint); non-GAAP gross margin 56%", "Convertible notes pricing release, 2025-09-09 \u2014 $400M (upsized) 0.50% convertible senior notes due Oct 2030, conversion rate 83.6715 sh/$1,000 (~$11.95/sh), plus $60M option; $460M total per company counsel announcement, consistent with $447.6M carrying value", "Share price $22.36, close 2026-07-23, and shares outstanding 356.40M \u2014 stockanalysis.com; shares_diluted 394.9M = 356.4M outstanding + 38.5M if-converted note shares; net_debt stated on the matching if-converted basis (notes as equity, $730.8M cash+STI, zero debt)" ], "net_debt": -730835000, "price": 22.36, "rev_ttm": 335612000, "shares_diluted": 394900000 }, "kill_conditions": [ "Backlog falls below $800M in two consecutive quarterly earnings releases, or backlog growth is negative year-over-year for two straight quarters (vs $906M, +72% YoY, at 4/30/2026) \u2014 the sovereign-subscription wave is over, not compounding.", "FY2027 revenue prints below $400M (guidance $425\u2013441M) or FY2027 free cash flow is negative \u2014 the 'first profitable year' ($52.9M FY2026 FCF) reverses and the inflection was a one-off.", "Non-GAAP gross margin below 50% for two consecutive quarters (60% in Q3 FY2026 \u2192 56% in Q1 FY2027) \u2014 the Pelican dedicated-capacity model is converting a data business into a hardware contractor.", "Percent recurring ACV disclosed below 90% (vs ~97% at Q3 FY2026) \u2014 the subscription character of revenue, the core of the thesis, is eroding." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 6.5, "name": "loss", "p": 0.05 }, { "dilution_pa": 0.04, "exit_multiple": 4, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "rev_cagr_5y": 0.15 }, { "dilution_pa": 0.035, "exit_multiple": 6, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "rev_cagr_5y": 0.27, "terminal_margin": 0.15 }, { "dilution_pa": 0.03, "exit_multiple": 8, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.4, "terminal_margin": 0.2 } ], "statement": "Sovereign daily-Earth-imaging subscriptions are inflecting Planet into a durable, FCF-positive data business: FY2026 delivered the first profitable year ($52.9M FCF, backlog +79%), and we expect backlog above $1.2B and revenue above $500M by FY2029 with FCF remaining positive. But at $22.36 \u2014 roughly 24x TTM EV/Sales even after halving from the May 2026 peak \u2014 that success is already more than fully priced: our probability-weighted value is about $10 per share. This publishes as a pre-registered watchlist thesis with an entry gate near $8, not a buy.", "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "PL", "version": 1 }, "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "PL", "valuation": { "base_irr": -0.0678, "discount_rate": 0.1, "ev_to_price": 0.455, "expected_pv": 10.17, "gates": { "base_irr_gate": { "actual": -0.0678, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.455, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2189, "multiple_type": "ev_sales", "name": "loss", "p": 0.05, "price_5y": 6.5, "pv_today": 6.5, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.04, "exit_multiple": 4.0, "irr_5y": -0.2041, "multiple_type": "ev_sales", "name": "bear", "p": 0.3, "price_5y": 7.14, "pv_today": 4.43, "rev_cagr_5y": 0.15, "terminal_margin": 0.0 }, { "dilution_pa": 0.035, "exit_multiple": 6.0, "irr_5y": -0.0678, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "price_5y": 15.74, "pv_today": 9.78, "rev_cagr_5y": 0.27, "terminal_margin": 0.15 }, { "dilution_pa": 0.03, "exit_multiple": 8.0, "irr_5y": 0.0819, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "price_5y": 33.14, "pv_today": 20.58, "rev_cagr_5y": 0.4, "terminal_margin": 0.2 } ], "sensitivity": { "current_price": 22.36, "growth_rows": [ 0.17, 0.22, 0.27, 0.32, 0.37 ], "multiple_cols": [ 3.0, 4.5, 6.0, 7.5, 9.0 ], "pv_grid": [ [ 3.89, 5.35, 6.81, 8.27, 9.73 ], [ 4.57, 6.37, 8.17, 9.97, 11.78 ], [ 5.37, 7.57, 9.78, 11.98, 14.18 ], [ 6.31, 8.98, 11.65, 14.32, 16.99 ], [ 7.4, 10.62, 13.83, 17.05, 20.27 ] ] } }, "version": 1 }, "ab559f3351d54604a333da5604727b1bde92c105e2ebd031580887739f77b5b2": { "actionable_below": 9.95, "company": "Firefly Aerospace, Inc.", "kind": "watchlist_note", "markdown": "## Thesis\n\nFirefly's ~$1.3B backlog converts into $420\u2013450M of 2026 revenue and compounds roughly 20\u201325%/yr through 2031 as Eclipse reaches launch cadence, Blue Ghost lunar deliveries become annual, and SciTec's missile-warning software rides Golden Dome funding. But at $20.70 (~6.6x EV / 2026 guided sales) that base case produces only a ~1%/yr 5-year IRR against a 3x mature-comp exit multiple \u2014 the base case is already in the price despite a 72% drawdown from the high. This is a watchlist thesis, not a buy: it becomes actionable near ~$10, or earlier if Eclipse cadence plus Golden Dome awards move the defensible base toward ~$2B of 2031 revenue.\n\n## Why Now\n\nThe revenue inflection is real and filed, not promised. FY2025 revenue was $159.9M, up 163% year-over-year, with Q4 2025 alone at $57.7M versus $9.0M a year earlier (10-K FY2025, period ended 2025-12-31). Q1 2026 accelerated again to $80.9M \u2014 up 44.7% y/y and 40% sequentially \u2014 split $67.6M Spacecraft Solutions and $13.3M Launch (10-Q Q1 FY2026, period ended 2026-03-31, and the accompanying May 2026 earnings release). Management reiterated 2026 guidance of $420\u2013450M against a total backlog of roughly $1.3B, flat sequentially \u2014 meaning bookings are keeping pace even as recognition ramps 2.6\u20132.8x over 2025.\n\nThree structural events sit behind the ramp. First, the $855M acquisition of SciTec closed 2025-11-05 (8-K): $300M cash plus ~$555M of stock issued at $50/share, bringing ~$164M of trailing national-security revenue in missile-warning and space-domain-awareness data processing \u2014 the piece that makes Firefly a named Golden Dome participant (SciTec supplies fire-control and ground-segment software; Golden Dome received its initial ~$25B appropriation in the July 2025 reconciliation act). Second, Alpha returned to flight successfully in spring 2026 (Flight 7) after two 2025 failures, with the upgraded Block 2 debut targeted for late summer and three more launches guided for 2026. Third, lunar demand is compounding: a $144M NASA CLPS task order awarded 2026-06-30 for an accelerated 2028 Blue Ghost mission, a $13M Mars SkyFall aeroshell subcontract, and a DoD/DIU Elytra on-orbit mission slated for 2027.\n\nThe reason the name is on the desk now is price, not fundamentals. Firefly sold 4M primary and 8M secondary shares at $48.00 on 2026-05-29 (424B4); seven weeks later the stock closed at $20.70 (2026-07-23) \u2014 down 57% from the offering and 72% from the $73.80 high \u2014 on supply overhang, resale registrations, 13% short interest of float, and a sector-wide derating, with no operational miss in between. That is a genuine dislocation. The honest problem, worked through below, is that even the post-crash price still fully discounts a defensible base case.\n\n## Business Quality\n\nFirefly's moat is narrow but real in two places. Blue Ghost Mission 1 (March 2025) remains the only fully successful commercial soft landing on the Moon, and NASA has responded with repeat business \u2014 the June 2026 award was Firefly's fourth lunar delivery, priced around $144M per mission, with the company compressing build time to roughly two years per lander from a dedicated Austin-area spacecraft facility. SciTec is the second: entrenched, hard-to-displace ground software for missile warning and overhead persistent infrared, exactly the layer Golden Dome must buy. Launch is the weakest leg \u2014 Alpha has three full successes in seven attempts, and the medium-lift Eclipse (co-developed with Northrop Grumman, which is both partner and anchor customer as its Antares successor) has yet to fly, targeted \"late 2026\" and realistically 2027.\n\nUnit economics are early-stage: Q1 2026 GAAP gross margin was 21.6% (down from 27.7% the prior quarter on mix), GAAP operating loss $95.7M, and FY2025 free cash flow was \u2212$237.8M against adjusted EBITDA of \u2212$198.6M. The counterweight is a clean balance sheet: $551.6M cash and short-term investments against ~$53M of debt at 3/31/26, $811.6M total liquidity including a $260M undrawn revolver, plus ~$184M net primary proceeds from the June offering \u2014 roughly 2.5\u20133 years of runway at the current burn, likely more as guidance implies burn moderation into 2027.\n\nCapital allocation is the open question. Paying $855M (~5.2x trailing revenue) for SciTec was strategically coherent \u2014 it diversified the company away from binary launch risk into recurring defense software and bought Golden Dome relevance \u2014 but it was funded substantially with stock issued at $50 that now trades at $20.70, and it layered ~$700M+ of goodwill and intangibles onto the balance sheet. Competition is severe on every axis: SpaceX rideshare compresses small-launch pricing beneath Alpha, Rocket Lab's Neutron races Eclipse to the medium-lift gap, and Blue Origin and Intuitive Machines contest lunar delivery. Firefly's edge is that it is the only mid-cap with all three legs \u2014 launch, landers, and defense software \u2014 under one roof; the risk is that three capital-hungry programs at once is exactly how mid-caps burn out.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $185M, 170.0M diluted shares, net debt of $-499M, and a share price of $20.70. Sources:\n\n- 10-Q Q1 FY2026 (period ended 2026-03-31, filed May 2026, SEC accession 0001860160-26-000009) \u2014 revenue $80.9M; cash + short-term investments $551.6M; 160,067,383 shares outstanding on cover; total debt incl. finance leases ~$53M\n- 10-K FY2025 (period ended 2025-12-31, filed March 2026) \u2014 FY2025 revenue $159.855M (+163% y/y); Q4 2025 revenue $57.673M; net loss $298.3M; adjusted EBITDA \u2212$198.6M; free cash flow \u2212$237.8M\n- Q1 FY2026 earnings release (May 2026) \u2014 backlog ~$1.3B flat q/q; 2026 revenue guidance $420\u2013450M reiterated; total liquidity $811.6M ($551.6M cash/ST investments + $260M revolver)\n- 424B4 prospectus, offering priced 2026-05-29 \u2014 4.0M primary + 8.0M secondary shares at $48.00; ~$184M net primary proceeds (post-3/31 balance sheet, not in net-debt figure above)\n- 8-K filed on/about 2025-11-05 \u2014 SciTec acquisition closed: $855M total, $300M cash + ~$555M in stock at $50/share; SciTec trailing revenue ~$164M (12 months to June 2025)\n- Price $20.70 = Nasdaq close 2026-07-23 (stockanalysis.com); shares outstanding 164.24M post-offering; TTM revenue cross-check $184.88M = Q2'25 $15.5M (derived) + Q3'25 $30.8M + Q4'25 $57.7M + Q1'26 $80.9M\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (12%): Compounded failures \u2014 Alpha Block 2 loss, Eclipse slip past 2028 or failure, a lunar mishap, CLPS wind-down \u2014 force down-round financing. The floor is not zero: ~$3/share of net cash plus SciTec's standalone defense-software value (bought for $855M) support roughly a third of today's price.\n- **Bear** (28%): 2026 lands near guide but growth stalls: Eclipse slips repeatedly, Alpha stays subscale against SpaceX rideshare, lunar cadence stays at one mission every 18\u201324 months. 2031 revenue ~$700M, valued at 1.8x EV/S \u2014 the mature defense-prime band (Lockheed/Northrop ~1.5\u20132.5x) \u2014 with 5%/yr dilution from raises at depressed prices.\n- **Base** (40%): Guidance hit, then ~23%/yr from the 2026 base (the 46.5% CAGR off TTM is mostly the SciTec-annualization step): Eclipse flying by 2028, roughly annual lunar missions, SciTec growing high-teens on Golden Dome. 2031 revenue ~$1.25B still growing ~20%, valued at 3.0x EV/S \u2014 a blend of defense primes (~2x) and higher-margin defense software (~4x), well below today's froth.\n- **Bull** (20%): Eclipse reaches ~8\u201312 flights/yr by 2030\u201331 (~$500M+ launch revenue), Golden Dome makes SciTec a program-of-record fire-control layer, and Elytra wins recurring DoD constellation work. 2031 revenue ~$2.1B at 4.0x EV/S \u2014 top-quartile defense-tech-at-scale multiple for a 25%+ grower with a software mix, still below where current-era space names trade.\n\n## Kill Conditions\n\n1. Total backlog reported below $1.0B for two consecutive quarters (versus ~$1.3B at Q1 FY2026) \u2014 demand thesis broken.\n2. 2026 revenue guidance cut below $380M at any quarterly report, or FY2026 actual revenue below $380M (versus $420\u2013450M guided).\n3. Fewer than three Alpha launches completed in calendar 2026, or a Block 2 (Flight 8) mission failure \u2014 launch leg loses credibility.\n4. No Eclipse first-launch attempt disclosed by 2027-12-31 in filings or company updates \u2014 base case requires Eclipse revenue by 2028.\n5. Cash plus short-term investments below $250M in any 10-Q without a committed financing in place (operating cash burn ran ~$211M over the trailing twelve months).\n6. Spacecraft Solutions segment revenue declines year-over-year for two consecutive quarters \u2014 the SciTec/Golden Dome growth leg failing.\n\n## Risk Register\n\n- Cash burn \u2014 HIGH: FY2025 FCF was \u2212$237.8M and TTM operating cash flow \u2212$211M; runway is ~2.5\u20133 years, so a delayed ramp forces dilution at unfavorable prices.\n- Launch failure \u2014 HIGH: Alpha is 3-for-7 on full mission success with two 2025 failures plus a ground-test booster loss; a Block 2 failure would hit both revenue and the Eclipse narrative.\n- Eclipse execution \u2014 HIGH: first flight targeted 'late 2026' is likely 2027; Rocket Lab's Neutron is racing for the same medium-lift gap, and the base case leans on Eclipse revenue by 2028.\n- Share-supply overhang \u2014 MEDIUM/HIGH: SciTec sellers hold ~11.1M shares issued at $50, AE Industrial retains a large sponsor stake, and resale registrations plus 13% short-of-float drove the 57% post-offering slide; more supply can cap any recovery.\n- Customer concentration \u2014 MEDIUM: NASA and DoD dominate backlog; CLPS program politics, Artemis restructuring, or Golden Dome re-scoping would directly hit bookings.\n- Goodwill/integration \u2014 MEDIUM: SciTec at ~5.2x trailing revenue loaded ~$700M+ of goodwill/intangibles; an impairment would not burn cash but would validate the overpayment critique.\n- Competition \u2014 MEDIUM: SpaceX rideshare compresses small-launch pricing; Blue Origin and Intuitive Machines contest lunar delivery; primes could in-source Golden Dome ground software.\n\n## Theme Position\n\nFirefly is effectively a 100%-exposure space-economy name: every revenue dollar comes from launch (Alpha, Eclipse), lunar and in-space vehicles (Blue Ghost, Elytra, Ocula imaging), or national-security space software (SciTec's missile-warning and space-domain-awareness processing, the Golden Dome hook). Q1 FY2026 split was $67.6M Spacecraft Solutions (84%) versus $13.3M Launch (16%), so today it is better understood as a defense-space-systems company with a launch option attached \u2014 which is also what makes the $1.3B backlog more bankable than a pure launch book.\n\nAlternatives considered. Rocket Lab (RKLB): the execution leader in the category with proven cadence, but its valuation already embeds flawless Neutron execution \u2014 no dislocation to buy, and the gates fail there even harder on any mature-multiple exit. Intuitive Machines (LUNR): the closest lunar pure-play, but concentrated in CLPS/NSNS awards with no equivalent defense-software leg and a weaker balance sheet; Firefly is the higher-quality expression of the same lunar thesis. Legacy primes (Northrop, Lockheed, L3Harris) as Golden Dome plays: real program exposure but diluted to a single-digit percentage of revenue \u2014 no torque to the theme. Firefly was retained as the best risk/reward expression of the launch-plus-lunar-plus-Golden-Dome angle; the failure is price, not selection.\n\n## Benchmark\n\nBeating means FLY total return exceeds Invesco QQQ total return over the full five-year window from publication (2026-07-24 to 2031-07-24). Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Firefly total backlog ~$1.3B at Q1 FY2026, flat sequentially, with 2026 revenue guidance of $420\u2013450M reiterated (Q1 FY2026 earnings release, May 2026). Sector corroboration: Golden Dome received its initial ~$25B appropriation in the July 2025 reconciliation act, and NASA CLPS continued awarding \u2014 Firefly's $144M Blue Ghost task order on 2026-06-30.", "company": "Firefly Aerospace, Inc.", "confidence_notes": "THE GATES FAIL AT TODAY'S PRICE, AND NO DEFENSIBLE ASSUMPTION SET FIXES THAT. Base-case 5-year IRR computes to ~0.8%/yr (year-5 value $21.52 vs $20.70 today) versus the required 15%, and probability-weighted PV is ~$12.94 = 0.63x price versus the required 1.3x. Even the bull case (2031 revenue ~$2.1B at 4.0x EV/S) only just clears 15%/yr. Passing both gates requires an entry near ~$10 (15% base IRR needs \u2264$10.70; 1.3x PV coverage needs \u2264$9.95). To force a pass at $20.70 I would need ~$2.5B of 2031 revenue in the BASE case or a 7x+ exit multiple \u2014 neither is defensible against mature comps. This therefore publishes as a WATCHLIST note with a ~$10 action level, not a buy. Estimates and unverified items: (1) Q2 2025 revenue ($15.5M) is derived by subtracting disclosed quarters from the FY2025 10-K total, not separately reported; TTM $184.88M cross-checks against aggregator data to within $0.03M. (2) shares_diluted of 170M is an estimate: 164.24M outstanding post-June-offering (10-Q cover 160.07M + 4M primary) plus ~6M assumed options/RSUs; GAAP diluted equals basic due to losses and the true equity-award overhang was not verified from the 10-K. (3) net_debt of \u2212$498.6M is the 3/31/26 balance sheet (cash + ST investments $551.6M minus ~$53M debt incl. finance leases; aggregators disagree $30M vs $53M \u2014 I used the larger); it excludes ~$184M net June primary proceeds and ~one quarter of burn since, which roughly offset. (4) Exact filing days for the 10-K/10-Q were not pinned; forms, periods, and figures were verified via SEC-hosted documents and the company's releases. (5) The headline base rev_cagr_5y of 46.5% off the TTM base is an annualization artifact \u2014 SciTec (closed 2025-11-05) contributes only ~5 months to TTM; off the 2026 guide midpoint it equals ~23%/yr, which is the number to judge. (6) Backlog composition (funded vs. options) and SciTec standalone growth were not verifiable from public data. Price $20.70 is the 2026-07-23 Nasdaq close.", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q Q1 FY2026 (period ended 2026-03-31, filed May 2026, SEC accession 0001860160-26-000009) \u2014 revenue $80.9M; cash + short-term investments $551.6M; 160,067,383 shares outstanding on cover; total debt incl. finance leases ~$53M", "10-K FY2025 (period ended 2025-12-31, filed March 2026) \u2014 FY2025 revenue $159.855M (+163% y/y); Q4 2025 revenue $57.673M; net loss $298.3M; adjusted EBITDA \u2212$198.6M; free cash flow \u2212$237.8M", "Q1 FY2026 earnings release (May 2026) \u2014 backlog ~$1.3B flat q/q; 2026 revenue guidance $420\u2013450M reiterated; total liquidity $811.6M ($551.6M cash/ST investments + $260M revolver)", "424B4 prospectus, offering priced 2026-05-29 \u2014 4.0M primary + 8.0M secondary shares at $48.00; ~$184M net primary proceeds (post-3/31 balance sheet, not in net-debt figure above)", "8-K filed on/about 2025-11-05 \u2014 SciTec acquisition closed: $855M total, $300M cash + ~$555M in stock at $50/share; SciTec trailing revenue ~$164M (12 months to June 2025)", "Price $20.70 = Nasdaq close 2026-07-23 (stockanalysis.com); shares outstanding 164.24M post-offering; TTM revenue cross-check $184.88M = Q2'25 $15.5M (derived) + Q3'25 $30.8M + Q4'25 $57.7M + Q1'26 $80.9M" ], "net_debt": -498640000, "price": 20.7, "rev_ttm": 184880000, "shares_diluted": 170000000 }, "kill_conditions": [ "Total backlog reported below $1.0B for two consecutive quarters (versus ~$1.3B at Q1 FY2026) \u2014 demand thesis broken.", "2026 revenue guidance cut below $380M at any quarterly report, or FY2026 actual revenue below $380M (versus $420\u2013450M guided).", "Fewer than three Alpha launches completed in calendar 2026, or a Block 2 (Flight 8) mission failure \u2014 launch leg loses credibility.", "No Eclipse first-launch attempt disclosed by 2027-12-31 in filings or company updates \u2014 base case requires Eclipse revenue by 2028.", "Cash plus short-term investments below $250M in any 10-Q without a committed financing in place (operating cash burn ran ~$211M over the trailing twelve months).", "Spacecraft Solutions segment revenue declines year-over-year for two consecutive quarters \u2014 the SciTec/Golden Dome growth leg failing." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 7, "name": "loss", "p": 0.12 }, { "dilution_pa": 0.05, "exit_multiple": 1.8, "multiple_type": "ev_sales", "name": "bear", "p": 0.28, "rev_cagr_5y": 0.305 }, { "dilution_pa": 0.03, "exit_multiple": 3, "multiple_type": "ev_sales", "name": "base", "p": 0.4, "rev_cagr_5y": 0.465 }, { "dilution_pa": 0.04, "exit_multiple": 4, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.626 } ], "statement": "Firefly's ~$1.3B backlog converts into $420\u2013450M of 2026 revenue and compounds roughly 20\u201325%/yr through 2031 as Eclipse reaches launch cadence, Blue Ghost lunar deliveries become annual, and SciTec's missile-warning software rides Golden Dome funding. But at $20.70 (~6.6x EV / 2026 guided sales) that base case produces only a ~1%/yr 5-year IRR against a 3x mature-comp exit multiple \u2014 the base case is already in the price despite a 72% drawdown from the high. This is a watchlist thesis, not a buy: it becomes actionable near ~$10, or earlier if Eclipse cadence plus Golden Dome awards move the defensible base toward ~$2B of 2031 revenue.", "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "FLY", "version": 1 }, "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "FLY", "valuation": { "base_irr": 0.0078, "discount_rate": 0.1, "ev_to_price": 0.625, "expected_pv": 12.94, "gates": { "base_irr_gate": { "actual": 0.0078, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.625, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.1949, "multiple_type": "ev_sales", "name": "loss", "p": 0.12, "price_5y": 7.0, "pv_today": 7.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.05, "exit_multiple": 1.8, "irr_5y": -0.171, "multiple_type": "ev_sales", "name": "bear", "p": 0.28, "price_5y": 8.1, "pv_today": 5.03, "rev_cagr_5y": 0.305, "terminal_margin": 0.0 }, { "dilution_pa": 0.03, "exit_multiple": 3.0, "irr_5y": 0.0078, "multiple_type": "ev_sales", "name": "base", "p": 0.4, "price_5y": 21.52, "pv_today": 13.36, "rev_cagr_5y": 0.465, "terminal_margin": 0.0 }, { "dilution_pa": 0.04, "exit_multiple": 4.0, "irr_5y": 0.1577, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "price_5y": 43.05, "pv_today": 26.73, "rev_cagr_5y": 0.626, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 20.7, "growth_rows": [ 0.365, 0.415, 0.465, 0.515, 0.565 ], "multiple_cols": [ 1.5, 2.25, 3.0, 3.75, 4.5 ], "pv_grid": [ [ 5.71, 7.78, 9.85, 11.92, 13.99 ], [ 6.53, 9.01, 11.48, 13.96, 16.44 ], [ 7.47, 10.42, 13.36, 16.31, 19.26 ], [ 8.54, 12.03, 15.52, 19.0, 22.49 ], [ 9.77, 13.88, 17.98, 22.08, 26.18 ] ] } }, "version": 1 }, "0bc1235288706ad1d9ef43ad02ec40b27cb8c4449a45f4f866f140f4f0037793": { "actionable_below": 5.82, "company": "Intuitive Machines, Inc.", "kind": "watchlist_note", "markdown": "## Thesis\n\nIntuitive Machines has converted itself \u2014 mostly by acquisition \u2014 from a lunar-lander niche player into a $900M\u2013$1B/yr vertically integrated space prime, and we forecast it converts its $1.055B backlog into roughly $1.6B of revenue by 2031 at a ~2.0\u00d7 EV/Sales exit, which is worth about $11.70 per share in 2031 \u2014 below today's $13.71. The inflection is real but already more than priced: holders only beat the market if the bull case (full NSNS ramp plus major defense satellite awards driving ~$2.6B revenue) materializes. We therefore pre-register this as a watchlist thesis, falsified if backlog erodes below $900M for two quarters or FY2026 lands under $800M, and actionable as a buy only near $6 or on evidence that materially raises the base case.\n\n## Why Now\n\nThe headline inflection is genuine on its face: Q1 2026 revenue was a record $186.7M, nearly triple the $62.5M of Q1 2025, with the company's first positive quarterly adjusted EBITDA of $2.7M (vs. \u2212$6.6M a year earlier) and a record contracted backlog of $1.055B, up $842M from year-end 2025 (Q1 2026 earnings release, 8-K filed 2026-05-14; 10-Q for the period ended 2026-03-31, filed 2026-05-15). New awards of $428.9M in the quarter \u2014 including the IM-5 lunar mission and a government defense contract \u2014 put Q1 book-to-bill near 2.3\u00d7. Management reiterated full-year 2026 guidance of $900M\u2013$1B revenue with positive adjusted EBITDA, against $210.1M of revenue in all of 2025 (10-K FY2025, filed 2026-03-19).\n\nHonesty requires decomposing that triple. Per the Q1 2026 10-Q, Lanteris Space Systems \u2014 the former Maxar Space Systems satellite-manufacturing prime, acquired on January 13, 2026 for $851.0M in total consideration ($403.3M cash, $404.0M in 22,991,028 Class A shares, $43.7M in bonuses and adjustments) \u2014 contributed $141.6M of the $186.7M, driven by the SDA Tracking Layer program ($39.5M) and NASA's Gateway Power & Propulsion Element ($30.6M). Legacy Intuitive Machines organic revenue was therefore roughly $45.1M, *down* about 28% from $62.5M in Q1 2025 as IM-2 mission revenue rolled off; full-year 2025 revenue of $210.1M had likewise declined from $228M in 2024. Lanteris produced just $0.2M of operating income on its $141.6M of revenue \u2014 this is a scale acquisition, not a margin acquisition.\n\nWhy the setup still merits a pre-registered thesis now rather than later: the pieces assembled in the last ten months \u2014 the $345M 2.5% convertible notes (issued 2025-08-18, due 2030), a $175M strategic equity placement at $15.12 (11,574,069 shares, Q1 2026), the Lanteris close, and the KinetX deep-space navigation acquisition \u2014 give the company, for the first time, prime-contractor positions across cislunar transport (CLPS, IM-4/IM-5), cislunar infrastructure (Gateway PPE), lunar communications and navigation (Near Space Network Services, ceiling up to $4.82B over ten years), and defense satellites (SDA Tracking Layer). The next four quarters will show whether $900M\u2013$1B of guided revenue and positive adjusted EBITDA are a run-rate or a promise, and the stock \u2014 $13.71 on 2026-07-23, off a 52-week range of $7.78\u2013$46.75 \u2014 will reprice hard on that answer in either direction.\n\n## Business Quality\n\nThe moat, such as it is, rests on incumbency and integration rather than economics. Intuitive Machines is the only company with two CLPS lunar landings (IM-1 and IM-2, both of which tipped over at touchdown \u2014 a fact competitors' marketing does not let anyone forget), holds NASA's Near Space Network Services award with a ceiling up to $4.82B, and via Lanteris inherits the Gateway Power & Propulsion Element \u2014 the literal cislunar tug for NASA's lunar space station \u2014 plus decades of GEO satellite heritage and SDA constellation work. Post-Lanteris, the company can plausibly claim vertical integration from spacecraft manufacture through delivery, navigation (KinetX), and communications relay. That combination is genuinely hard to replicate and creates multi-year, sole-source-flavored revenue visibility.\n\nUnit economics are the weak flank. Q1 2026 gross margin was ~16% ($30.1M gross profit on $186.7M), adjusted EBITDA margin was 1.4%, GAAP net loss was $52.5M, and free cash flow was \u2212$64.6M in a single quarter against $231.6M of cash. Lanteris's 0.1% operating margin reflects the reality of fixed-price satellite manufacturing \u2014 the business Boeing and Airbus have struggled to make money in \u2014 and brings $52.0M of pension obligations and $217.5M of orbital receivables onto the balance sheet. Fixed-price lunar missions carry binary technical risk. Competition is intensifying precisely where margins might have improved: Firefly executed a fully upright Blue Ghost landing in 2025, Blue Origin's MK1 lander is flying, and Rocket Lab, York, and Lockheed contest the SDA constellation work Lanteris depends on.\n\nCapital allocation has been aggressive and dilutive: an $851M acquisition (2.5\u00d7 the legacy company's annual revenue) funded with converts struck at $13.1125 \u2014 essentially at the money today, with capped calls offsetting dilution only up to $20.98 \u2014 plus equity at $15.12. The share count across Class A and C stood at 217.0M at May 7, 2026, and the dual-class structure leaves founder-affiliated Class C holders (56.6M shares) with effective control. Management deserves credit for buying scale and backlog cheaply relative to peers' multiples, and for guiding to positive full-year adjusted EBITDA; whether they can integrate a satellite prime, fly two lunar missions, and hold FCF burn under control simultaneously is the open question the next four quarters will answer.\n\n## Financial Base\n\nReference figures as of 2026-07-23: trailing-twelve-month revenue of $334M, 217.0M diluted shares, net debt of $113M, and a share price of $13.71. Sources:\n\n- 10-Q Q1 FY2026 (period ended 2026-03-31), filed 2026-05-15 \u2014 revenue $186.7M (Lanteris $141.6M, operating income $0.2M); cash & equivalents $231.6M; long-term debt $335.8M net ($345.0M principal, 2.500% convertible senior notes due 2030-10-01, conversion price $13.1125, capped calls to $20.98); 160,452,309 Class A + 56,568,640 Class C shares outstanding as of 2026-05-07; backlog $1.055B; FCF \u2212$64.6M in Q1\n- 10-K FY2025, filed 2026-03-19 \u2014 FY2025 revenue $210.1M; Q4 2025 revenue $44.8M; FY2025 net loss $106.8M; adjusted EBITDA \u2212$64.2M; cash $582.6M and backlog $213.1M at 2025-12-31\n- Q1 2026 earnings release (8-K, 2026-05-14) \u2014 record revenue $186.7M vs $62.5M in Q1 2025; first positive adjusted EBITDA $2.7M; new awards $428.9M; FY2026 guidance $900M\u2013$1B revenue, positive adjusted EBITDA\n- Q2 2025 earnings release (8-K exhibit filed 2025-08-07) \u2014 Q2 2025 revenue $50.3M; Q3 2025 revenue of $52.5M derived as FY2025 $210.1M minus Q1 $62.5M, Q2 $50.3M, Q4 $44.8M\n- Lanteris acquisition (8-K 2026-01-13; purchase accounting in Q1 2026 10-Q) \u2014 total consideration $851.0M: $403.3M cash + $404.0M in 22,991,028 Class A shares + $43.7M bonuses/adjustments\n- Share price $13.71 at 2026-07-23 close, market cap $2.98B (stockanalysis.com; investing.com quotes $14.00 intraday 2026-07-23)\n\n## Scenario Valuation\n\nFive-year scenario ranges under the published methodology \u2014 the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:\n\n- **Loss** (10%): Lanteris integration fails (fixed-price satellite losses, pension drag, GEO decline), an IM-4/IM-5 landing failure stalls CLPS/NSNS momentum, and quarterly FCF burn near Q1's \u2212$64.6M forces heavily dilutive raises below the $13.11 convert strike ahead of the 2030 maturity.\n- **Bear** (25%): FY2026 guidance is roughly met but growth then stalls near $1.05B by 2031 as GEO satellite decline offsets NSNS ramp; a flat-revenue, low-single-digit-margin prime exits at 1.2\u00d7 EV/Sales, in line with legacy satellite manufacturers (Airbus/Thales space units ~1\u00d7). CAGR is stated off the depressed $334M TTM base, which embeds the Lanteris annualization step-up.\n- **Base** (45%): FY2026 lands near the $950M guidance midpoint, then ~11%/yr organic growth (NSNS task orders, 1\u20132 lunar missions/yr, modest Lanteris defense growth) reaches ~$1.6B by 2031; exit at 2.0\u00d7 EV/Sales sits between mature defense primes (LMT/NOC ~1.7\u20132.0\u00d7) and satellite manufacturers (~1\u00d7), with credit for the services mix. The 36.8% stated CAGR is mechanical off the $334M TTM base that contains only one partial Lanteris quarter.\n- **Bull** (20%): NSNS ramps hard toward its $4.82B ceiling, Lanteris wins meaningful SDA/Golden Dome constellation awards, lunar cadence holds through Artemis, and higher-margin recurring data-relay services prove out \u2014 ~$2.6B revenue by 2031 exiting at 3.0\u00d7 EV/Sales, a premium to defense primes justified only by a demonstrated recurring-services mix, and still far below today's high-growth space multiples.\n\n## Kill Conditions\n\n1. Contracted backlog falls below $900M for two consecutive quarters (vs $1.055B at 2026-03-31) \u2014 sustained book-to-bill below 1 disproves the growth-conversion premise; checkable in each quarterly earnings release/10-Q.\n2. FY2026 revenue comes in below $800M, or management cuts guidance below $800M (vs the $900M\u2013$1B range reiterated 2026-05-14) \u2014 an >11% miss versus the guidance floor.\n3. FY2026 adjusted EBITDA is negative (vs guided positive), or adjusted EBITDA is at or below \u2212$10M for two consecutive quarters \u2014 the margin leg of the inflection fails.\n4. Cash and equivalents drop below $120M in any 10-Q while quarterly free-cash-flow burn exceeds $40M \u2014 under ~3 quarters of runway, forcing dilution with the stock likely below the $13.11 convert strike.\n5. An IM-4 or IM-5 mission failure that triggers a contract termination or a loss provision exceeding $50M in the filings, or no new NSNS task-order awards disclosed for two consecutive quarters.\n\n## Risk Register\n\n- Integration risk \u2014 HIGH: Lanteris is ~2.5\u00d7 legacy LUNR's revenue with 0.1% operating margin, $52M of pension obligations, and $217.5M of orbital receivables; satellite manufacturing has broken larger primes.\n- Cash burn / financing risk \u2014 HIGH: \u2212$64.6M FCF in Q1 2026 against $231.6M cash; another year at that pace forces a raise, and the $345M converts mature October 2030.\n- Customer concentration \u2014 HIGH: NASA and U.S. government programs dominate revenue; proposed NASA science/Artemis budget restructuring could descope CLPS, Gateway PPE, or NSNS task orders.\n- Fixed-price mission risk \u2014 MEDIUM-HIGH: IM-1 and IM-2 both tipped at landing; a third landing anomaly on IM-4/IM-5 would damage CLPS standing and trigger loss provisions.\n- Dilution overhang \u2014 MEDIUM: converts at $13.1125 (at the money; capped calls protect only to $20.98), warrant liabilities of $69.8M, and heavy SBC on a 217M-share base.\n- Competition \u2014 MEDIUM: Firefly's fully successful Blue Ghost landing, Blue Origin MK1, and Rocket Lab/York/Lockheed in SDA constellations pressure both lunar and satellite segments.\n- Governance \u2014 MEDIUM: dual-class structure with 56.6M Class C shares gives founder-affiliated holders control; minority shareholders ride along on M&A decisions.\n\n## Theme Position\n\nEffectively 100% of revenue is space-economy exposure \u2014 there is no terrestrial segment. Within the theme, the cislunar-infrastructure sub-thesis specifically maps to roughly 40% of Q1 2026 revenue: legacy Intuitive Machines lunar programs (~$45.1M \u2014 CLPS, OMES III, NSNS) plus Lanteris's Gateway Power & Propulsion Element ($30.6M), per the Q1 2026 10-Q. The remaining ~60% is defense and commercial satellite manufacturing (SDA Tracking Layer $39.5M, GEO comsats), which is space-economy but not cislunar \u2014 a mix investors should not gloss over, since it dilutes the pure lunar-infrastructure story with a lower-margin, more contested market.\n\nAlternatives considered: **Rocket Lab (RKLB)** \u2014 the best executor in the theme, but it trades at an EV/Sales multiple many times any defensible mature exit, so it fails our valuation gates by an even wider margin than LUNR. **Firefly Aerospace (FLY)** \u2014 the cleanest lunar execution record (Blue Ghost landed fully upright in 2025), but a short public history, heavy single-program concentration, and a post-IPO valuation that offers no margin of safety. **Redwire (RDW)** \u2014 optically cheaper space-infrastructure exposure, but a serial acquirer with chronic dilution and weaker backlog quality; the discount is earned. LUNR was chosen as the theme vehicle because it pairs the largest contracted cislunar backlog ($1.055B, NSNS ceiling $4.82B) with a market cap small enough ($2.98B) that the bull case matters \u2014 but as the scenarios show, even that combination does not clear our gates at $13.71.\n\n## Benchmark\n\nBeating means LUNR's 5-year total return from publication (2026-07-24) must exceed QQQ's total return over the identical window \u2014 and our base case of roughly \u22123%/yr from $13.71 implies it does not. Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.\n", "params": { "adoption_metric": "Contracted backlog $1.055B as of 2026-03-31 (Q1 2026 earnings release 2026-05-14 and 10-Q filed 2026-05-15), up from $213.1M at 2025-12-31 (FY2025 10-K) \u2014 $842M of the increase from the Lanteris acquisition; Q1 2026 organic book-to-bill ~2.3\u00d7 ($428.9M new awards vs $186.7M revenue), with remaining performance obligations of $792.3M.", "company": "Intuitive Machines, Inc.", "confidence_notes": "THE PUBLICATION GATES FAIL AT TODAY'S PRICE, AND WE SAY SO PLAINLY: at $13.71 the base-case 5-year IRR is approximately \u22123.1%/yr (needs \u226515%) and the probability-weighted PV is ~$7.73, about 0.56\u00d7 the current price (needs \u22651.3\u00d7). We could not construct a defensible base case that passes \u2014 clearing both gates requires ~$2.9B of 2031 revenue at 2.5\u00d7 EV/Sales as the BASE case, which would mean underwriting ~25%/yr organic growth for a company whose acquired core is a near-zero-margin satellite manufacturer and whose backlog covers ~1.1 years of guided revenue. This therefore publishes as a WATCHLIST note: both gates clear at an entry near $5.80\u2013$5.95 (the 52-week low was $7.78), or on evidence that raises the base case \u2014 e.g., two consecutive quarters of \u2265$250M revenue with \u22655% adjusted EBITDA margin and backlog above $1.3B. Estimates and caveats: (1) Q3 2025 revenue of $52.5M is derived by subtraction (FY2025 $210.1M minus disclosed Q1/Q2/Q4), not separately verified against the Q3 10-Q; (2) TTM revenue of $334.3M materially understates the ~$900M+ run-rate because it includes only one partial Lanteris quarter \u2014 scenario CAGRs are stated off this depressed base and embed the annualization step-up, which is mechanical, not organic; (3) net debt uses the $345M convert principal rather than the $335.8M carrying value and excludes $69.8M of warrant liabilities and ~$90M of operating lease liabilities; (4) shares_diluted = 217.0M economic shares (Class A + Class C as of 2026-05-07) and excludes ~26.3M potential convert shares (capped calls offset dilution only between $13.11 and $20.98) and outstanding warrants/RSUs; (5) the $13.71 price is the 2026-07-23 close per stockanalysis.com (investing.com showed $14.00 intraday the same day); (6) exit multiples are judgment calls anchored to mature defense primes (~1.7\u20132.0\u00d7 EV/Sales) and satellite manufacturers (~1\u00d7), not to current space-sector multiples; (7) Q2 2026 results (due ~August 2026) will be the first clean full-Lanteris quarter and should be checked before any action.", "financials": { "as_of": "2026-07-23", "citations": [ "10-Q Q1 FY2026 (period ended 2026-03-31), filed 2026-05-15 \u2014 revenue $186.7M (Lanteris $141.6M, operating income $0.2M); cash & equivalents $231.6M; long-term debt $335.8M net ($345.0M principal, 2.500% convertible senior notes due 2030-10-01, conversion price $13.1125, capped calls to $20.98); 160,452,309 Class A + 56,568,640 Class C shares outstanding as of 2026-05-07; backlog $1.055B; FCF \u2212$64.6M in Q1", "10-K FY2025, filed 2026-03-19 \u2014 FY2025 revenue $210.1M; Q4 2025 revenue $44.8M; FY2025 net loss $106.8M; adjusted EBITDA \u2212$64.2M; cash $582.6M and backlog $213.1M at 2025-12-31", "Q1 2026 earnings release (8-K, 2026-05-14) \u2014 record revenue $186.7M vs $62.5M in Q1 2025; first positive adjusted EBITDA $2.7M; new awards $428.9M; FY2026 guidance $900M\u2013$1B revenue, positive adjusted EBITDA", "Q2 2025 earnings release (8-K exhibit filed 2025-08-07) \u2014 Q2 2025 revenue $50.3M; Q3 2025 revenue of $52.5M derived as FY2025 $210.1M minus Q1 $62.5M, Q2 $50.3M, Q4 $44.8M", "Lanteris acquisition (8-K 2026-01-13; purchase accounting in Q1 2026 10-Q) \u2014 total consideration $851.0M: $403.3M cash + $404.0M in 22,991,028 Class A shares + $43.7M bonuses/adjustments", "Share price $13.71 at 2026-07-23 close, market cap $2.98B (stockanalysis.com; investing.com quotes $14.00 intraday 2026-07-23)" ], "net_debt": 113376000, "price": 13.71, "rev_ttm": 334300000, "shares_diluted": 217020949 }, "kill_conditions": [ "Contracted backlog falls below $900M for two consecutive quarters (vs $1.055B at 2026-03-31) \u2014 sustained book-to-bill below 1 disproves the growth-conversion premise; checkable in each quarterly earnings release/10-Q.", "FY2026 revenue comes in below $800M, or management cuts guidance below $800M (vs the $900M\u2013$1B range reiterated 2026-05-14) \u2014 an >11% miss versus the guidance floor.", "FY2026 adjusted EBITDA is negative (vs guided positive), or adjusted EBITDA is at or below \u2212$10M for two consecutive quarters \u2014 the margin leg of the inflection fails.", "Cash and equivalents drop below $120M in any 10-Q while quarterly free-cash-flow burn exceeds $40M \u2014 under ~3 quarters of runway, forcing dilution with the stock likely below the $13.11 convert strike.", "An IM-4 or IM-5 mission failure that triggers a contract termination or a loss provision exceeding $50M in the filings, or no new NSNS task-order awards disclosed for two consecutive quarters." ], "position_disclosure": { "held": false, "note": "no position as of publication" }, "scenarios": [ { "fixed_price": 4, "name": "loss", "p": 0.1 }, { "dilution_pa": 0.06, "exit_multiple": 1.2, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "rev_cagr_5y": 0.257 }, { "dilution_pa": 0.04, "exit_multiple": 2, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "rev_cagr_5y": 0.368 }, { "dilution_pa": 0.05, "exit_multiple": 3, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "rev_cagr_5y": 0.507 } ], "statement": "Intuitive Machines has converted itself \u2014 mostly by acquisition \u2014 from a lunar-lander niche player into a $900M\u2013$1B/yr vertically integrated space prime, and we forecast it converts its $1.055B backlog into roughly $1.6B of revenue by 2031 at a ~2.0\u00d7 EV/Sales exit, which is worth about $11.70 per share in 2031 \u2014 below today's $13.71. The inflection is real but already more than priced: holders only beat the market if the bull case (full NSNS ramp plus major defense satellite awards driving ~$2.6B revenue) materializes. We therefore pre-register this as a watchlist thesis, falsified if backlog erodes below $900M for two quarters or FY2026 lands under $800M, and actionable as a buy only near $6 or on evidence that materially raises the base case.", "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "LUNR", "version": 1 }, "theme": "Space Economy", "theme_slug": "space-economy", "ticker": "LUNR", "valuation": { "base_irr": -0.0312, "discount_rate": 0.1, "ev_to_price": 0.564, "expected_pv": 7.73, "gates": { "base_irr_gate": { "actual": -0.0312, "passed": false, "required": 0.15 }, "ev_gate": { "actual": 0.564, "passed": false, "required": 1.3 } }, "horizon_years": 5, "scenarios": [ { "dilution_pa": 0.02, "exit_multiple": 0.0, "irr_5y": -0.2184, "multiple_type": "ev_sales", "name": "loss", "p": 0.1, "price_5y": 4.0, "pv_today": 4.0, "rev_cagr_5y": 0.0, "terminal_margin": 0.0 }, { "dilution_pa": 0.06, "exit_multiple": 1.2, "irr_5y": -0.2206, "multiple_type": "ev_sales", "name": "bear", "p": 0.25, "price_5y": 3.94, "pv_today": 2.45, "rev_cagr_5y": 0.257, "terminal_margin": 0.0 }, { "dilution_pa": 0.04, "exit_multiple": 2.0, "irr_5y": -0.0312, "multiple_type": "ev_sales", "name": "base", "p": 0.45, "price_5y": 11.7, "pv_today": 7.27, "rev_cagr_5y": 0.368, "terminal_margin": 0.0 }, { "dilution_pa": 0.05, "exit_multiple": 3.0, "irr_5y": 0.1513, "multiple_type": "ev_sales", "name": "bull", "p": 0.2, "price_5y": 27.73, "pv_today": 17.22, "rev_cagr_5y": 0.507, "terminal_margin": 0.0 } ], "sensitivity": { "current_price": 13.71, "growth_rows": [ 0.268, 0.318, 0.368, 0.418, 0.468 ], "multiple_cols": [ 1.0, 1.5, 2.0, 2.5, 3.0 ], "pv_grid": [ [ 2.31, 3.6, 4.89, 6.18, 7.46 ], [ 2.86, 4.42, 5.99, 7.55, 9.11 ], [ 3.5, 5.38, 7.27, 9.15, 11.03 ], [ 4.24, 6.49, 8.75, 11.0, 13.25 ], [ 5.09, 7.77, 10.45, 13.13, 15.81 ] ] } }, "version": 1 }, "d3fdb5daf992a7176dbcbe94cb5363a7acdd0c97400d132e2db300738b93f5c3": { "basket_return": null, "basket_vs_qqq": null, "closed_count": 0, "kind": "scoreboard_snapshot", "open_count": 0, "rows": [ { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "ALAB", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "BWXT", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "CCJ", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "CLS", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "CRDO", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "FLY", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "LEU", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "LUNR", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "MOD", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "PL", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "RKLB", "vs_qqq": null, "vs_spy": null }, { "entry_date": null, "entry_price": null, "last_date": null, "last_price": null, "return": null, "status": "WATCH", "ticker": "UEC", "vs_qqq": null, "vs_spy": null } ] }, "756723f8a842c64b21ad9c55189d028705da303fd83264eede747553ecd9116c": { "basket_return": null, "basket_vs_qqq": null, "closed_count": 0, "kind": "scoreboard_snapshot", "open_count": 0, "rows": [ { "entry_date": "2026-07-24", "entry_price": 291.58, "last_date": "2026-07-27", "last_price": 282.52, "return": -0.0311, "status": "WATCH", "ticker": "ALAB", "vs_qqq": -0.028, "vs_spy": -0.0313 }, { "entry_date": "2026-07-27", "entry_price": 176.53, "last_date": "2026-07-27", "last_price": 176.53, "return": 0.0, "status": "WATCH", "ticker": "BWXT", "vs_qqq": 0.0, "vs_spy": 0.0 }, { "entry_date": "2026-07-24", "entry_price": 87.86, "last_date": "2026-07-27", "last_price": 89.35, "return": 0.017, "status": "WATCH", "ticker": "CCJ", "vs_qqq": 0.02, "vs_spy": 0.0167 }, { "entry_date": "2026-07-24", "entry_price": 305.28, "last_date": "2026-07-27", "last_price": 318.24, "return": 0.0425, "status": "WATCH", "ticker": "CLS", "vs_qqq": 0.0455, "vs_spy": 0.0422 }, { "entry_date": "2026-07-24", "entry_price": 213.15, "last_date": "2026-07-27", "last_price": 208.14, "return": -0.0235, "status": "WATCH", "ticker": "CRDO", "vs_qqq": -0.0204, "vs_spy": -0.0237 }, { "entry_date": "2026-07-24", "entry_price": 19.69, "last_date": "2026-07-27", "last_price": 19.88, "return": 0.0096, "status": "WATCH", "ticker": "FLY", "vs_qqq": 0.0127, "vs_spy": 0.0094 }, { "entry_date": "2026-07-27", "entry_price": 175.98, "last_date": "2026-07-27", "last_price": 175.98, "return": 0.0, "status": "WATCH", "ticker": "LEU", "vs_qqq": 0.0, "vs_spy": 0.0 }, { "entry_date": "2026-07-24", "entry_price": 12.92, "last_date": "2026-07-27", "last_price": 13.31, "return": 0.0302, "status": "WATCH", "ticker": "LUNR", "vs_qqq": 0.0333, "vs_spy": 0.03 }, { "entry_date": "2026-07-27", "entry_price": 230.4, "last_date": "2026-07-27", "last_price": 230.4, "return": 0.0, "status": "WATCH", "ticker": "MOD", "vs_qqq": 0.0, "vs_spy": 0.0 }, { "entry_date": "2026-07-24", "entry_price": 20.47, "last_date": "2026-07-27", "last_price": 21.0, "return": 0.0259, "status": "WATCH", "ticker": "PL", "vs_qqq": 0.029, "vs_spy": 0.0257 }, { "entry_date": "2026-07-24", "entry_price": 63.91, "last_date": "2026-07-27", "last_price": 66.94, "return": 0.0474, "status": "WATCH", "ticker": "RKLB", "vs_qqq": 0.0505, "vs_spy": 0.0472 }, { "entry_date": "2026-07-24", "entry_price": 9.51, "last_date": "2026-07-27", "last_price": 9.91, "return": 0.0421, "status": "WATCH", "ticker": "UEC", "vs_qqq": 0.0451, "vs_spy": 0.0418 } ] }, "385f790c52c4f78072807d44698f72845c9e0ae3833476b96d92d8a7ba124dfd": { "kind": "method_change", "methodology_sha256": "08310b1f85cbc978223f7e494f93721dcabd0166fc74b26664e4d7e70d83cfb9", "summary": "Methodology v1.1: evidence-graded selection engine \u2014 quality gate (GP/A top-third + ROIC persistence), red-flag vetoes (issuance/asset-growth/accruals/cash-conversion), compounder vs moonshot classes with lottery-tax vetoes and basket rules, TAM discipline, momentum timing gate with crash guard, portfolio construction rules, forecast calibration and signal-decay policy. Every rule cites its evidence in /methodology.", "version": "1.1" }, "3e45184f8799dd05ee1345027bbf255536fb5accdf36ce42976ee7ad2bef9aef": { "basket_return": null, "basket_vs_qqq": null, "closed_count": 0, "kind": "scoreboard_snapshot", "open_count": 0, "rows": [ { "entry_date": "2026-07-24", "entry_price": 291.58, "last_date": "2026-07-28", "last_price": 260.23, "return": -0.1075, "status": "WATCH", "ticker": "ALAB", "vs_qqq": -0.0947, "vs_spy": -0.1101 }, { "entry_date": "2026-07-24", "entry_price": 174.52, "last_date": "2026-07-28", "last_price": 169.67, "return": -0.0278, "status": "WATCH", "ticker": "BWXT", "vs_qqq": -0.015, "vs_spy": -0.0304 }, { "entry_date": "2026-07-24", "entry_price": 87.86, "last_date": "2026-07-28", "last_price": 86.96, "return": -0.0102, "status": "WATCH", "ticker": "CCJ", "vs_qqq": 0.0025, "vs_spy": -0.0129 }, { "entry_date": "2026-07-24", "entry_price": 305.28, "last_date": "2026-07-28", "last_price": 350.2, "return": 0.1471, "status": "WATCH", "ticker": "CLS", "vs_qqq": 0.1599, "vs_spy": 0.1445 }, { "entry_date": "2026-07-24", "entry_price": 213.15, "last_date": "2026-07-28", "last_price": 192.28, "return": -0.0979, "status": "WATCH", "ticker": "CRDO", "vs_qqq": -0.0851, "vs_spy": -0.1005 }, { "entry_date": "2026-07-24", "entry_price": 19.69, "last_date": "2026-07-28", "last_price": 19.32, "return": -0.0188, "status": "WATCH", "ticker": "FLY", "vs_qqq": -0.006, "vs_spy": -0.0214 }, { "entry_date": "2026-07-24", "entry_price": 163.89, "last_date": "2026-07-28", "last_price": 169.65, "return": 0.0351, "status": "WATCH", "ticker": "LEU", "vs_qqq": 0.0479, "vs_spy": 0.0325 }, { "entry_date": "2026-07-24", "entry_price": 12.92, "last_date": "2026-07-28", "last_price": 12.37, "return": -0.0426, "status": "WATCH", "ticker": "LUNR", "vs_qqq": -0.0298, "vs_spy": -0.0452 }, { "entry_date": "2026-07-24", "entry_price": 241.79, "last_date": "2026-07-28", "last_price": 208.06, "return": -0.1395, "status": "WATCH", "ticker": "MOD", "vs_qqq": -0.1267, "vs_spy": -0.1421 }, { "entry_date": "2026-07-24", "entry_price": 20.47, "last_date": "2026-07-28", "last_price": 20.42, "return": -0.0024, "status": "WATCH", "ticker": "PL", "vs_qqq": 0.0103, "vs_spy": -0.0051 }, { "entry_date": "2026-07-24", "entry_price": 63.91, "last_date": "2026-07-28", "last_price": 63.89, "return": -0.0003, "status": "WATCH", "ticker": "RKLB", "vs_qqq": 0.0125, "vs_spy": -0.0029 }, { "entry_date": "2026-07-24", "entry_price": 9.51, "last_date": "2026-07-28", "last_price": 9.44, "return": -0.0074, "status": "WATCH", "ticker": "UEC", "vs_qqq": 0.0054, "vs_spy": -0.01 } ] }, "47901194067bbef57bf96895c1d4496d765e5045f5f5d3a8776b434adadc9cc5": { "basket_return": null, "basket_vs_qqq": null, "closed_count": 0, "kind": "scoreboard_snapshot", "open_count": 0, "rows": [ { "entry_date": "2026-07-24", "entry_price": 291.58, "last_date": "2026-07-29", "last_price": 249.74, "return": -0.1435, "status": "WATCH", "ticker": "ALAB", "vs_qqq": -0.1106, "vs_spy": -0.1307 }, { "entry_date": "2026-07-24", "entry_price": 174.52, "last_date": "2026-07-29", "last_price": 157.44, "return": -0.0979, "status": "WATCH", "ticker": "BWXT", "vs_qqq": -0.065, "vs_spy": -0.0851 }, { "entry_date": "2026-07-24", "entry_price": 87.86, "last_date": "2026-07-29", "last_price": 84.57, "return": -0.0374, "status": "WATCH", "ticker": "CCJ", "vs_qqq": -0.0046, "vs_spy": -0.0246 }, { "entry_date": "2026-07-24", "entry_price": 305.28, "last_date": "2026-07-29", "last_price": 328.43, "return": 0.0758, "status": "WATCH", "ticker": "CLS", "vs_qqq": 0.1087, "vs_spy": 0.0886 }, { "entry_date": "2026-07-24", "entry_price": 213.15, "last_date": "2026-07-29", "last_price": 177.45, "return": -0.1675, "status": "WATCH", "ticker": "CRDO", "vs_qqq": -0.1346, "vs_spy": -0.1547 }, { "entry_date": "2026-07-24", "entry_price": 19.69, "last_date": "2026-07-29", "last_price": 17.84, "return": -0.094, "status": "WATCH", "ticker": "FLY", "vs_qqq": -0.0611, "vs_spy": -0.0811 }, { "entry_date": "2026-07-24", "entry_price": 163.89, "last_date": "2026-07-29", "last_price": 159.69, "return": -0.0256, "status": "WATCH", "ticker": "LEU", "vs_qqq": 0.0073, "vs_spy": -0.0128 }, { "entry_date": "2026-07-24", "entry_price": 12.92, "last_date": "2026-07-29", "last_price": 11.39, "return": -0.1184, "status": "WATCH", "ticker": "LUNR", "vs_qqq": -0.0855, "vs_spy": -0.1056 }, { "entry_date": "2026-07-24", "entry_price": 241.79, "last_date": "2026-07-29", "last_price": 178.04, "return": -0.2637, "status": "WATCH", "ticker": "MOD", "vs_qqq": -0.2308, "vs_spy": -0.2508 }, { "entry_date": "2026-07-24", "entry_price": 20.47, "last_date": "2026-07-29", "last_price": 19.47, "return": -0.0489, "status": "WATCH", "ticker": "PL", "vs_qqq": -0.016, "vs_spy": -0.036 }, { "entry_date": "2026-07-24", "entry_price": 63.91, "last_date": "2026-07-29", "last_price": 58.6, "return": -0.0831, "status": "WATCH", "ticker": "RKLB", "vs_qqq": -0.0502, "vs_spy": -0.0703 }, { "entry_date": "2026-07-24", "entry_price": 9.51, "last_date": "2026-07-29", "last_price": 9.04, "return": -0.0494, "status": "WATCH", "ticker": "UEC", "vs_qqq": -0.0165, "vs_spy": -0.0366 } ] }, "f9fe79d5960ecfb597fc0ac17d8c7a9732ed89b1b41e96d5d329d9817ff5e0ed": { "basket_return": null, "basket_vs_qqq": null, "closed_count": 0, "kind": "scoreboard_snapshot", "open_count": 0, "rows": [ { "entry_date": "2026-07-24", "entry_price": 291.58, "last_date": "2026-07-30", "last_price": 299.69, "return": 0.0278, "status": "WATCH", "ticker": "ALAB", "vs_qqq": 0.0288, "vs_spy": 0.0241 }, { "entry_date": "2026-07-24", "entry_price": 174.52, "last_date": "2026-07-30", "last_price": 165.59, "return": -0.0512, "status": "WATCH", "ticker": "BWXT", "vs_qqq": -0.0502, "vs_spy": -0.0549 }, { "entry_date": "2026-07-24", "entry_price": 87.86, "last_date": "2026-07-30", "last_price": 88.23, "return": 0.0042, "status": "WATCH", "ticker": "CCJ", "vs_qqq": 0.0052, "vs_spy": 0.0005 }, { "entry_date": "2026-07-24", "entry_price": 305.28, "last_date": "2026-07-30", "last_price": 352.59, "return": 0.155, "status": "WATCH", "ticker": "CLS", "vs_qqq": 0.156, "vs_spy": 0.1512 }, { "entry_date": "2026-07-24", "entry_price": 213.15, "last_date": "2026-07-30", "last_price": 201.08, "return": -0.0566, "status": "WATCH", "ticker": "CRDO", "vs_qqq": -0.0556, "vs_spy": -0.0604 }, { "entry_date": "2026-07-24", "entry_price": 19.69, "last_date": "2026-07-30", "last_price": 20.29, "return": 0.0305, "status": "WATCH", "ticker": "FLY", "vs_qqq": 0.0315, "vs_spy": 0.0267 }, { "entry_date": "2026-07-24", "entry_price": 163.89, "last_date": "2026-07-30", "last_price": 176.75, "return": 0.0785, "status": "WATCH", "ticker": "LEU", "vs_qqq": 0.0795, "vs_spy": 0.0747 }, { "entry_date": "2026-07-24", "entry_price": 12.92, "last_date": "2026-07-30", "last_price": 12.25, "return": -0.0519, "status": "WATCH", "ticker": "LUNR", "vs_qqq": -0.0509, "vs_spy": -0.0556 }, { "entry_date": "2026-07-24", "entry_price": 241.79, "last_date": "2026-07-30", "last_price": 193.91, "return": -0.198, "status": "WATCH", "ticker": "MOD", "vs_qqq": -0.197, "vs_spy": -0.2018 }, { "entry_date": "2026-07-24", "entry_price": 20.47, "last_date": "2026-07-30", "last_price": 20.22, "return": -0.0122, "status": "WATCH", "ticker": "PL", "vs_qqq": -0.0112, "vs_spy": -0.0159 }, { "entry_date": "2026-07-24", "entry_price": 63.91, "last_date": "2026-07-30", "last_price": 64.68, "return": 0.012, "status": "WATCH", "ticker": "RKLB", "vs_qqq": 0.013, "vs_spy": 0.0083 }, { "entry_date": "2026-07-24", "entry_price": 9.51, "last_date": "2026-07-30", "last_price": 9.74, "return": 0.0242, "status": "WATCH", "ticker": "UEC", "vs_qqq": 0.0252, "vs_spy": 0.0204 } ] }, "f9a747e124919df0053c82cf7d344caddfd7dc96b4f40e4f1f71211440ba6fca": { "basket_return": null, "basket_vs_qqq": null, "closed_count": 0, "kind": "scoreboard_snapshot", "open_count": 0, "rows": [ { "entry_date": "2026-07-24", "entry_price": 291.58, "last_date": "2026-07-31", "last_price": 311.23, "return": 0.0674, "status": "WATCH", "ticker": "ALAB", "vs_qqq": 0.0619, "vs_spy": 0.0564 }, { "entry_date": "2026-07-24", "entry_price": 174.52, "last_date": "2026-07-31", "last_price": 168.7, "return": -0.0333, "status": "WATCH", "ticker": "BWXT", "vs_qqq": -0.0388, "vs_spy": -0.0443 }, { "entry_date": "2026-07-24", "entry_price": 87.86, "last_date": "2026-07-31", "last_price": 86.38, "return": -0.0168, "status": "WATCH", "ticker": "CCJ", "vs_qqq": -0.0223, "vs_spy": -0.0278 }, { "entry_date": "2026-07-24", "entry_price": 305.28, "last_date": "2026-07-31", "last_price": 331.44, "return": 0.0857, "status": "WATCH", "ticker": "CLS", "vs_qqq": 0.0802, "vs_spy": 0.0747 }, { "entry_date": "2026-07-24", "entry_price": 213.15, "last_date": "2026-07-31", "last_price": 206.99, "return": -0.0289, "status": "WATCH", "ticker": "CRDO", "vs_qqq": -0.0344, "vs_spy": -0.0399 }, { "entry_date": "2026-07-24", "entry_price": 19.69, "last_date": "2026-07-31", "last_price": 20.33, "return": 0.0325, "status": "WATCH", "ticker": "FLY", "vs_qqq": 0.027, "vs_spy": 0.0215 }, { "entry_date": "2026-07-24", "entry_price": 163.89, "last_date": "2026-07-31", "last_price": 176.93, "return": 0.0796, "status": "WATCH", "ticker": "LEU", "vs_qqq": 0.0741, "vs_spy": 0.0686 }, { "entry_date": "2026-07-24", "entry_price": 12.92, "last_date": "2026-07-31", "last_price": 12.34, "return": -0.0449, "status": "WATCH", "ticker": "LUNR", "vs_qqq": -0.0504, "vs_spy": -0.0559 }, { "entry_date": "2026-07-24", "entry_price": 241.79, "last_date": "2026-07-31", "last_price": 201.06, "return": -0.1685, "status": "WATCH", "ticker": "MOD", "vs_qqq": -0.1739, "vs_spy": -0.1794 }, { "entry_date": "2026-07-24", "entry_price": 20.47, "last_date": "2026-07-31", "last_price": 20.48, "return": 0.0005, "status": "WATCH", "ticker": "PL", "vs_qqq": -0.005, "vs_spy": -0.0105 }, { "entry_date": "2026-07-24", "entry_price": 63.91, "last_date": "2026-07-31", "last_price": 64.95, "return": 0.0163, "status": "WATCH", "ticker": "RKLB", "vs_qqq": 0.0108, "vs_spy": 0.0053 }, { "entry_date": "2026-07-24", "entry_price": 9.51, "last_date": "2026-07-31", "last_price": 9.6, "return": 0.0095, "status": "WATCH", "ticker": "UEC", "vs_qqq": 0.004, "vs_spy": -0.0015 } ] } }, "verify_spec": "chain_hash = sha256(prev|payload_sha256|type|ts_utc|seq); ed25519_verify(pub, sig, chain_hash); sha256(canonical_json(payload)) == payload_sha256; canonical_json = sorted keys, separators (',',':')", "generated_at": "2026-08-03T20:35:57+00:00" }